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ABSTRACT
Little is known about the survival mechanics of Mycobacterium tuberculosis 
within the human host. A number of genes are likely to be activated during infection, 
especially within macrophages, and these potential virulence determinants will be of 
great importance in the ultimate development of new vaccines and 
antimycobacterials.
In an effort to identify some of these virulence determinants, a M. tuberculosis 
H37Rv gene promoter-probe library in a BCG host was constructed using an E.coli - 
mycobacterial shuttle vector with lacZ as the reporter gene. 4800 individual clones 
were arrayed in a 96 well microtitre™ format, enabling the testing of individual 
clones for promoter activity under a variety of environmental stressing conditions. 
Two separate in vitro screenings of the arrayed clones identified 53 clones that 
exhibited up-regulation of lacZ when stressed. 50 of these clones were 
bi-directionally sequenced to determine the cloned M.tuberculosis H37Rv DNA 
sequence. Identification of the location of the cloned DNA within the MJuberculosis 
H37Rv genome identified 32 clones likely to containing potential promoter 
sequences. By measuring the levels of lacZ expression post-infection of macrophages, 
compared to in vitro expression, clones were identified which contained potential 
promoter sequences up-regulated within the macrophage.
Quantitative Reverse Transcriptase-PCR was employed, using cDNA obtained 
from MJuberculosis from infected and un-infected macrophages, to measure the 
levels of expression of 5 MJuberculosis H37Rv genes identified as potentially up- 
regulated during infection. The results suggest that two of the five genes, genes 
Rvl265 and Rv2711, are indeed up-regulated during infection. The protein coded for 
by the gene Rvl265 has an unknown function whilst the gene Rv2711 encodes the 
protein IdeR, which is an iron-dependent repressor.
Sequence and lacZ expression analysis identified four independently selected 
and screened clones which contained near identical sequences for the same promoter 
- that of the gene Rv0440 (groEL2). Gene Rv0440 codes for a 60KDa heat shock 
protein previously identified as up-regulated during infection. The identification of 
four independent clones containing the promoter for this gene validates this 
technology as a means of identifying MJuberculosis H37Rv genes up-regulated 
during infection.
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CHAPTER 1 
GENERAL INTRODUCTION
1
1.1 Introduction to Mycobacteria
Chapter I Introduction
The genus Mycobacterium contains bacteria that are non-sporing, non-motile 
and Gram positive, which exist as straight or curved rods as well as filamentous or 
branched forms. They have been classified in the actinomycete branch of Gram 
positive bacteria along with the genera Nocardia and Streptomyces since they have 
certain common features such as a primarily aerobic metabolism and DNA with a 
high GC content (55-70%). Due to an extremely high lipid content (approximately 
40% of the total cell dry weight), mycobacteria are impermeable to hydrophilic agents 
and grow as pellicles in liquid media and hydrophobic colonies on solid media. The 
high lipid content is also responsible for staining difficulties encountered with 
conventional stains such as the Gram stain. However, once stained, the cells 
withstand decolourisation with 95% (v/v) ethanol or with 3% (v/v) hydrochloric acid. 
This is the basis of the Ziehl-Neelsen stain, which utilises this unique property of 
acid-fastness in the identification o f mycobacteria.
_  _  _  _ . „  *1.2 Mycobacterial species
Mycobacterium is the only genus in the Mycobacteriacae family and contains 
over forty species, which can be divided into two main groups: the fast-growers and 
the slow-growers of which a selection o f species is shown in Table 1.1. The 
Mycobacterium genus are infamous for their slow growth with doubling times 
ranging from 3 to 24 hours meaning that the slow-growing species can take up to six 
weeks for colonies to form on solid media. The slow-growing mycobacteria include 
most of the pathogenic species with the fast-growers consisting mainly of 
environmental and saprophytic species. Mycobacterium leprae is an exception to
these two groups because, to this day, it has never been cultivated in vitro and can 
only be cultivated in infected animals, specifically the nine-banded armadillo and 
from the footpads of laboratory mice.
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Slow growing mycobacteria Fast glowing mycobacteria
Thv MJuberculosis complex: M.fortuitum
MJuberculosis M.smegmatis
M.bovis M.vaccae
M.africanum M.aurum
M.microti
The M. avium complex:
M.avium
M.paratuberculosis
M. lepraemurium
M. intracellulare
M. leprae
Table 1.1: Brief list of mycobacterial species.
On the whole mycobacteria are soil and water dwelling bacteria. However, 
certain species have adapted to life within a host resulting in infection, the best known 
being Mycobacterium tuberculosis and Mycobacterium leprae, which are the 
aetiological agents of tuberculosis (TB) and leprosy, respectively. This level of 
adaptation ranges from rare opportunistic pathogens to obligate parasites. Members of 
the M.tuberculosis complex can also cause TB in animals as well as humans, for 
example M.bovis is responsible for the bovine form of the disease and M.microti is 
known to cause TB specifically in rodents. Many pathogenic species are included in 
the M.avium complex with the most clinically important being M.avium itself. 
M.avium is an opportunistic pathogen that has been shown to cause TB in 
immunocompromised individuals, particularly those with Acquired Immune 
Deficiency Syndrome (AIDS) (Collins, 1993), but is essentially the aetiological agent 
for TB in birds. A number of the fast growing mycobacterium species, such as
3
M.fortuitum and M.smegmatis, have been shown to be rare opportunistic pathogens 
that are occasionally associated with soft tissue and joint infections in humans 
(Newton et al., 1993). M.fortuitum and M.smegmatis are more frequently used as 
model species within the laboratory to study mycobacterial biology and genetics.
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1.3 Tuberculosis
Approximately 8 million new cases and 3 million deaths caused by tuberculosis 
infections are reported annually to the World Health Organisation (WHO) meaning 
that tuberculosis remains one of the most important infectious bacterial diseases in the 
world. As much as one third of the worlds population may be infected with 
M.tuberculosis, predominantly in the third world. This means that 30 million people 
could die from TB in the next 10 years and someone is infected with TB every 
second.
Due to scientific advancement, chemotherapy, vaccination and improved living 
standards, the incidence of pulmonary TB in the western world has been declining 
steadily over the last 150 years. In England and Wales there were 117139 tuberculosis 
notifications in 1913, whilst in 1987 the number of notifications had dropped to 5085 
(www.phls.co.uk/facts/TB/). However in recent years, tuberculosis in the western 
world has increased slightly, particularly among the homeless population, largely as a 
result of the AIDS epidemic, which renders those immunocompromised individuals 
highly susceptible to TB (Collins, 1993). Figure 1.1 uses data obtained from the 
Public Health Service Laboratories (PHLS) website (www.phls.co.uk/facts/TB/) to
4
indicate the increase in total tuberculosis notifications in England and Wales in recent 
years.
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Date (Yea rs)
Figure 1.1: Graph indicating the number o f  total tuberculosis notifications in England and Wales over 
recent years. Data obtained from the Public Health Service Laboratories (PHLS) website 
(www.phls.co.uk/facts/TB/)
M.tuberculosis is spread by aerosols, normally generated by coughing. Once 
inhaled by the host, alveolar macrophages phagocytose the bacteria. M.tuberculosis is 
able to replicate intracellularly and then from the macrophages spread throughout the 
body via the lymphatic system. Most individuals do not develop the disease during 
this initial stage of infection; only 5% of individuals proceed to develop the 
symptoms of primary tuberculosis. In the latter cases, the lesions may progress to 
form cavities within the lung as a result of tissue damage. However, the spread of the
5
disease within the body can produce lesions in any of the organs resulting in, for 
example, tuberculous meningitis or genitourinary tuberculosis, which are not 
particularly common. Multiple lesions throughout the body are caused by 
disseminated tuberculosis, which arises because of the inadequacy of the host 
defences in containing the infection. Therefore, in addition to immuno-compromised 
AIDS sufferers, tuberculosis predominately affects children in the third world 
presumable due to their immunological immaturity.
Post-primary pulmonary tuberculosis is generally regarded as the most 
frequent form of the disease. Disease symptoms develop several years following the 
initial infection usually as a result of temporary immunosuppression due to old age or 
illness. Bacteria that were previously dormant begin to replicate within the 
granuloma, which results in the discharge of live, virulent bacteria in the bronchial 
tree. Coughing expels these bacteria and therefore completes the infection cycle 
(Hopewell, 1994).
1.4 Prevention of Tuberculosis
Bacille Calmette-Guerin (BCG) is a live attenuated strain of M.bovis and is 
used for vaccination as the current preventative measure against tuberculosis infection 
in the United Kingdom. North America and the Netherlands, in particular, do not use 
the BCG vaccine on a national scale (Fine, 1989) but rather rely on skin testing to 
identify infected individuals, who are then given prophylactic treatment. BCG is 
administered to populations world-wide with varying levels of efficacy and acquired 
protective immunity. Although the average efficacy of BCG as a vaccine is stated to
Chapter I Introduction
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be 50% (Fine, 1998), this figure varies dramatically according to geographic location. 
For example, a 70-80% efficacy for the vaccine has been reported in the United 
Kingdom (Hart and Sutherland, 1977) whereas in South India the efficacy is only 
0-30% (Tuberculosis Prevention Trial, 1980). The variation in vaccine efficacy has 
been blamed on a number of factors, including socioeconomic conditions, genetic 
composition of the population, climate, diet and nutrition and the presence of 
nontuberculosis mycobacteria (such as the Mycobacterium avium complex) in the 
environment. However the true reason for the variation remains unclear.
A further problem caused by the use of the current vaccine is that it can, 
indeed generally does, cause the tuberculin skin test to become reactive, which 
reduces the usefulness of this particular diagnostic test for MJuberculosis infections 
(Fine, 1989). The tuberculin skin test is routinely used in the identification of those 
potentially infected with MJuberculosis and a delayed-type hypersensitive (DTH) 
reaction post-BCG-vaccination reduces the efficacy of this use of the tuberculin skin 
test. This is presumably why some countries prefer not to use BCG as a vaccine for 
TB.
The search for a new and improved vaccine against tuberculosis has employed 
the use of a number of different strategies. Subunit vaccination based on major 
secretory proteins from M.tuberculosis has provided protective immunity in animal 
models (Horwitz et a l,  1995). Strong humoral and cellular immune responses to a 
variety of M.tuberculosis antigens have been demonstrated in murine models (Stover 
et a l , 1991; Bosio and Orme, 1998). The use of DNA as a vaccination method by 
plasmid vectors to deliver genes coding for antigens is also being investigated
Chapter 1 Introduction
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(Lowrie et al., 1997; Velaz-Faircloth et al., 1999). Lowrie et al. reported that DNA 
vaccines carrying only the Hsp65 antigen are as effective at conferring protection as 
the BCG vaccine.
1.5 Treatment for Tuberculosis
Due to the relatively low efficacy of BCG as a vaccine, the diagnosis and quick 
and effective treatment of M.tuberculosis infection is of paramount importance. The 
primary chemotherapeutic agents for the treatment of tuberculosis are the antibiotics 
rifampicin and isoniazid. These antibiotics are favoured for their high efficiency and 
low toxicity and are used in conjunction with secondary drugs, such as ethambutol, 
pyrazinamide, p-aminosalicylic acid and streptomycin, which are given in 
combination to prevent the emergence of antibiotic resistant bacilli. This treatment is 
effective in rendering patients non-infectious, however, treatment must be continued 
for extended periods to prevent relapse. The standard drug regime requires 12 months 
of treatment whereas the current preferred regime of treatment is DOTS (Directly 
Observed Treatment Short course) which lasts for 6-8 months. DOTS is a World 
Health Organisation (WHO) initiative and has been proven to be successful in 
countries such as Bangladesh, Vietnam, Peru and the countries of West Africa. There 
are five elements to the DOTS strategy stated below and obtained from the WHO web 
s ite (http ://www.who. int/gpv-dvacc/diseases/TB .htm):
Chapter I Introduction
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1) Case detection by sputum smear microscopy among symptomatic patients self- 
reporting to health services.
2) Standardised treatment regimen of 6-8 months for at least all smear positive cases, 
with directly observed treatment (DOT) for at least the initial 2 months.
3) A regular, uninterrupted supply o f all essential anti-TB drugs.
4) A  standardised recording and reporting system that allows assessment of 
treatment results for each patient and of the TB control programme overall.
5) Government commitment to sustained TB control activities.
The lengthy treatment requirements immediately impose difficult logistic, medical 
and financial burdens for disease control, particularly for those Third World countries 
where tuberculosis is endemic and where there is poor compliance to treatment. 
However, DOTS, is proving successful when it is implemented.
One of the alarming consequences of the lack of compliance is the emergence of 
multidrug-resistant strains of M.tuberculosis (MDR-TB), which are associated with 
high mortality. Multidrug resistance of M.tuberculosis has been defined as resistance 
to rifampicin and isoniazid (Bradford et al., 1998), but other strains have been shown 
to be resistant to streptomycin (Edlin et al., 1992). The highest rates of acquired 
MDR-TB have been reported in Nepal (48.0%), Gujarat, India (33.8%) and, 
surprisingly, New York City (30.1%), with the figures indicating the percentage of 
total isolates tested which were found to be multidrug resistant (Cohn et al., 1997). 
MDR-TB outbreaks are associated with very high death rates and more than 80% of 
cases occur in patients co-infected with HIV (Dooley et al., 1992), however the high 
mortality rates may be due to the high predominance of HIV. Delayed recognition of
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drug resistance, which results in delayed initiation of effective treatment, is one of the 
major factors contributing to MDR-TB outbreaks.
With the increased incidence of tuberculosis and of multidrug resistant 
tuberculosis in particular, the identification of methods employed by M.tuberculosis 
to survive the host defence mechanism is essential in the development of both a new, 
more effective vaccine and new drug treatments. Therefore the identification of 
M.tuberculosis virulence factors and factors responsible for dormancy in 
M.tuberculosis (thought to be the cause of post-primary pulmonary tuberculosis) need 
to be identified. In addition, identification of specific factors involved in the host 
response to M.tuberculosis would also be of value for the development of an 
immuo-potentiating therapy.
1.6 Entry and Survival of M .tuberculosis within the Macrophage.
Mycobacterium tuberculosis requires entry into the host macrophage in order to 
initiate infection. However, there is much debate and confusion as to exactly how 
mycobacteria enter the host cell and the conditions that the bacteria are exposed to 
once they have gained entry. It is believed that there are a number of different 
receptors that the bacterium binds to in order to gain entry. M.tuberculosis can 
become sufficiently coated with serum-derived ligands, to allow binding to various 
types of complement receptors (CR1, CR3 and CR4) and is subsequently 
phagocytosed and enclosed in membrane-bound endosomes. Mycobacteria also 
display numerous and diverse ligands on their surface, such as capsular 
polysaccharides, which are likely to engage a number of different receptor types. In
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vivo, M.tuberculosis is unlikely to be internalised by macrophages via a single 
receptor-mediated pathway. However, it appears that the extent of survival or the rate 
of intracellular growth is unaltered by the type of receptor used to gain entry (Ernst,
1998).
Material passing through the endosomal network to the lysosome of higher 
eukaryotes usually experiences a drop in pH. However, whether pathogenic 
mycobacteria species remain within phagosomes after uptake is unclear. The majority 
of evidence suggests that the mycobacteria reside almost exclusively intravacuolar 
(Clemens and Horwitz, 1995). However, it has also been noted that once internalised, 
phagosomes, containing mycobacteria, fuse with lysosomes, in fact within 2 hours of 
phagocytosis 85% of the bacteria reside in fused phagolysosomes (McDonough et al., 
1993). Unlike other bacteria such as Brucella suis which requires a low pH for 
survival in murine macrophages, the fused phagolysosome containing M.tuberculosis 
equilibrates to pH 6.3-6.5, due to the exclusion of the vesicular proton-adenosine 
triphosphatase (ATPase), from the phagosome membrane, which is responsible for 
phagosome acidification (Porte et a l,  1999; Sturgill-Koszycki et a l,  1994).
The above suggests that the mycobacterium-containing vacuole behave 
differently to vacuoles containing other bacteria and that vacuoles containing 
mycobacteria fail to mature into phagosomes containing a low pH. However 
Sturgill-Koszycki et a l (1996) also noted that vacuoles containing mycobacteria are 
positive for lysosome associated membrane protein (LAMP-1). LAMP-1 is a sialic 
acid-rich membrane protein that is usually associated with late endosomes and 
lysosomes of mammalian cells. It has subsequently been demonstrated that vacuoles
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containing mycobacteria do interact with early endosomes by demonstrating the 
presence of transferrin (used to internalise iron in mammalian cells) on 
M.avium-infected murine macrophages (Sturgill-Koszycki et a l , 1996).
A further discrepancy in vacuole maturation exists. Macrophages possess an 
innate resistance to bacterial infection that is associated with a single gene encoding 
Nramp (natural resistance-associated macrophage protein). Arias et a l  (1997) used 
congenic resistant and sensitive murine macrophages (which express or do not 
express Nramp) and showed that the sensitive macrophages (not expressing Nramp) 
exhibited a reduced ability to stop the growth o i M.tuberculosis. It has been suggested 
that Nramp plays a role in ion transport and therefore plays a role in decreasing 
superoxide dismutase activity (Supek et a l,  1997). An Nramp rat homologue 
(DCT-1) has been shown to be an unusually broad-range ion transporter, which is 
proton-coupled and requires a membrane potential (Gunshin et a l,  1997). The Nramp 
protein has also been shown to be present in endosomal and phagosomal membranes 
(Gmenheid et a l,  1997).
Whether the vacuoles containing mycobacteria are acidified is therefore 
unclear. Data suggests that the vacuoles do not contain the vesicular proton-adenosine 
triphosphatase (ATPase), and therefore acidic conditions are believed not to exist 
within the vacuole, but do contain the Nramp protein which requires a membrane 
potential in order to function as an ion transporter.
However, the main method employed by the macrophage to kill internalised 
mycobacteria is believed to be through the use of free radicals such as reactive
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oxygen intermediates (ROI) and reactive nitrogen intermediates (RNI). Adams et a l 
(1997) studied the role of ROI and RNI in the host response to MJuberculosis with 
the use of two strains of knockout (KO) mice. One strain of KO mouse was unable to 
produce ROI whilst the second strain lacked an inducible nitric oxide synthase 
(iNOS) and therefore failed to make RNI. The survival of MJuberculosis in both KO 
mice was increased compared to control mice. In addition, mice infected with a 
virulent Erdmann strain of Mycobacterium tuberculosis and given inhibitors of nitric 
oxide synthase showed an increase in morbity, bacterial burden and pathological 
tissue damage (Chan et a l , 1995). In a separate study, congenic resistant and 
susceptible murine macrophages were infected with MJuberculosis in vitro. The 
resistant macrophages inhibited the incorporation of radioisotopes by the internalised 
mycobacteria and were also observed to be producing higher amounts of nitric oxide 
compared to the susceptible macrophages (Alias et a l , 1997).
If ROI and RNI are utilised by the macrophage to kill MJuberculosis, the 
generation of these compounds would be a rapid response by the macrophage so that 
the infection can be eliminated as quickly as possible. Nitric oxide can be induced in 
mice with either live or heat-killed M.bovis BCG -  with nitrite levels reaching a 
maximum after 7 days (Saito and Nakano, 1996). With MJuberculosis grown in 
monocytes cultures in vitro, soluble nitrite in the medium can be detected as early as 
72 hours post-infection and levels increase progressively up to day 10. The induction 
of nitrite correlates with an increase in inducible nitric oxide synthase (iNOS) mRNA 
(Jagannath et a l , 1998).
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This clearly indicates that there is much confusion and lack of real 
understanding regarding the conditions internal to mycobacteria-containing vacuoles 
and shows that there is still a considerable need to research this particular area of 
mycobacterial infection.
1.7 Mycobacterial Virulence Factors
There is a considerable volume of literature including a number of reviews 
detailing the different techniques that can be used in the identification of virulence 
factors in bacteria, and mycobacteria in particular (Clark-Curtiss, 1998; Gordon and 
Andrew, 1996; Quinn et al., 1997; Shinnick et al., 1995; Marston and Shinnick, 1996; 
Pelicic et a l, 1998; Mahan et a l,  1993). However only a few mycobacterial genes 
associated with virulence have actually been identified. Until recently, only two genes 
associated with virulence determinants had been identified. Collins et a l (1995) first 
noted that the sigma factor gene rpoV (subsequently annotated as Rv2703/ sig A (Cole 
et a l,  1998)) of the M.tuberculosis complex was associated with virulence. Since it is 
believed to be the principal sigma factor and is therefore involved in the expression of 
both house keeping genes as well as potential important virulence factors, it is 
perhaps not entirely surprising that a mutation in rpoV causes a loss of virulence. 
Another gene associated with virulence is katG, since isoniazid resistant strains of 
M.tuberculosis have a reduced virulence in Guinea pigs (Zhang and Young, 1993). 
Over the last couple of years and with the aid of new investigative techniques, the 
flow of reported virulence factors has greatly increased. Biosynthetic enzymes 
involved in the assembly of virulence-conferring siderophores (Quadri et a l, 1998), 
the macrophage-induced gene (mig) of M.avium (Meyer et a l,  1998), the
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M.tuberculosis erp gene which encodes an exported protein (Berthet et al., 1998) 
have all been associated with virulence in mycobacteria, to name but a few.
1.8 Molecular Tools for Mycobacterial Investigation.
The development of a number of effective genetic tools has considerably 
expanded the knowledge of mycobacteria by allowing the characterisation of genes 
and proteins. These molecular genetic tools are proving invaluable, particularly for 
the study of M.tuberculosis, by allowing the identification of potential drug targets, 
characterisation of virulence determinants and ultimately the construction of 
attenuated strains.
1.8.1 Gene Cloning in Mycobacteria
The use of mycobacterial plasmids and mycobacterial-E. coli shuttle vectors in 
mycobacterial research is a relatively new development but their use is now 
widespread and is required for a number of techniques that are currently being used to 
identify potential virulence factors.
Mycobacterial plasmids were first reported in the M.avium-intracellulare 
complex (Crawford and Bates, 1979) and these vectors are now routinely used for 
gene cloning in mycobacteria. The most frequently used replicon is from the 
M.fortuitum plasmid pAL5000 (Labidi et a l ,  1984). A number of selectable antibiotic 
markers have been inserted into this vector to confer resistance to antibiotics such as
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streptomycin, hygromycin and kanamycin and allow subsequent selection after 
transformation.
The replicon in pAL5000 (4837bp) is the basis for shuttle vectors in genetic 
manipulation in both slow and fast growing mycobacteria. The sequence of pAL5000 
was first reported by Rauzier et al. (1988). However, the minimum region from 
pAL5000 required for replication has now been identified as being approximately 
1.6Kb, which includes two open reading frames present in tandem and designated 
repA and repB (Stolt and Stoker, 1996b; Stolt and Stoker, 1996a). These open reading 
frames are thought to be transcribed as an operon and overlap by lbp. Located within 
a region with a high incidence of repeated sequences and directly up-stream of repA 
is a 435bp segment that contains the origin of replication (ori) (Stolt and Stoker, 
1996a). Both RepA and RepB proteins are required for plasmid replication, with 
RepB binding to a high affinity site within its own promoter region and to a low 
affinity site within the ori region (Stolt and Stoker, 1996b). Therefore the RepB 
protein auto-regulates its own expression and also plays a role in the initiation of 
plasmid replication. Although essential for plasmid replication, the role of the RepA 
protein is unclear.
Plasmid DNA is effectively introduced into electrocompetent M.smegmatis 
mc2155 by electroporation yielding 104 -  105 transformants fig'1 of plasmid DNA 
(Snapper et a l, 1990). Electroporation of slow growing mycobacteria, such as 
M.bovis BCG, is currently carried out at elevated temperatures, compared to 
electroporation of M.smegmatis, and can generate as many as 106 transformants jig'1 
of plasmid DNA (Wards and Collins, 1996).
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Mycobacteriophages are viruses of mycobacteria and over 250 
mycobacteriophages are currently known. The best characterised is the temperate 
mycobacteriophage L5. The entire L5 genome has been sequenced (Hatfull and 
Sarkis, 1993) and the genes involved in integration and lysogeny have been 
identified, including the integrase (int) and attachment (attP) genes and the 
chromosomal attachment site attB. Mycobacteriophages can be used to deliver DNA 
to mycobacteria, generate mutant libraries or study the survival characteristics of 
mycobacteria in the presence of antibiotics. Plasmids can be introduced and stably 
maintained by site-specific integration into the genomes of M.smegmatis, 
M.tuberculosis and BCG by mycobacteriophages and such a system can be used for 
the construction of recombinant BCG vaccines (DasGupta et a l , 1998; Lee et a l , 
1991).
Phasmids are chimeric molecules capable of replicating as plasmids in E.coli 
and as phages in mycobacteria (Jacobs Jr et a l,  1987), which are capable of 
delivering genetic elements such as reporter genes or transposons to the bacteria. 
Using luciferase reporter phages, Jacobs et al. (1993) showed that M.tuberculosis 
infected with this phage resulted in substantial light production which was sensitive to 
the presence of antibiotics and could therefore be used in the testing of novel drugs.
1 .8 .2  M y c o b a c t e r io p h a g e s
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Undoubtedly the greatest advancement in mycobacterial research in recent 
years has been the sequencing of the complete M.tuberculosis genome which is 
4,411,529bp long and contains around 4000 genes (Cole et al., 1998), The genome 
sequence can be accessed from the World Wide Web at 
www.sanger.ac.uk/projects/M_tuberculosis/. These databases can be used to search 
for homologies of M.tuberculosis genes with genes from other organisms, which can 
enable the identification of the potential function of M.tuberculosis proteins. A  
physical and genetic map of the genome displaying the currently known genes and 
coding sequences can also be found at the Sanger centre web site. A  number of novel 
techniques are currently being used to exploit the genome sequence data.
High density DNA arrays that contain probes for all potentially expressed 
MJuberculosis genes can be used for the identification of genes that are differentially 
expressed under varying environmental conditions which the organism is likely to 
encounter during infection. Simply, the entire complement of genes, contained within 
a genome of an organism, can be arrayed in an ordered fashion on slides, membranes 
or ‘chips’ and mRNA obtained from the organism can be used for the generation of 
cDNA probes to be hybridized to the array. Since the cDNA can be labelled with a 
fluorescence marker, it can be detected via dual-laser scanning confocal microscopy. 
If the mRNA is obtained from the organism grown in different conditions (such as in 
vitro and intra-macrophage in the case of MJuberculosis), a comparison between the 
levels of fluorescence of each individual gene can be compared. It would be expected 
that certain genes would remain constitutively expressed while the expression of
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others would be altered by the different growth conditions. This has recently been 
used to show that HIV alters the expression of human host cells during infection 
(Geiss et ah, 2000).
High density arrays have also been used to identify the genetic composition 
and gross genome differences between M.tuberculosis, M.bovis and various M.bovis 
BCG daughter strains (Behr et a l ,  1999). Microarray technology is now used to 
investigate the in vivo! in vitro expression differences with organisms for which we 
have the entire genome sequence. Recently, however, microarray technology has been 
applied to the parasite Plasmodium falciparum, the causative agent of malaria, for 
which the entire genome sequence is not available (Hayward et al., 2000). A  
randomly generated nuclease genomic library was arrayed and through differential 
hybridization and sequencing, large differences in gene expression were identified 
between the blood stage form and the sexual stage form of the parasite.
Analysis of the total protein content or ‘proteome’ analysis can also be used to 
study the characterisation of proteins expressed under differing conditions by 
two-dimensional gel electrophoresis as with the high-density DNA arrays. 
Two-dimensional gel electrophoresis is used to separate all of the proteins expressed 
by an organism. Differentially expressed proteins, obtained from the organism grown 
in different conditions, can be remove from the gel and sequenced using in-gel trypsin 
digests and time-of-flight mass spectometry. The protein sequences obtained can be 
used to identify the genes that encode them. Two-dimensional gel electrophoresis has 
been used to identify proteins differentially expressed by M.tuberculosis (Garbe et a l, 
1996), although at the time the M.tuberculosis H37Rv genome sequence was not
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available and therefore the reverse identification of the coding genes could not be 
carried out. Proteomics has also been used to identify genes differentially expressed 
under conditions of high and low concentrations of iron in M.tuberculosis (Wong et 
a l, 1999) and to characterise a sulfate starvation-induced response in Pseudomonas 
aeruginosa PAOl (Quadroni et a l,  1999).
It is clear that the sequence data will remain invaluable in conjunction with 
new technologies, such as high density microarrays and proteomics, to further the 
current understanding of M.tuberculosis. However these techniques are high 
technology and are therefore very expensive to set-up and run for the majority of 
laboratories.
1.8.4 Mutagenesis in Mycobacteria
Mutagenesis involves the disruption of genes and the phenotype of the 
generated mutant is then compared to that of the parental wild-type strain. 
Mutagenesis has become an important means of characterisation of mycobacterial 
genes and in particular the identification of virulence determinants.
Allelic exchange exploits the homologous recombination mechanism of the 
host. Homologous recombination occurs between donor and target DNA molecules 
that have a certain level of sequence identity. Norman et a l  (1995) first demonstrated 
allelic exchange in the M.tuberculosis complex by replacing the accBC target gene, 
encoding a subunit of biotin carboxylase, with the aph gene on the M.bovis BCG 
chromosome. This was carried out using a replicating shuttle vector harbouring a
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counter selectable marker katG (conferred isoniazid resistance) and a copy of the 
target gene, which had been inactivated by an aph gene insertion. Homologous 
recombination-mediated, double cross-over events were selected for by loss of the 
vector generating the replacement of the accBC target gene and therefore kanamycin 
resistant clones. A  further example o f allelic exchange mutagenesis is that of an ideR 
mutant of M.smegmatis that exhibited an altered oxidative stress response compared 
to the wild-type strain (Dussurget et al., 1996).
An alternative technique used in the generation of mutants for subsequent 
characterisation of genes is that of transposon mutagenesis. This method uses mobile 
elements, called transposons, that upon transposition randomly disrupt chromosomal 
genes. Mobile genetic elements have been identified in both prokaryotes and 
eukaryotes and are discrete DNA sequences that can move from one location on a 
DNA molecule to another location on the same or on a different molecule. This is an 
illegitimate recombination event, since no sequence homology is required between 
the transposon and the site of insertion, and is not dependent on the host cell’s 
homologous recombination system. Mycobacteria have a number of different families 
of transposons, called insertion (IS) elements, which in addition to transposon 
mutagenesis are used for strain-specific probes for RFLP analysis and 
epidemiological studies.
The advantage of the transposon mutagenesis technique is that no previous 
assumptions are made regarding the identity of the gene responsible for a particular 
phenotype, thus a library of random mutants can be generated and analysed. 
Transposon mutants have been generated in M.smegmatis using a conditionally
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replicating plasmid to deliver the M.fortuitum insertion sequence IS6100 (Guilhot et 
al., 1994), M.bovis BCG using a non-replicating plasmid to deliver the M.smegmatis 
insertion sequence IS 1096 (Mcadam et al., 1995) and in M.tuberculosis using a 
conditionally replicating mycobacteriophage to deliver the transposon Tn5367 
(Bardarov et a l,  1997) (an IS1096-derived transposon containing a kanamycin 
resistance marker (Mcadam et a l ,  1995)).
Signature-tagged transposon mutagenesis (STM) is a relatively novel 
technique that can be used to identify genes associated with virulence (Hensel et a l,  
1995). Each signature-tagged mutation carries a different DNA tag, which allows 
mutants to be differentiated from each other. Transposons, flanked by highly variant 
and invariant flanking sequences, are delivered to the bacteria, usually by a 
temperature-sensitive plasmid. With the elevation of temperature, the plasmid is lost 
and the transposon inserts itself, randomly, into the genome of the bacteria being 
studied. Mutants are subsequently pooled and used in infection studies, either cell or 
whole animal. At an appropriate time after inoculation, bacteria are recovered from 
the infection and the tags in the recovered pool and the inoculation pool are used to 
probe filters arrayed with the different tags representing mutants in the inoculum. 
Mutants with an attenuated virulence are those with tags that are present in the 
inoculum pool but are absent from the recovered pool of tags.
Using STM, 50 mutants with attenuated virulence were identified in 
Staphylococcus aureus (Mei et a l,  1997). Approximately half of the genes identified 
via this method had no known function in S.aureus. STM has also recently been used 
to identify a cluster of virulence genes located on a 50Kb chromosomal region of
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MJuberculosis (Camacho et a l,  1999). The genes identified in M.tuberculosis are 
thought to be involved in the production of phthiocerol and phenolphthiocerol 
derivatives, which are a group of molecules restricted to eight mycobacterial species. 
Seven of these species are either strict or opportunistic pathogens. These molecules 
are thought to be involved in the biosynthesis of components of the cell envelope.
1.8.5 In Vivo Expression Technology (IVET)
IVET was first described by Mahan et al. (1993). A  suicide vector containing 
promoterless purA gene and promoterless lacZ gene was constructed as a fusion and a 
partial digest of Salmonella tryphimurium DNA was cloned directly up-stream of this 
gene fusion. When properly positioned, a S. tryphimurium promoter drives the 
expression of both the purA and the lacZ genes. Introduction of this pool of gene 
fusion plasmids in to a ApurA S. tryphimurium strain, which has an attenuated growth 
in vivo, and selection for antibiotic resistance required integration of the plasmid into 
the chromosome of the bacteria by homologous recombination. The pool of 
purA-lacZ fusion strains was injected into mice. Bacteria harvested from the mice 
spleens three days post-inoculation had therefore complemented the purA mutation. 
Analysis of lacZ expression of each purA-lacZ fusion strain grown in vitro and in vivo 
indicated that p-galactosidase production was elevated during in vivo growth. With 
the sequencing of the cloned S.tryphimurium DNA, identification of the genes 
controlled by any cloned promoter was possible. IVET technology has been used to 
identify genes induced in Pseudomonas aeruginosa (Wang et al., 1996) and 
Staphylococcus aureus (Lowe et a l ,  1998) in the human host, Actinobacillus
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pleuropneumoniae (Fuller et a l,  1999) in swine and in Candida albicans (Staib et a l,
1999), a fungal pathogen of humans.
1.8.6 Gene Transfer
It is possible to identify virulence factors by transferring cloned DNA from a 
pathogenic strain of an organism to a related non-pathogenic species, a mutant with 
attenuated virulence or a distant genus that can efficiently express the transferred 
DNA and subsequent screening for the acquisition of pathogenic traits. This 
methodology has been used to great effect with M.tuberculosis. Collins et a l  (1995) 
constructed a plasmid library of virulent M.bovis genomic DNA, which was 
transferred into an avirulent strain of M.bovis. A  number of clones had regained the 
ability to cause spleen lesions in guinea pigs and were subsequently found to contain 
a common M.bovis DNA fragment, which contained the rpoV open reading frame 
whose product has a high homology to the principal bacterial sigma (a) factor. It was 
also noted that the avirulent strain of M.bovis contained two mutations in this gene, 
either of which could alter the expression of a subset of virulence factors.
The transfer of M.tuberculosis DNA to a non-invasive strain of E.coli has also 
identified a region of DNA associated with entry and survival of the macrophage 
(Arruda et a l,  1993). The E.coli clone harboured a plasmid containing cloned 
M.tuberculosis DNA, which conferred the ability to invade HeLa cells, induce 
macrophage phagocytosis and survival within the macrophage for up to 24 hours. The 
M.tuberculosis fragment has recently been sequenced (accession number: X70901)
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and has been found to contain a gene, mcel, which has no similarities with DNA 
sequences of other organisms in the databases.
1.8.7 Subtractive Hybridization
The rational behind this technique is to hybridize DNA or cDNA fragments 
obtained from either a single strain grown in different environmental conditions or 
from two related strains, one of which is virulent and the other avirulent, and 
eliminate from the hybridization mixture all double-stranded nucleic acid fragments 
thus present in both pools representing sequences common to both. After a number of 
rounds, the resulting subtractive probes can be used to identify genes that may be 
specific and perhaps important for virulence.
Subtractive hybridization, using DNA, has been used to identify gross DNA 
differences between M.bovis and M.bovis BCG (Mahairas et al., 1996). This 
identified three regions of difference (RD) between the two genomes, representing 
30Kb of DNA. When these were sequenced, a number of previously identified 
TB-specific antigen genes were found to be located within these regions of the 
genome. In a separate study, cDNA subtractive hybridization was used to identify a 
macrophage-induced gene (mig) in M.avium grown in either liquid culture or in 
human-derived macrophages (Plum and Clark-Curtiss, 1994). It has subsequently 
been shown that the mig gene is not present in the M.tuberculosis genome which 
perhaps underlines different mechanisms of pathogenesis in these two mycobacteria 
(Cole et al., 1998).
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Differential display PCR can be used with two different template types. It can 
be used to either identify gene expression differences between closely related 
organisms or to identify differences in the levels of expression of an organism 
growing in different conditions. Unfortunately results obtained using this technique 
should be viewed with caution as DD-PCR is renowned for generating false positives.
Using reverse transcribed mRNA (cDNA) as a template, genes that are 
up-regulated during infection can be identified. As stated above, M.tuberculosis 
infects and survives inside macrophages. It would be expected that both the 
M.tuberculosis and the macrophage each react to the infection process by altering the 
expression of certain genes. Ragno et al. (1997) used DD-PCR to study the effect of 
M.tuberculosis infection on the gene expression of the invaded macrophage. Roughly 
20 PCR bands were identified as representing differentially expressed products. 
However, only one PCR product was investigated further - a band of 158bp that was 
down-regulated during infection - which was found to have a high degree of sequence 
homology to the murine mitochondrial enzyme cytochrome C oxidase subunit VIIc 
(COX VIIc). It was suggested that down-regulation of COX VIIc could be either an 
early apoptotic signalling event or a down-stream consequence of apoptotic 
signalling.
RNA arbitrarily-primed differential display PCR (RAP-PCR) has been used to 
identify differentially expressed genes between attenuated and virulent laboratory 
strains of M.tuberculosis (Rivera-Marrero et al., 1998). Using this method, cDNA
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fragments with homology to three known mycobacterial genes and six hypothetical 
genes were identified, four of which were later identified as differentially up- 
regulated.
1.8.9 Gene Fusions
Potential virulence factors in pathogenic mycobacteria can be identified by 
fusions to promoterless reporter genes whose expression can be easily monitored. The 
most useful application of reporter genes in the identification of virulence factors is 
with reporter genes whose expression can be easily followed intracellularly.
The Green Fluorescent Protein (GFP) from the jellyfish Aequorea victoria 
absorbs ultraviolet light, at a wavelength of 395nm, and emits green light at 510nm. 
The protein folds without any external influences and does not require any 
exogeneous substances or co-factors, which means that the excitation of GFP can be 
seen intracellularly. GFP was first used as a reporter gene in mycobacteria in 1995 
(Dhandayuthapani et a l,  1995; Kremer et a l,  1995) and it has been shown that the 
presence of GFP does not affect the bacteria’s ability to invade and survive within the 
host cell (Parker and Bermudez, 1997; Valdivia et a l,  1996). Since bacteria 
expressing GFP fluoresce, they can be separated from non-fluorescing bacteria with a 
fluorescence-activated cell sorter (FACS). This has been shown in the identification 
of 14 Salmonella typhimurium genes specifically induced in host macrophages and 
which are therefore potential virulence factors (Valdivia and Falkow, 1997). A  similar 
study identified 12 Mycobacterium marinum genes that are differentially expressed in 
macrophages (Barker et a l,  1998).
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An alternative reporter system to GFP is that of P-galactosidase, which is 
coded for by the lacZ gene and requires an external substrate in order to report 
expression levels. Dellagostin et al. (1995) used a translational fusion of an 
amino-terminally truncated E.coli lacZ reporter gene with mycobacterial promoters 
for the M.bovis BCG hsp60 gene, the M.leprae 28KDa gene and the M.leprae 18KDa 
gene to measure the activity of the promoters during intracellular and extracellular 
growth. The lacZ gene has also been used to analyse transcription and expression of 
(3-lactamase gene isolated from a natural isolate of M.fortuitum and from a high-level 
amoxicillin-resistant mutant (Timm et al., 1994). This method identified a single base 
pair difference in the promoter region was responsible for the high-level production 
of the (3-lactamase in the mutant. The lacZ reporter system has also been applied for 
methodologies to rapidly identify antimycobacterial drugs (Srivastava et al., 1997a; 
Srivastava et al., 1997b).
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1.9 Aims
The identification of virulence factors is central to the understanding of 
tuberculosis and its survival within the host. Currently few M.tuberculosis genes have 
been identified as virulence factors (Gordon and Andrew, 1996). Newly identified 
virulence factors will be invaluable in furthering our understanding of the process of 
mycobacterial infection and could be used to a generate a new, more effective vaccine 
(either DNA, subunit or a live, attenuated strain similar BCG).
It is clear from the above that there are a number of different techniques that are 
currently being used to identify virulence factors and range from low technology,
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labour intensive gene fusions through to high technology high density DNA arrays. 
All of the techniques mentioned have positive virtues regarding their ability to 
identify potential virulence factors but it is unlikely that one technique will identify 
all M.tuberculosis virulence factors. Even if this were to be the case, other techniques 
would be required to support any initial findings. The aim of this work is to identify 
M.tuberculosis genes that are up-regulated during infection, using a gene fusion 
methodology.
To this end, a M.tuberculosis H37Rv gene library has been constructed using a 
promoter probe vector using lacZ as a promoterless reporter gene. Once transformed 
into M.bovis BCG Pasteur, discrete clones were randomly selected and arrayed in a 
96 well microtitre™ format. Each clone was screened for up-regulated expression of 
the reporter gene, lacZ, by exposure to stressing environmental conditions designed to 
mimic those inside the macrophage. A  smaller number of clones identified via this 
type of screening have been used in macrophage infection studies and the level of 
lacZ expression measured and compared to the level of expression in vitro. The 
M.tuberculosis H37Rv DNA cloned within the plasmid of each clone was sequenced. 
The genes, whose expression is driven by any of the promoters identified as having 
increased lacZ expression inside the macrophage compared to in vitro, were subjected 
to studies designed to measure the specific mRNA expressed during in vitro and 
intra-macrophage growth.
Chapter I Introduction
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2.1 Introduction . ; V ' Ig |g
Despite the advent of the sequenced Mycobacterium tuberculosis genome, little 
is known about the structure of mycobacterial promoters or which genes are critical 
during the processes of infection and intracellular survival (Cole et a l 1998). A  
number of methods have been employed to study genes whose expression may be 
altered under different conditions. Differential display PCR has been used to identify 
differences in the expression levels of mitochondrial cytochrome c oxidase of the host 
macrophage prior to and post-infection with M.tuberculosis and has identified genes 
that are differentially expressed between virulent and avirulent M.tuberculosis strains 
(Ragno et al., 1998; Rivera-Marrero et al., 1998). Two dimensional gel 
electrophoresis of Mycobacterium tuberculosis cell extracts grown in conditions of 
either high or low iron concentrations has been used to identify 15 induced proteins 
and 12 proteins whose expression is decreased (Wong et al., 1999).
The latest method currently being employed to identify differentially regulated 
genes is microarray technology. The genes of a particular organism, in this case 
MJuberculosis, are amplified and arrayed on small glass ‘chips’ and position of each 
arrayed gene recorded. mRNA obtained from the organism grown in different 
conditions can be hybridised to the ‘chip’-bound DNA. Differentially expressed genes 
can be detected by measuring the amount of hybridisation to the DNA. The power of 
microarray technology is best shown in the work carried out by Behr et al. (1999) and 
their identification of the differences between MJuberculosis H37Rv and the M.bovis 
BCG strains at the genome level. This type of high technology is increasingly being 
used but sadly is not currently available to all laboratories. DNA microarrays have not
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as yet been used successfully to identify any potential virulence factors of 
M.tuberculosis.
However, one of the methods most likely to identify differentially expressed 
M.tuberculosis genes is the use of promoter probe vectors. Promoter-less reporter 
genes have been employed to identify promoter fragments of Mycobacterium 
marinum genes that are differentially expressed in vitro and in vivo (Barker et al., 
1998). The M.marinum genes were identified with the use o f a promoter-less green 
fluorescent protein (GFP). To further support the use of promoter-less reporter genes, 
Dellagostin et al (1995) showed that an amino-terminally truncated E.coli lacZ 
reporter gene could be used to follow expression of the Mycobacterium bovis BCG 
hsp60 gene (Rv0440/ groEL2), the Mycobacterium leprae 28 kDa gene and the 
M.leprae 18 kDa gene in vivo. The ability to be able to follow expression levels in 
vivo is crucial to identify genes involved in the virulence and pathogenicity of 
Mycobacterium tuberculosis.
2.1.1 Strategy
In order to study the activity of mycobacterial promoters, an effective 
replicating vector system based on pUS1781 (Pers. Comm.: constructed by Stewart, 
G.R. -  See Section 2.2.2) carrying a promoter-less reporter gene was constructed. A  
promoter-less E.coli lacZ gene was amplified from pMC1871 (Promega) with a small 
multiple cloning site directly up-stream. Using a heat shock protein promoter (groEL2 
-  Rv0440), a positive control vector was constructed and analysed for expression
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compared to the basal vector. The standard j3-galactosidase assay (Miller, 1972) for 
the reporter gene lacZ was optimised for mycobacteria.
Fragments of genomic Mycobacterium tuberculosis H37Rv DNA, between 1.0 
and 0.3 Kb in size, were inserted into the multiple cloning site directly up-stream of 
the promoterless lacZ and the resulting plasmid promoter library was used to 
transform Mbovis BCG Pasteur. Individual clones were randomly selected and 
arrayed in a 96 well microtitre™ format.
Chapter 2: Construction o f  Mycobacterium tuberculosis U3?Rv Plasmid Library
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2.2 Materials and Methods
2.2.1 Oligonucleotide Primers
Primer Sequence (5’-3’)a Details
Z-Bgl-Nar GAAGATCTGCATGCGGCGCCATG
ATACCGCGAGACCCACG
LacZ gene nt 1-20, 5’ Bglll 
Sphl and Narl restriction 
sites
Z-Bgl-
Kpn
GAAGATCTGGTACCTTATTTTTGC
ACCAGACCAACTG
LacZ gene nt 3290-3267 
(complementary strand), 5’ 
Bglll and Kpnl restriction 
sites
RH22 GACTGAGGCGCCGACCACAACGA 
CGCG
M.tuberculosis genome nt 
528218-528232, gene 
Rv0440. 5’ Narl restriction 
site.
RH23 GACTGAGGCGCCGTGATTCCTCC
GGATCGG
M.tuberculosis genome nt 
528600-528582 
(complementary strand), 
gene Rv0440. 5’ Narl 
restriction site.
RH20 CGGTTTACAAGCATAAAG pUS1800 (and subsequent 
plasmids) nt 109-126 of 
plasmid
RH21 GGTCTCGCGGTATCATGG pUS 1800 (and subsequent 
plasmids) nt 169-152 
(complementary strand) of 
plasmid
“Under scored sequences represent endonuclease restriction sites in the order stated in details column
2.2.2 Construction of Promoter Probe Shuttle Vector
The plasmid pUS1781 was constructed using pUC19 as the starting plasmid 
(Pers. Comm.: Constructed by G.R.Stewart) (See Figure 2.1). Into the multiple 
cloning site of pUC19 a 1.6Kb Mycobacterial origin of replication from pAL5000 and 
a kanamycin resistance gene (the aph gene from Tn903) were inserted using the Kpnl 
and the Pstl restriction sites respectively. The resulting plasmid was digested with 
Narl restriction enzyme and Bsal restriction enzymes, in order to remove the 
ampicillin resistance gene. The resulting ‘sticky ends’ were polished and the DNA
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re-circularised. The T4 terminator was PCR amplified with the 5’ primer containing 
an SpeI restriction site and the 3’ primer containing an Xbal restriction site. The DNA 
was cloned into the Xbal restriction site of the pUC19 multiple cloning site generating 
the plasmid pUS 1781.
T4 Term
| X b a  1
B am H  1
OriM
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Figure 2.1: Vector map of plasmid pUS 1781.The mycobacterial origin of replication (Myco Ori), the 
E.coli origin of replication (OriE), the selectable kanamycin resistance marker (Kan(R)) and the T4 
terminator are all indicated. The BamWl restriction site into which the promoterless lacZ is cloned is 
also indicated.
A promoterless lacZ, including the translational start site, was amplified using
the primers, Z-Bgl-Nar and Z-Bgl-Kpn. Z-Bgl-Nar anneals to the first 20 bp of the
lacZ gene, and carries a small multiple cloning site up-stream, whilst Z-Bgl-Kpn
anneals to the last 23 bp of the lacZ gene. These primers were used to generate a
3.3Kb DNA fragment by PCR, using the plasmid pMC1871 (Promega) as the
template. PCR amplification reaction conditions consisted of an initial denaturation at
95°C for 2 minutes, followed by 35 cycles with denaturation 95°C, primer annealing
at 67°C and extension at 72°C for 1 minute, 1 minute and 4 minutes respectively. The
final cycle was extension at 72°C for 5 minutes. The promoter probe
Mycobacterial - E . c o l i shuttle vector, pUS1800, was constructed by inserting the 3.3
35
Kb lacZ gene as a BglII fragment into the BamH\ site of pUS1781. The required 
orientation of the promoterless lacZ with transcription away from the T4 terminator 
was identified by digestion with EcoRV. Clones containing lacZ in the right 
orientation generated fragments of 6482 bp and 1348 bp (clones containing lacZ 
transcribing in the opposite direction generated 5864 bp and 1966bp fragments). 
Figure 2.2 shows a plasmid map of pUS1800. All cloning was performed in E.coli 
DH5a. The efficiency of pUS1800 as a promoter probe vector was assessed once a 
positive control had been constructed.
T4 Term
Xba 1 
Nar I
lacZ
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Figure 2.2: Vector map of plasmid pUS1800. The mycobacterial origin of replication (OriM), the 
E.coli origin of replication (OriE), the selectable kanamycin resistance marker (Kan(R)), the T4 
terminator (T4 Term) and the promoterless lacZ reporter gene are all indicated. The restriction sites 
indicated are unique.
2.2.3 Construction of Positive Control for Promoter Probe Vector
In order to test the efficacy of the promoter probe Mycobacterial-£.co// shuttle 
vector in identifying promoters, the promoter for the hsp60 gene (Rv0440/ groEL2) of
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M.tuberculosis H37Rv was amplified by PCR using the primers RH22 and RH23, 
which generated a 0.4 Kb DNA fragment. PCR reaction conditions consisted of an 
initial denaturation at 95°C for 2  minutes, followed by 35 cycles with denaturation 
95°C, primer annealing at 55°C and extension at 72°C each for 1 minute. The final 
cycle was extension at 72°C for 5 minutes. The amplified DNA contains the 
transcription signals and the ribosome binding site of the M.tuberculosis H37Rv 
hsp60 gene (Rv0440/ groEL2). The positive control promoter probe 
Mycobacterial-i?.coli shuttle vector, pUS1808, was constructed by inserting the 0.4 
Kb hsp60 promoter (Rv0440/ groELl) as a Narl fragment into the same site of the 
dephosphorylated plasmid pUS1800. The required orientation of the cloned promoter 
to promote transcription of lacZ was identified via restriction digest with the enzyme 
Aatll. If the hsp60 promoter has been cloned into pUS1800 in the right orientation 
two fragments are generated - 7032 bp and 1170 bp. With the hsp60 promoter in the 
wrong orientation fragments of 7332 bp and 870 bp are created. The efficiency of 
pUS1800 and pUS1808 as a negative and a positive control promoter probe vector 
were assessed with the use of the (3-galactosidase assay (Miller, 1972).
2.2.4 (3-galactosidase Assay with ONPG Substrate
Assays were performed as described by Miller (Miller, 1972). Cultures of
M.bovis BCG Pasteur were grown to mid-exponential phase (AtooOS) or to stationary
phase (rfeoo2 .0) from which a given volume (between 0 .2 ml and 0 .8ml) was diluted in
Z buffer (60 mM Na2HP04, 40 mM NaH2P04, 10 mM KC1, 1 mM MgS04, 50 mM
(3-mercaptoethanol) to a final 1 ml volume. Cells were permeabilised with 2.0% (v/v)
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chloroform and 0.001% (v/v) SDS and the solution equilibrated at 28°C for 5
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minutes. The substrate, ONPG (o-nitrophenyl-(3-D-galactopyranoside) was then 
added to a concentration of 0.8 mg ml' 1 and the reaction carried out at 28°C until 
sufficient yellow colour had developed as a result of hydrolysis of ONPG by 
p-galactosidase. The reaction was stopped by the addition of 500 pi IM Na2C0 3  and 
the solution centrifuged at 10 000 g for 2 minutes. The A420 of the supernatant was 
measured and the p-galactosidase activity expressed in Miller Units using the 
following equation:
^420(1 000) / (/Qrteoo -  p-galactosidase activity (Miller Units),
where t — incubation time (minutes) and v = volume of culture (ml).
2.2.5 P-galactosidase Assay Optimised for BCG
Assays performed as described above identified two problems when used to 
measure the difference in expression of lacZ from the two plasmids pUS1800 and 
pUS1808 harboured within M.bovis BCG Pasteur. Firstly lysis of the mycobacteria 
was inconsistent. Secondly, due to the relatively low levels of expression of lacZ by 
both clones, the activity of the enzyme had to be increased. Therefore p-galactosidase 
assays were performed as above but with alterations to the assay temperature and 
method of cell lysis.
Cultures of M.bovis BCG Pasteur harbouring the plasmids pUS1800 and 
pUS 1808 were grown to mid exponential phase (rteoo0.8) and 1ml of culture was 
added to a Hybaid Ribolyser™ blue tube (a 2 ml skirted screw-capped
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microcentrifuge tube with 'O ’ ring seal, containing acid-washed 0.1 mm 
silica/ceramic beads) and processed in a Hybaid Ribolyser™ at speed 5.0 for 40 
seconds. The Ribolyser tube, containing the lysed bacteria, were cooled on ice for 1 
minute and then centrifuged at 14000g for 1 minute to sediment the silica beads.
A known volume of lysed bacteria was diluted in Z buffer (60mM Na2HPC>4, 
40mMNaH2PC>4, lOmM KC1, ImM MgSC>4, 50mM (3-mercaptoethanol) to a final 1ml 
volume and equilibrated to an assay temperature between 28 and 50°C. Temperatures 
used for incubation were 28°C , 37°C , 42°C , 45°C and 50°C. The substrate, ONPG 
was then added to a concentration of 0.8 mg ml-1 and the reaction carried out at the 
chosen equilibration temperature until sufficient yellow colour had developed as a 
result of hydrolysis of ONPG by (3-galactosidase. The reaction was stopped by adding 
500pi 1M Na2C0 3  and (3-galactosidase activity calculated and expressed as described 
previously in section 2.2.4.
2.2.6 Preparation of M.tuberculosis H37Rv Genomic DNA Fragments
MJuberculosis H37Rv genomic DNA was digested individually with Acil, 
Hpall and Taql restriction enzymes. Genomic DNA (Ipg) was digested with 1 unit of 
enzyme in a final volume of 50pl of water. At time intervals of 0, 5, 10, 20, 40, 60 
minutes, 8 pi of the reaction was removed and added to loading buffer and stored at 
-80°C (to stop the reaction) until required at a later date. The digested DNA was 
analysed as described in Appendix 2 (Agarose gel electrophoresis) and fragments of 
each restriction digest between 1 and 0.3 Kb were excised and gel purified.
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2.2.7 M.tuberculosis H37Rv Library Construction
The plasmid pUS1800 was digested with the restriction enzyme Narl, 
dephosphoiylated and gel purified. The purified, digested genomic DNA from section
2.2.6 was pooled in equal quantities. The M.tuberculosis H37Rv promoter library 
Mycobacterial-E. coli shuttle vector was constructed by insertion of the Acil, Hpall 
and Taql digested and pooled genomic MJuberculosis H37Rv DNA into the Narl 
restriction site in pUS1800. The cloning efficacy was estimated by a standard 
transformation of the MJuberculosis H37Rv library into E.coli DH5a. Individual 
clones were picked and subjected to PCR analysis. Primers RH20 and RH21 were 
used to amplify across the Narl restriction site of the plasmid pUS1800. Reaction 
conditions consisted of an initial denaturation at 95°C for 2 minutes, followed by 35 
cycles with denaturation 95°C, primer annealing at 67°C and extension at 72°C for 1 
minute, 1 minute and 2 minutes respectively. The final cycle was extension at 72°C 
for 5 minutes. The amplified DNA fragments were visualised as described in 
Appendix 2 (Agarose gel electrophoresis). In order to generate sufficient 
M.tuberculosis H37Rv library plasmid DNA with few or no re-circularised pUS1800, 
a number of ligation reactions were carried out. The ligation reaction mix showing the 
least number of re-circularised plasmid was introduced into Epicurian Coli® 
XL2-Blue ultracompetent cells (Stratagene). The E.coli clones harbouring the 
M.tuberculosis H37Rv library plasmid were grown on selective solid media and 
resuspended in LB broth. The plasmid DNA from the pooled E.coli clones was 
recovered with the Qiagen Midi Kit used as described by the manufacturer.
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2.2.8 Generation of MJuberculosis H37Rv Library in M.bovis BCG Pasteur.
The MJuberculosis H37Rv library was introduced by electroporation (see 
appendix 2) into M.bovis BCG Pasteur and grown on selective media containing 
5-Bromo-4-chloro-3-indolyl-(3-D-galactopyranoside (X-gal) for between 14 and 21 
days. Discrete clones were randomly selected and arrayed in microtitre plates and 
grown in selective 7H9 broth media at 37°C for 7 days. Each clone was subcultured 
three times, with the use of 96 pin replicator, into selective 7H9 broth media and 
grown at 37°C to late exponential growth phase. This generated four identical copies 
of the MJuberculosis H37Rv library harboured in M.bovis BCG Pasteur. Three copies 
were stored at -80°C whilst the fourth copy was maintained for continued work.
Chapter 2: Construction o f  Mycobacterium tuberculosis 1137 Rv Plasmid Library
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2.3.1 Construction and Expression Analysis of Plasmids pUS1800 and pUS1808
A promoter probe Mycobacterial-^, coli shuttle vector (pUS1800) was 
constructed containing the amplified E.coli promoterless lacZ gene from pMC1871 
(Promega). Into the multiple cloning site directly up-stream of the promoterless lacZ, 
the hsp60 promoter was cloned so as to generate pUS1808 as a positive control vector 
for pUS1800. The hsp60 promoter, amplified directly for Mycobacterium tuberculosis 
H37Rv genomic DNA, was cloned so that the ribosome binding site was separated 
from the translational start site of lacZ by the same number of bases which separate it 
from the translational start site of the hsp60 gene. These two plasmids were 
subsequently used independently to transform M.bovis BCG Pasteur (See Figure 2.3).
M.bovis BCG Pasteur transformants separately harbouring vectors pUS1800 
and pUS1808 were cultured in kanamycin-supplemented 7H9 broth at 37°C until the 
cultures were at mid-log phase. Cultures were harvested and assayed for 
P-galactosidase activity, using ONPG substrate, as described by Miller (Miller, 1972). 
The difference in Miller units between the two vectors pUS1800 and pUS1808 was 
always a factor of a log. However, assays carried out at different times using cultures 
at similar growth phases generated a wide range of different values making 
comparison between cultures assayed on different days extremely difficult (See 
Figure 2.4).
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Figure 2.3: Construction of plasmids pUS1800 and pUS1808. The 3.3 kb PCR-amplified E.coli lacZ 
gene from pMC1871 was inserted into pUS1781 on a BgM/BamHl site to produce pUS1800. pUS1808 
was generated by the insertion of the 0.4 kb PCR-amplified M.bovis BCG Pasteur hsp60 promoter 
(Rv0440/ groEL2) on a Narl site. M.bovis BCG Pasteur transformants harbouring pUS1808 and 
pUS1800 are shown (left to right).
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Figure 2.4: Three [3-galactosidase assays, using method according to Miller, on M.bovis BCG Pasteur 
harbouring pUS1800 or pUS1808. Identical M.bovis cultures harbouring pUS1800 and pUS1808 were 
subcultured 2 days apart and assayed 5 post-inoculation.
Bacterial cells in the Miller method are disrupted by the addition of 
chloroform and 0.001% SDS. The variation, in Miller units, when using M.bovis BCG 
Pasteur cells is most probably due to inconsistent lysis of the mycobacterial cell wall 
by the chloroform and the SDS. The P-galactosidase assay as described by Miller was 
therefore altered in two ways -  the lysis method of the mycobacterial cells and the 
temperature at which the assay is carried out. Disruption of the mycobacterial cell 
was found to be optimal in a Hybaid Ribolyser™. The second alteration to the 
P-galactosidase assay described by Miller was to elevate the incubation temperature 
(28°C). The time required for sufficient yellow colour to develop from the hydrolysis 
of the substrate ONPG by p-galactosidase is included in the calculation of Miller 
units. The incubation temperature was probably set by Miller to 28°C to slow down 
the activity of the P-galactosidase enzyme which allows a reasonable length of time to
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pUS1800
pUS1808
pass between the addition of ONPG and the stopping of the reaction with sodium 
carbonate. When the two M.bovis BCG Pasteur cultures harbouring pUS1800 and 
pUS 1808 were assayed by incubating at 28°C, the time required for sufficient yellow 
colour to develop was too long. They generated low values of Miller units signifying 
low levels of expression of lacZ. Elevated incubation temperatures for the 
p-galactosidase assay were therefore tested. Cultures were ribolysed and constant 
volumes of the same lysate were incubated at 5 temperatures varying from 28°C to 
50°C
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Figure 2.5: P-galactosidase assays carried out at elevated temperatures. Assays carried out on M.bovis 
BCG Pasteur harbouring pUS1800 and pUS1808 carried at 28, 37, 42, 45, 50°C in triplicate. Values for 
the plasmid pUS1800 harboured by M.bovis BCG Pasteur at 28°C and 42°C are shown but the values 
are very small. The error bar for the plasmid pUS1800 harboured within M.bovis BCG Pastern- 
incubated at 37°C is also present but is so small that it can not be seen.
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The results in Figure 2.5 clearly demonstrate that an increase in temperature 
raised the Miller units observed. At 50°C the activity of the (3-galactosidase enzyme is 
reduced in the lysate from M.bovis BCG Pasteur harbouring pUS1808. However at 
that temperature the activity of the pUS1800 lysate appears to be increased but this is 
probably due to the substrate ONPG, which needs to be made fresh for each assay, 
spontaneously hydrolysing. Therefore an assay incubation temperature of 42°C was 
used subsequently.
M.bovis BCG Pastern* harbouring the plasmid pUS1800 displays no significant 
levels of (3-galactosidase expression. The positive control plasmid, whose expression 
is being driven by the hsp60 promoter, is exhibiting Miller units in the order of 40 
units compared to the 0 units produced by pUS1800. Therefore, pUS1800 has the 
potential to be used as an effective promoter trap vector.
2.3.2 Construction of Mycobacterium tuberculosis Promoter Library
MJuberculosis H37Rv total genomic DNA was digested individually with the 
restriction enzymes Acil, Hpall and Taql. DNA fragments of between 0.3 and 1 Kb 
were gel-purified and cloned into the Narl restriction site of the plasmid pUS1800 
(See Figure 2.6). E.coli DH5a were transformed with a small sample of the cloned 
MJuberculosis H37Rv plasmid library. Individual clones were subjected to PCR with 
the primers RH20 and RH21, amplifying across the Narl cloning site (See Figure 
2.7).
Chapter 2: Construction o f  Mycobacterium tuberculosis H3~Rv Plasmid Library
46
Chapter 2: Construction of Mycobacterium tuberculosis 113 ~Rv Plasmid Library 
Actl Hpall Taq\ Enzyme
0 5 10 20 40 60 0 5 10 20 40 60 0 5 10 20 40 60 Time of digest in minutes
12216 bp 
5090 bp
1636 bp 
1018 bp
  517/506 bp
—  396 bp
——  298 bp-----  220/201 bp
  154/134 bp
12216 bp 
5090 bp
1636 bp 
1018 bp
517/506 bp
298 bp 220/201 bp 
154/134 bp
Figure 2.6: M.tuberculosis plasmid library construction. M.tuberculosis genomic DNA was digested 
with Acil, Hpall and Taql for 0, 5, 10, 20, 40, and 60 minutes. Fragments of between 0.3 and 1 Kb 
were gel-purified and inserted on the Narl site of pUS1800 thus generating a M.tuberculosis promoter 
trap library.
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Figure 2.7: Agarose gel of PCR products of discrete E.coli DH5a clones harbouring M.tuberculosis 
plasmid library. Amplification carried out using primers RH20 and RH21. Lanes 1,15, 29, 30, 44 and 
58 are 1 Kb ladder and lanes 2, 16, 31 and 45 are the region amplified from pUS1800.
Figure 2.7 clearly shows that all of the E.coli clones, harbouring the 
M.tuberculosis library plasmid, subjected to PCR contain cloned DNA since the 
amplified regions of the clones are larger than the basal plasmid amplification. Indeed 
380 discreet clones were subjected to PCR with the primers RH20 and RH21 and 
none were found be re-circularised pUS1800 plasmid. The maximum amplified 
fragment seen was 1.5 Kb, with the smallest amplified fragment being just 150 bp. 
The average insert size was found to be 400bp.
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The M.tuberculosis H37Rv plasmid library ligation was introduced into 
Epicurian Coli® XL2-Blue ultracompetent E.coli cells with a transformation 
efficiency greater than 5xl09 pg"1 of plasmid DNA and the plasmid DNA recovered. 
In excess of 1.5x10 ' discrete E.coli clones were harvested. M.bovis BCG Pasteur was 
transformed with the library plasmid purified from the pooled E.coli clones and 
individual clones selected for on solid media containing kanamycin and X-gal (See 
Figure 2.8).
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Figure 2.8: M.bovis BCG Pasteur harbouring the M.tuberculosis plasmid library grown on 7H11 solid 
media containing kanamycin and X-gal. It can be clearly seen that about 15% of the independent 
clones are expressing lacZ and are therefore blue. Red arrows identify two clones, which are 
expressing lacZ but, in the presence of X-gal, are not completely blue in colour. The clone at the top of 
the plate is blue in the centre of the colony and white at the edges whilst the clone at the bottom of the 
plate is white but has turned the media below it blue.
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2.3.3 Selection and Arraying of Individual M.bovis BCG Pasteur Library 
Clones.
Despite the fact that little is known about the structure and function of 
M.tuberculosis promoters, it is more than likely that a number of genes required 
during infection will be silent in vitro. It is quite clear from Figure 2.8 that roughly 
15% of the clones are, to varying degrees, blue, as they are expressing lacZ and 
therefore appear to have some sort of promoter activity. However the M.tuberculosis 
DNA cloned in the other 85% of the clones may be extremely significant.
Before any clones can be arrayed in a 96 well microtitre™ format, the number 
of clones required to statistically cover the entire M.tuberculosis genome had to be 
estimated by using the equation below.
The number of clones needed =ln (T-P)
ln (1-1/N)
where P = the probability of selecting a specific point on the genome, and
N = The number of nucleotide bases in the genome
The average size of the cloned fragment (in nucleotide bases)
The size of the genome and the cloned fragment sizes are known to be 4.4x106 
and 400 bp respectively. If 95% of the M.tuberculosis genome is to be statistically 
covered then the number of clones that need to be arrayed can be calculated thus:
ln (1-0.95)
ln (1-1/(4.4x106/400)).
=32951
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The use of this equation to estimate the number of clones that need to be 
arrayed in order to statistically cover the entire M.tuberculosis H37Rv genome 
requires an assumption to be made. The equation is designed to be used when a 
genome is cloned randomly. As described earlier, three restriction enzymes were used 
to generate the small DNA fragments that were subsequently inserted directly up­
stream of the promoterless lacZ in pUS1800. Obviously even a partial enzymatic 
digest of DNA could never be considered to be random and even with three 
restriction enzymes increasing the randomness, this equation can only be used to 
suggest a number of clones to be arrayed had the cloning been entirely random.
The use of robotics was investigated to aid in selecting and arraying this 
number of clones. It was hoped that a robot could be instructed to identify an M.bovis 
BCG Pasteur clone, grown on selective solid 7H11 media containing X-gal, and 
decide whether it was blue or white. Once the colour had been determined, the clone 
would be arrayed in a 96 well microtitre™ format with clones of similar colour 
intensity.
When E.coli is grown on solid media, discrete clones are fonned which are 
soft, malleable and the diameter of the clone is relatively constant. M.bovis BCG 
Pasteur clones, however, do not form regular shaped or sized colonies. In addition to 
their inconsistent size, unless the M.bovis BCG clone is expressing large levels of 
lacZ, the bacteria do not always turn blue in the presence of X-gal - the media on 
which they are growing can be turned blue (See Figure 2.7). The two clones identified 
with arrows clearly show two of the different colony colourings. The clone in the 
bottom right hand comer of the plate appears to be white but has a definite blue
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colouring to the agar beneath it. In the top half of the plate, the identified clone is blue 
in the centre and white around the edges of the colony. The reason for some clones 
expressing lacZ and turning blue while others cleave X-gal and turn the media blue is 
unclear. The reason for the clone in the top half of the plate having a blue centre and a 
white outside is probably due either to expression late in the growth phase or due to a 
response to some type of starvation (such as anaerobic growth or nutrient deprivation) 
of the bacteria in the centre of the colony.
On advice from experts, the use of robotics was never actually tested with 
M.bovis BCG Pasteur due to all of these distinctive properties of M.bovis BCG 
Pastern* clones. A  robot would never have been able to discern the different sizes and 
discriminate between the different intensities of blue of M.bovis BCG Pasteur clones 
grown in the presence of X-gal. However, had the robot had sufficient power to 
overcome these problems, all 32951 clones required to statistically cover the 
M.tuberculosis genome would have been arrayed.
Thus it was decided that a smaller number of clones generated by the 
transformation of M.bovis BCG Pasteur with the M.tuberculosis promoter probe 
library would be selected and arrayed in a 96 well microtitre™ format manually. The 
aim of a study of a smaller library sample size was to identify some of the 
up-regulated promoters of M.tuberculosis H37Rv and not to carry out a 
comprehensive study of up-regulation. Therefore, due to the prohibitive length of 
time required to array clones, 15% of the desired maximum 32951 clones were 
arrayed. Discrete clones were selected randomly and arrayed, where possible, by 
colour intensity caused by the expression of lacZ in the presence of X-gal in vitro,
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under no external stimuli. Clones expressing lacZ (and therefore blue) were arrayed in 
the same 96 well microtitre™ plate, with white clones being arrayed separately. In 
total fifty 96 well microtitre™ plates were arrayed - 8 contained blue clones with the 
rest of the plates contained white clones. These arrayed plates represent 768 blue 
clones and 4032 white clones, suggesting that 19% of the arrayed clones are 
expressing lacZ in vitro under no external stimuli.
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The use of the p-galactosidase assay as described by Miller (1972) does not 
generate constant results when used for the detection of lacZ expression in slow 
growing Mycobacteria (see Figure 2.3). There are probably two reasons for this. The 
first is that there is insufficient or inconsistent lysis of the mycobacteria probably due 
to the thickness of the cell wall. Secondly, Mycobacterium bovis BCG is thought to 
have relatively low levels of gene expression. As such, the amounts of 
P-galactosidase protein being produced make detection of the enzyme more difficult. 
If the p-galactosidase assay is to be used to assay the levels of expression of lacZ of a 
number of different, unknown promoters in vitro and in vivo, the assay must generate 
consistent results for a known promoter.
The Miller assay was therefore adapted for the slow growing M.bovis BCG 
Pasteur by altering the method of lysis and increasing the activity of the low levels of 
P-galactosidase enzyme present. Ribolysing the mycobacteria prior to the addition of 
the ONPG substrate in the Miller assay ensures that the bacteria are completely lysed 
whilst raising the incubation temperature of the assay increases the activity of the 
enzyme thus making the enzyme more detectable.
With the ability to detect the p-galactosidase enzyme consistently, the plasmid 
pUS1808 harboured in M.bovis BCG Pasteur generates 40 Miller units compared to 
the expression of lacZ from pUS1800 harboured within M.bovis BCG Pasteur, which 
does not produce any detectable Miller Units.
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This clearly indicates that the plasmid pUS1800 is a suitable vector for 
identifying promoter fragments of cloned DNA. Genomic M.tuberculosis H37Rv 
DNA fragments were randomly generated by partial digestion with the 3 enzymes 
Acil, Hpall and Taql and cloned into the Narl restriction enzyme site directly 
up-stream of lacZ in plasmid pUS1800. O f the 380 discrete E.coli clones examined 
via PCR, no plasmids were found to be re-circularised pUS1800. All of the PCR 
products generated were different sizes, between 1500 and 150 bp, with an average 
insert size of 400 bp. With a genome the size of M.tuberculosis and an average cloned 
fragment size of 400 bp, statistically to have cloned the entire MJuberculosis H37Rv 
genome, about 3.3xl04 discreet clones would need to be arrayed. However without 
the ability to use automatic selection, 4800 clones were arrayed, which was a library 
size sufficient for a pilot study of Mycobacterium tuberculosis gene promoter 
expression in vivo.
4800 clones represents 15% of the total number of clones required to cover 95% 
of the MJuberculosis genome had the generation of the MJuberculosis H37Rv DNA 
fragments been completely random. As the DNA was digested with three restriction 
enzymes, the fragments are not random and therefore the number of clones required 
to statistically cover the entire MJuberculosis genome is fewer than the 32951 
previously stated. If promoters involved in the infection process are to be identified 
then a method to select clones harbouring these promoters must be developed.
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With 4800 clones of the Mycobacterium tuberculosis H37R.V promoter trap 
vector harboured within M.bovis BCG Pasteur (the library clones) selected randomly 
and arrayed in a 96 well microtitre™ format, the next requirement was to develop a 
method that identifies genes involved in the intracellular survival of MJuberculosis. 
To identify genes up-regulated during infection a screening method would compare 
the expression of each of the 4800 clones in vitro and in cultured macrophages. This 
idyllic situation is impractical due to the enormous task required to infect cultured 
macrophages with all 4800 of these clones and to assay the level of expression of lacZ 
in vitro and in vivo.
3.1.1 In Vitro MJuberculosis Stress Stimuli Mimicking Intracellular Conditions.
The conditions within the phagosome, discussed in Section 1.7, presumably 
control the ability of mycobacteria to survive and grow. Workers have therefore 
sought to mimic in vitro these intracellular environmental conditions. In 1978, Jackett 
et al. (1978) investigated the connection between the resistance of 6 strains of 
MJuberculosis, with different virulence in guinea pigs, to their sensitivity to low pH, 
to hydrogen peroxide (H2O2) at different pH values and to superoxide (O2'). Low 
virulence was associated with susceptibility to hydrogen peroxide except for the 
laboratory-attenuated strain H37Ra. Susceptibility to an acid environment showed no 
correlation with the virulence of the strain but the tuberculocidal effect of H2O2 was 
significantly increased at low pH. All strains were uniformly resistant to superoxide. 
Later experiments by other workers attempted to induce de novo synthesis of proteins
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using stress stimuli (Monahan et al., 1994). The stimuli used were heat and oxidative 
stress. Heat shock induced known heat shock proteins but de novo protein synthesis 
was not detected in mycobacteria exposed to oxidative stress and in some cases 
protein synthesis was inhibited. Superoxide had no effect on protein synthesis. 
Importantly, Monahan et a l  acknowledged the fact that heat and oxidative stress were 
the only stress stimuli studied and the effect of other stimuli associated with 
intra-macrophage environment, such as low pH, iron deprivation and reactive 
nitrogen intermediates, were not investigated.
The effects of low pH, iron concentration and reactive nitrogen intermediates 
on Mycobacteria have been investigated by other groups. The susceptibility of three 
different strains of the Mycobacterium avium complex (one strain of M.avium and 
two strains of M  intracellare) to nitric oxide generated chemically by the acidification 
of nitrite ions, as well as nitric oxide generated by rat alveolar macrophages, showed 
that the M.avium strain was more susceptible to both forms of generated nitric oxide 
than the M.intracellare strains (Doi et al., 1993). The in vitro resistance of 
mycobacteria to reactive nitrogen intermediates, generated by sodium nitrite at an 
acidic pH, has been foimd to have a significant positive correlation to virulence of 
strains in guinea pigs (Obrien et a l,  1994).
In vitro infection of human THP-1 cells with M.tuberculosis has identified 16 
induced proteins and 28 repressed proteins (Lee and Horwitz, 1998). In the same 
study the effects of stress conditions including heat-shock, low pH and hydrogen 
peroxide were also investigated with the pattern of induced and repressed proteins
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being unique to each stress condition. However, 10 of the MJuberculosis proteins 
induced by the macrophages were also induced with the stress conditions.
One of the molecular methods of showing the effect of in vitro stress stimuli 
on de novo MJuberculosis protein synthesis is two-dimensional (2D) gel 
electrophoresis. Garbe et al. (1996) used both reactive oxygen and nitrogen 
intermediates generated by chemical donors in vitro to investigate the effect on 
MJuberculosis protein synthesis. Menadione, a redox cycling compound, caused the 
enhanced synthesis of seven polypeptides -  six of these proteins were heat shock 
proteins. However the chemical release of nitric oxide induced 8 polypeptides of 
which only 1 could be identified as a heat shock protein. Heat shock proteins 
routinely appear in 2D gel analysis as proteins induced by in vitro stress stimuli 
(Garbe et a l , 1999). Iron concentration has been shown to be another stress stimuli 
(Wong et a l, 1999). Again with the use of two-dimensional (2D) gel electrophoresis, 
in MJuberculosis Erdmann at least 15 proteins were induced and 12 repressed under 
low iron conditions.
Infecting macrophages with all the library clones would prove an enormous 
task. The intracellular environment that MJuberculosis is exposed to is evidently a 
complex environment, which is still not entirely understood. However key elements 
of the bactericidal abilities of the macrophage have been identified.
Reactive nitrogen and oxygen intermediates have been identified as chemicals 
likely to be utilised by the macrophage to kill intracellular MJuberculosis. Iron 
depravation is also a mechanism by which macrophages inhibit the growth of
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ingested bacilli. It has been suggested that acidic conditions do not play a role in the 
microbicidal ability of the macrophage when infected with M.tuberculosis 
(Sturgill-Koszycki et al., 1994). Phagosomes containing mycobacteria failed to 
acidify below pH6.3 -  pH6.5. However the study only measured the pH for only a 
short length of time (100 minutes) post-infection and this may not reflect the early or 
steady state events. This may be important considering the previously mentioned 
work by Jackett (1978) that showed that the bactericidal effect of hydrogen peroxide 
was enhanced by the presence of low pH. Obviously, due to our poor understanding 
of the phagosome environment, there are likely to be other conditions that 
M.tuberculosis could be exposed to. All of these conditions undoubtedly act in unison 
against an invading microorganism but each environmental condition probably causes 
a specific response from M.tuberculosis. The response by M.tuberculosis is likely to 
involve an alteration in the level of expression of certain genes and it is reasonable to 
expect that proteins generated by the expression of these genes would be involved in 
the survival of M.tuberculosis intracellularly.
3.1.2 Strategy
The ability of Mycobacterium bovis BCG Pasteur to tolerate low pH and high 
reactive nitrogen intermediates, generated by acidified sodium nitrite, was 
investigated by exposing in vitro grown M.bovis BCG Pasteur to these stresses. 
Initially, the survival of M. bovis BCG Pasteur grown in media at low pH and 
containing a high concentration of reactive nitrogen intermediates was measured. This 
identified the lowest pH and highest concentration of RNI which would allow 
M.bovis BCG Pasteur to grow and these conditions were subsequently used with the
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Mycobacterium tuberculosis H37Rv promoter trap vector library harboured within 
M.bovis BCG Pasteur. If the 4800 M.bovis BCG Pasteur promoter trap clones were to 
be exposed to one of these suspected environmental conditions in vitro, it may be 
possible to identify clones harbouring promoter-like MJuberculosis DNA which 
regulate gene expression related to that specific condition. If this were the case, the 
expression of lacZ in these clones would be up-regulated in the presence of this 
environmental chemical stimuli compar ed to the control.
Therefore all of the 4800 clones of the library were exposed to two conditions 
which may be part of the defence mechanism employed by the macrophage. Each 
clone was grown in control media, media at a low pH and media at a low pH 
containing sodium nitrite. At acid pH, nitrite ions are converted to nitrous acid which 
subsequently decomposes to generate other reactive nitrogen intermediates including 
nitric oxide (Taylor et a l , 1927). Bacteria grown in acidified media did not only 
identify promoter fragments up-regulated by the low pH but also acted as a control 
for the RNI medium which is at the same low pH. The amount of (3-galactosidase 
enzyme produced by each clone would directly report the level of expression of lacZ 
being driven by the MJuberculosis DNA cloned within the plasmid. As the amount of 
(3-galactosidase produced by each clone can be measured, the expression of lacZ in 
the low pH and low pH with sodium nitrite media could be compared to the control 
medium and give a direct indication of the promoter activity. This preliminary in vitro 
screening mimicking in vivo conditions reduced the MJuberculosis library clones to a 
smaller number containing the most reactive promoter fragments. These few clones 
were subsequently be used to infect cultured macrophages.
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3.2.1 Initial Selection of M.tuberculosis H37Rv Library Clones of Interest.
The 4800 library clones arrayed in fifty 96 well microtre™ plates were 
subcultured with the use of a 96 pin replicator into selective 7H9 broth media at pH
6.6 (control), pH 5.4 and pH 5.4 containing fresh sodium nitrite (NaNO2)(0.5mM) 
and also onto solid selective 7H11 media at pH 6.6 (control), pH 5.4 and pH 5.4 
containing fresh NaN02 (0.5mM). The pH of both solid and liquid media was reduced 
to the required level by the addition of concentrated hydrochloric acid before 
autoclaving. All media contained 5-Bromo-4-chloro-3-indolyl P-D-galactopyranoside 
(X-gal) and clones were incubated at 37°C. Each of the clones in the liquid media 
were grown for 7 days and scored, by eye, on a scale of 0-3 on the level of blueness 
seen (with 0=no blue colouration and 3=very blue). The clones on solid media were 
grown for 20 days and scored, by eye, on a scale of 0-10 on the level of blueness seen 
(with 0=no blue colouration and 10=very blue).
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3.2 Materials and Methods
3.2.2 Selection of M.tuberculosis H37Rv Library Clones for Further 
Investigation
Clones identified as being of interest from section 3.2.1 were subcultured into 
a larger volume of selective 7H9 broth media and grown at 37°C, without shaking, for 
4 days. Each clone was then subcultured into selective 7H9 broth media at pH 6.6 
(control), pH 5.4 and pH 5.4 containing fresh NaN02 (0.5mM) as before.
62
Four days post-inoculation, a 0.5ml aliquot was removed from each culture, 
(diluted in 7H9 liquid media if  necessary) and the absorbance at 600nm of each 
sample was measured. A  further 0.5ml was removed and the activity of the 
P-galactosidase assayed. The culture was placed in a Hybaid Ribolyser™ blue tube 
containing 0.5ml DTT (0.5mM) in PBS, processed in a Hybaid Ribolyser™ at speed 
5.0 for 40 seconds, cooled on ice for 1 minute and frozen at -80°C to be assayed for 
p-galactosidase activity with Galacto-light plus. The p-galactosidase assay with 
Galacto-Light Plus substrate was carried out as described in Appendix 2.
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3.3.1 Growth of M.bovis B C G  Pasteur at Low pH and in the Presence of 
Reactive Nitric Intermediates (RNI).
M.bovis BCG Pasteur was grown in 40ml liquid 7H9 media at pH 6.6, pH 5.4, 
pH 5.0, pH 4.8, pH 4.6, pH 4.4, pH 4.2, pH 4.0 and incubated at 37°C, without 
shaking. It was already known that M.bovis BCG Pasteur was capable of growing in 
medium at pH 5.4 (pers. comm.: Stewart, G.R.). However, for this study it was 
necessary to stress the bacteria as much as possible whilst still allowing them to grow 
at, or near, the rate of mycobacteria grown in liquid medium at pH 6.6. Every 6 to 12 
hours, a 0.5ml aliquot was removed and the absorbance of the culture was measured 
at 600nm (diluting confluent samples in complete liquid 7H9 medium if necessary). 
The absorbance of each aliquot was plotted on a log scale against time. M.bovis BCG 
Pasteur grows in 7H9 medium at pH 5.4 almost as well as it grows in the same 
medium at pH 6.6 (Figure 3.1). However, when grown in more acidic media, M.bovis 
BCG Pasteur appears not to replicate as indicated by the lack of increase in OD6oo-
At pH 5.4, the acidity is low enough to generate reactive nitrogen 
intermediates from sodium nitrite. Therefore, M.bovis BCG Pasteur was grown in 
40ml 7H9 liquid media at pH 5.4 with final concentrations of 0.25mM, 0.5mM, 
l.OmM, 2mM, 4mM, 8mM and 12mM sodium nitrite. The sample aliquots were 
treated as described previously and the absorbance at 600nm measured. At 
concentrations of sodium nitrite above 2mM there is little if any bacterial growth (See 
Figure 3.2). M.bovis BCG Pasteur grown in medium containing ImM sodium nitrite 
do grow but, within the time scale of this experiment, only reach about half the cell
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density of bacteria grown in the control medium at pH 6.6. Figure 3.2 also shows that 
there is little difference in the growth of M.bovis BCG Pasteur when grown in liquid 
media at pH 6.6, pH 5.4 and liquid media at pH 5.4 containing 0.25 and 0.5mM 
sodium nitrite.
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-7H9 7H9 pH5.4 -*-7H9pH5.0 -*-7H9pH4.8
■ 7H9 pH4.6 -*-7H9pH4.4 7H9 pH4.2 7H9 pH4.0
Figure 3.1: Growth curve of M.bovis BCG Pasteur grown in liquid 7H9 medium at different pH values
The object of this short study was to identify the lowest pH value and highest 
sodium nitrite concentration that M.bovis BCG Pasteur can grow ‘normally’ at. With 
the knowledge that M.bovis BCG Pasteur is capable of growing in 7H9 liquid media 
at pH 5.4 and 7H9 liquid media at pH 5.4 containing 0.5mM sodium nitrite as well as 
it grows in the control media at pH 6.6, the entire library will be subjected to these 
condition.
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-*-7H9pH6.6 7H9 pH5.4 0.25mM NaNO
0.5mM NaNO — 1 .OmM NaNO — 2.0mM NaNO
—t—4.0mM NaNO ---8.0mM NaNO  12.5mMNaNO
Figure 3.2: Growth curve of M.bovis BCG Pasteur grown in liquid 7H9 medium at pH 5.4 with varying 
concentrations of sodium nitrite. All liquid 7H9 media at pH5.4 unless stated.
3.3.2 First Round In Vitro Screening of Library Clones.
All 4800 library clones were subcultured with a 96 pin replicator into both 
solid and liquid selective media containing X-gal, which will turn blue on expression 
of p-galactosidase by any clone. Solid and liquid media were both used because some 
clones grew better in one or other of the media. Additionally (as mentioned in 
Chapter 2) some clones grown on solid 7H11 media do not turn blue but rather turn 
the media blue. Clones that do not become blue but turn the medium blue or clones 
that are weakly expressing lacZ are easier to detect in liquid rather than solid media.
Each clone was subcultured in both solid 7H11 and liquid 7H9 media at pH
6.6 (control), pH 5.4 and pH 5.4 containing 0.5mM sodium nitrite. Differential
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expression of promoter activity can be directly related to the intensity of the blue 
colouration of the clone. This is the simplest method of identifying potentially 
up-regulated promoters for such a large number of clones. It is possible to measure 
levels of blue colour produced digitally by using an image analyser. However 
observational determination was as good at assigning an intensity of blue colouration 
in addition to being able to identify differences in clone morphology. In order to 
maintain consistency, the scale below was used to score clones grown on the three 
different types of selective solid media (see Figure 3). Each clone was subcultured 
and incubated at 37°C on each of the three solid 7H11 media types. After 21 days 
incubation, each clone was independently compared with the colouration scale and 
allocated a number representing the level of blueness.
Determination of blue colouration of clones in liquid medium was not without 
technical difficulty. Liquid 7H9 medium, despite being fairly clear, has a faint yellow 
colour. Therefore a colour scheme analysis was extremely difficult to devise. To 
minimise any inconsistencies a reduced scale was used with a range of only 0-3 with 
0 representing no blue colour at all and 3 being very blue. Each clone was subcultured 
and incubated at 37°C in each of the three liquid media types. After 7 days incubation, 
each clone was independently compared with the colouration scale and allocated a 
number representing the level of blueness.
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Figure 3.3: Scale of intensity of blue colouration generated by M.bovis BCG Pasteur clones harbouring 
the M.tuberculosis promoter trap vector when grown on solid 7H11 medium containing X-gal.
The scores, directly related to the expression of lacZ, for each clone grown on 
the control solid 7H11 medium were compared with the score given to the clone 
grown on solid media at pH5.4 and pH 5.4 containing 0.5mM sodium nitrite. The 
scores for each clone grown in the three liquid 7H9 media were compared in a similar 
manner. For example, Table 4.1 shows the scores, for the three different liquid media, 
for 6 clones from the same 96 well microtitre™ plate.
Clone Number Liquid 7H9 Liquid 7H9 pH 5.4 Liquid 7H9 pH5.4 0.5mM NaNC>2
A10 1 3 0
BIO 0 1 0
CIO 0 2 0
DIO 0 0 0
E10 0 2 1
F10 2 1 2
Table 3.1: Table of six M.bovis BCG Pasteur clones harbouring the M.tuberculosis promoter trap 
vector. All clones from the same 96 well microtitre™ plate and grown in liquid 7H9 medium at pH 6.6, 
pH 5.4 and pH 5.4 containing 0.5mM sodium nitrite. For example, clone A10 clearly expresses more 
lacZ when grown in medium at pH 5.4 than it does in the control medium. Clone A10 does not express 
any lacZ when grown in liquid 7H9 medium at pH 5.4 containing 0.5mM sodium nitrite.
A total of 333 clones were identified as showing a difference in the level of 
lacZ expression, either higher or lower compared to the solid or liquid control media, 
in either or both of the stressing media. These were selected for further investigation. 
Clones exhibiting up-regulation of lacZ expression when grown on stressing media, 
compared to the control medium, numbered 240, whilst 80 clones showed
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down-regulation. Thirteen clones grew and showed levels of expression when 
stressed but failed to grow on the control media. Since each of the clones were 
exposed to the stressing conditions in both solid and liquid media, there should be 
some correlation between the results of the two media types. Of the clones exhibiting 
up-regulation of lacZ expression only 4 correlated between solid and liquid media, 
whilst 14 down-regulated clones correlated. Twenty clones exhibited different 
regulation between solid and liquid media. The correlation between solid and liquid 
media is therefore quite low, however this may be due in part to technical difficulties 
when transferring clones to solid media using a 96 pin replicator. Indeed nearly 70% 
of the clones selected for further investigation were identified from growth in the 
liquid media. Roughly 4.5% of the 4800 clones failed to re-grow on any media, 
accordingly these clones were not re-tested.
When the 4800 clones were initially selected and arrayed from the 
transformation plates containing X-gal, each of the fifty 96 well microtitre™ plates 
contained either blue or white clones. The selection process described above 
identified clones that required further investigation from 32 different 96 well 
microtitre™ plates. Of the 333 clones identified, 207 had been initially arrayed as 
being blue.
3.3.3 Second Round Screening of M.tuberculosis H37Rv Plasmid Library Clones 
for Further Investigation
The 333 clones selected as having an altered level of lacZ expression when 
stressed, compared to unstressed, were identified previously using a qualitative assay.
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In order to reduce the number of clones to be progressed towards an in vitro 
macrophage infection experiment and to provide a quantitative verification of the 
results above, the 333 clones were individually subcultured into selective liquid 7H9 
broth at pH 6.6 (control), pH 5.4 and pH 5.4 containing 0.5mM sodium nitrite. Media 
contained no X-gal, as the level of expression of lacZ would be measured by using a 
|3-galactosidase assay. Four days post-inoculation, the number of mycobacterial cells 
present in each culture was estimated by measuring the absorbance of the culture at 
600nm. 0.5ml of the culture was also ribolysed in 0.5ml 0.5mM DTT in PBS and 
frozen. (DTT solution in PBS stabilises any (3-galactosidase enzyme present.)
To measure the (3-galactosidase expressed in this subset of clones, a different 
assay procedure was adopted, taking advantage of the availability of a more sensitive 
product to measure lacZ expression. The use of Galacto-Light Plus (Tropix Inc.) is 
described in the methods appendix. This chemiluminescent assay exhibits over three 
orders of magnitude greater sensitivity compared to colormetric fl-galactosidase 
assays, such as the Miller test. There is also a large signal-to-noise ratio making it 
suitable for monitoring low levels of reporter activity and thus it was used in 
preference over of the conventional Miller (3-galactosidase assay.
Ideally for reliable quantitative results, each clone would have been grown in 
the three media types and assayed in triplicate in the three liquid media generating 
8991 samples. Handling this number of samples is impractical in the circumstances of 
this project. The primary objective at this stage was to reduce the number of clones to 
a manageable number for studying the lacZ expression in cultured macrophages.
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Dispensing with replicate assays is a necessary compromise that still allows a rational 
selection of an appropriate number of clones. Therefore each clone and the two clones 
of M.bovis BCG Pasteur harbouring pUS1800 and pUS1808 respectively, as negative 
and positive controls, were subcultured into selective liquid 7H9 broth at pH 6.6 
(control), pH 5.4 and pH 5.4 containing 0.5mM sodium nitrite once and assayed only 
once.
Each 96 well microtitre™ plate was set up with a blank well of 20pl of 0.5mM 
DTT in PBS, with the rest of the wells containing samples. With the luminescence 
measured, the sample readings were compensated to reduce any background effect of 
the DTT and the PBS. As the absorbance at 600nm of each culture was measured 
prior to ribolysation, the number of cells added to each assay could be calculated by 
assuming that an M.bovis BCG Pasteur culture with an ODeoonm of 1.0 contains lx l08 
cells/ml. Using the value, light units (LU)/106 M.bovis BCG Pasteur cells were 
calculated and relative light units expressed in this fashion.
Appendix 3 contains a table that shows the LU/106 M.bovis BCG Pasteur cells 
of each clone grown in the control medium and ratios of LU/106 M.bovis BCG 
Pastern* cells of the clones grown in low pH and high nitric oxide media compared to 
the control medium.
A number of clones, highlighted in Appendix 3 with green ink, showed no 
Light Units (LU)/106 M.bovis BCG Pasteur cells when grown in control medium but 
exhibited luminescence when grown either or both of the stressing media. It these 
cases a ratio of regulation can not be generated. In many case this may be
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insignificant, especially when the Light Units (LU)/106 M.bovis BCG Pasteur cells 
generated from growth in stressing media is low. However this is not the case with a 
number of clones, such as clones 295 and 322, which exhibit considerable Light Units 
(LU)/106 M.bovis BCG Pasteur cells when grown in the stressing media. These clones 
may contain promoter like cloned DNA, which may be of interest.
Once all 333 clones grown in all three media had been assayed, the next step 
was to decide which clones were to be used in macrophage infection experiments. By 
dividing each of the LU/106 bacterial cells for both the stressing media by the LU/106 
bacterial cells produced by the clone grown in the control medium, a ratio of 
‘up-regulation’ was generated. All clones that generated an ‘up-regulation’ ratio from 
growth in the nitric oxide stressing media greater than 3 or more were selected for 
further investigation. This process was repeated using the ratio for growth in the pH 
stressing and control media for each clone. This process identified 53 clones, from the 
previous 333 clones, that were considered eligible by these selection criteria for future 
investigation.
It is important to note the wide variation in expression being exhibited by the 
clones identified for further investigation. The majority of the clones have a basal 
expression of between 100 and 1000 Light Units (LU)/106 M. bovis BCG Pasteur 
cells. This is in contrast to the clone harbouring pUS1808, containing the hsp60 
promoter, which exhibits 8945 Light Units (LU)/106 M.bovis BCG Pasteur cells. 
However it was observed with clone 233 that more than 2 fold more LU/106 M.bovis 
BCG Pasteur cells than the pUS1808 clone were expressed and this clone exhibits 
up-regulation of 4.7 when stressed by low pH medium. This implies that this is a very
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strongly expressing clone as the hsp60 promoter is generally considered a strong 
promoter. There are a number of clones which exhibit ratios of up-regulation greater 
that 10, but the majority of clones are up-regulated by between 3 and 5.
It can be clearly seen from Figure 3.4 that the clones selected by the process 
of a ratio of ‘up-regulation’ exhibit great variation in their relative levels of 
expression up to a 5 log variation in LU/106 bacterial cells. Some clones are 
‘up-regulated’ by the presence of either low pH or a high concentration of reactive 
nitrogen intermediates, some clones by both.
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The object of this study was to identify clones exhibiting greater promoter 
activity when grown in stressing conditions compared to growth in control medium.
It is believed that M.tuberculosis is exposed to high concentrations of reactive 
nitrogen intermediates in macrophages. However unlike other microbes, 
M.tuberculosis-containing phagosomes fail to acidify early on in the infection 
process. There are no studies of this in late infection. If the macrophage is incapable 
of acidifying the phagosome, this effect may, in part, be due to the actions of 
M.tuberculosis itself, which perhaps has a compensatory early protective response to 
ensure survival.
The 4800 clones were exposed to two conditions in vitro that are thought to 
play a pivotal role in arresting the infection of M.tuberculosis; low pH and high 
concentrations of reactive nitrogen intermediates. Clones were exposed to these 
conditions and the level of expression of lacZ of each clone was estimated by eye and 
compared to the control. This identified 333 clones which showed altered expression 
in one or both of the stressing conditions compared to the control medium. In the 
second screen these 333 clones were exposed to the same conditions and a more 
accurate measurement of lacZ expression was carried out using the Galacto Light 
Plus p-galactosidase assay.
It was originally thought that each screening regime might discard 
approximately 90% of the clones. The visual comparison reduced the number of
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clones carried forward to the p-galactosidase assay from 4800 to 333, whilst the 
p-galactosidase assay reduced the number of clones to be screened in macrophage 
infection to 53 clones, representing a 93% and a 84% discard rate respectively.
Each of 4800 M.bovis clones were selected at random but had been arrayed in a 
96 well microtitre™ format on the basis of whether they were blue or white when 
grown on solid 7H11 medium containing X-gal. The 53 clones selected for 
macrophage infection experiments come from 13 different 96 well microtitre™ plates. 
Of the clones selected for further investigation, 46 came from 96 well microtitre™ 
plates that were arrayed as containing blue clones and the remainder coming from the 
white arrayed plates. This is not really surprising as any genes up-regulated during 
infection will more than likely have some activity in vitro and therefore cloned 
promoters controlling these genes will be capable of driving lacZ expression in vitro 
without being stressed, hence being present in blue 96 well microtitre™ plates. 
However, perhaps more interesting are the clones originally arrayed as having no lacZ 
expression when arrayed but which have subsequently been selected as expressing 
lacZ under challenge conditions. The reason that these clones may be of greater 
interest is that, if they contain cloned promoters, the genes controlled by these 
promoters may only be activated by stressing conditions designed to mimic those in 
vivo.
During both of the stressing selection processes, not only were clones that 
potentially contain up-regulated promoters identified but also clones whose lacZ 
expression was reduced. These clones contain potential promoters which appear to be
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down-regulated and these may be just as important as any of those which appear 
up-regulated. However, within the remit of this study, these clones were not 
investigated any further.
One limitation of this study is that the growth phase of the assayed clones is not 
considered. The promoters of different genes are activated at different stages in the 
growth phase according to their function in the cell cycle. This is shown by the 
positive control plasmid, pUS1808. It has been previously identified that the Hsp60 
protein (GroEL2) is expressed at low levels during the in vitro exponential growth 
phase but expression is increased during the late-exponential and stationary phases 
(Batoni et a l 1998). Batoni et ah also found that hsp60 expression increased when 
M.bovis BCG was exposed to elevated temperatures but no up-regulation was 
observed when exposed to hydrogen peroxide (expression levels were not measured 
when M.bovis BCG was exposed to low pH or reactive nitrogen intermediates). 
However in this study, the pUS1808 clone containing the hsp60 promoter (expression 
being measured in 3 different growth conditions) has a lower level of expression of 
lacZ when the clone is stressed. This most likely due to the growth phase of the 
M.bovis BCG Pastern* cultures harbouring pUS1808 in the three different conditions 
(see Figure 3.4).
Clone 295, which comes from a 96 well microtitre™ plate initially selected as 
being blue, is another example of where care should be taken in interpreting the 
results from this in vivo mimicking study. This clone exhibited no lacZ expression 
when grown in the 7H9 liquid control medium. However when the expression of lacZ 
was measured, for the clone grown in stressing condition, significant LU/ 106
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bacterial cells were measured. This may or may not be due to the absence of lacZ 
expression when grown in the control medium or may be due to the fact that the each 
clone was only measured once and thus the measurement of lacZ expression is not 
actually correct. Since there was no detected expression when the clone was not 
stressed, a ratio of induction can not be calculated but clone 295 exhibited significant 
levels of lacZ expression when it was stressed. Clone 295 will therefore be included 
in further macrophage infection studies.
Importantly, the rationalising process of exposing the 4800 M.bovis library 
clones to conditions designed to mimic two of the environmental conditions believed 
to be within the M.tuberculosis-contammg phagosome has reduced the number of 
clones to be infected by 99%. These clones were selected for progression into the 
macrophage challenge assay to determine whether they would also differentially 
express IcicZ in vivo.
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Chapter 4: Macrophage Cell-Line Infections with Mycobacterium bovis BCG Pasteur Library.
4 . 1  I n t r o d u c t i o n
In Chapter 3, 53 of the 4800 M.bovis BCG Pasteur clones were identified as 
harbouring cloned M.tuberculosis DNA with promoter-like activity, which was 
up-regulated when stressed in vitro. The object of stressing the clones in vitro was to 
generate a smaller number of clones which could subsequently be used in 
macrophage infection studies.
Ideally both a positive and negative control should be used to compare the level 
of lacZ expression with the 53 selected clones during a macrophage infection 
experiment. In Chapter 2 two plasmids were constructed -  the basal plasmid, 
pUS1800, and the positive control plasmid, pUS1808. However the positive control 
plasmid pUS1808 was constructed with a heat shock promoter (hsp60) driving the 
expression of lacZ and, when constructed, it was thought the expression of the Hsp60 
protein was constitutive and unaltered during infection. However, during the time 
frame of this study it was shown that the hsp60 gene (Rv0440/ groELI) is 
up-regulated during infection and is therefore unsuitable for use as a positive control 
in this instance (Batoni et a l, 1998). pUS1800 was used as a negative control whilst 
pUS1808 was not used in the macrophage infection studies.
4.1.1 Strategy
All 53 clones, with the addition of Clone 295, (identified previously in 
Chapter 3) were used in cultured macrophage infection experiments. Two types of 
cultured macrophages cell lines, mouse J774 and human THP-1 macrophages, were
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infected with each of the clones (Unkeless, 1979; Auwerx, 1991). Both cell lines were 
used as it is not clear* whether there would be any difference in the environmental 
conditions inside the vacuoles of the two different macrophages. It is thought that the 
two cell lines may well differ in then* ability to generate reactive nitrogen and oxygen 
intermediates.
At pre-selected time intervals, the internalised M.bovis BCG Pasteur clones 
were recovered from the macrophages and P-galactosidase assays carried out using 
the Galacto Light Plus assay, along with any relevant controls. The Light Units of 
each clone post-infection was compared with any relevant controls and a small 
number of clones that still show up-regulated lacZ expression were selected for 
further investigation.
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4 . 2  M a t e r i a l s  a n d  M e t h o d s
4.2.1 Macrophage Infection
4.2.1.1 J774 mouse macrophage cell line (Unkeless, 1979)
The mouse macrophage cell line J774 was maintained as described in Appendix 
2. The pre-selected promoter probe and control recombinant clones were grown to 
mid-exponential growth phase and the bacterial numbers were estimated by 
measurement of the absorbance at 600nm (Amo)- The mycobacterial cultures were 
harvested by centrifugation at 3000g for 10 minutes. The medium was discarded and 
replaced with Dulbecco's modified Eagles medium containing 10% foetal calf serum. 
Mycobacteria were added to adherent macrophages with a multiplicity of infection 
(MOI) of 10. Infection was allowed to proceed for the required length of time, either 
2, 12 or 24 hours, and stopped by the removal of the medium. Any non-phagocytosed 
mycobacteria were removed by washing the J774 mouse macrophage cell line twice 
with 0.5 ml PBS. Mycobacteria were extracted from the macrophages by the addition 
of 0.6 ml SDS (0.0025% w/v). The number of internalised bacterial cells was 
estimated by serially diluted lOOpl aliquots of the macrophage lysate, containing the 
internalised M.bovis BCG Pasteur clones. A range of dilutions (between 10‘2 and 10"5) 
were plated on kanamycin selective solid 7H11 media and incubated at 37°C for 21 
days. After this time interval, colonies were counted.
The remaining mycobacteria (in 0.5 ml SDS (0.0025% w/v), extracted from 
each mouse macrophage infection, were transferred to Hybaid Ribolyser™ blue tube 
containing 0.5ml DTT (0.5mM) in PBS and were processed in a Hybaid Ribolyser™
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at speed 5.0 for 40 seconds, cooled on ice for 1 minute then frozen at -80°C. 
P-galactosidase activity was then measured with Galacto-light plus.
4.2.1.2 THP-1 human macrophage cell line (Auwerx, 1991)
The human macrophage cell line THP-1 was maintained and differentiated as 
described in Appendix 2. Mycobacterial numbers were estimated by absorbance at 
600nm (rteoo), after growth to mid-exponential growth phase in 7H9 broth. These 
were harvested by centrifugation at 3000g for 10 minutes, the medium discarded and 
replaced with Dulbecco's modified Eagles medium containing 10% foetal calf serum. 
Mycobacteria were added to adherent macrophages with a multiplicity of infection 
(MOI) of 10. Infection was allowed to proceed for the required length of time, either 
2, 12 or 24 hours, and stopped by the removal of the medium. Any non-phagocytosed 
mycobacteria were removed by washing the THP-1 human macrophage cells twice 
with 0.5 ml PBS. Mycobacteria were extracted from the macrophages by the addition 
of 0.6 ml SDS (0.0025% w/v). The number of internalised bacterial cells was 
estimated by serial diluting lOOpl of the macrophage lysate, containing the 
internalised M. bovis BCG Pasteur clones. A range of dilutions (between 10'2 and 10"5) 
were plated on kanamycin selective solid 7H11 media and incubated at 37°C for 21 
days. After this time interval, colonies were counted.
The remaining mycobacteria, extracted from each mouse macrophage 
infection, were transferred to Hybaid Ribolyser™ blue tube containing 0.5ml DTT 
(0.5mM) in PBS, processed in a Hybaid Ribolyser™ at speed 5.0 for 40 seconds,
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cooled on ice for 1 minute and frozen at -80°C. p-galactosidase activity was then 
measured with Galacto-light plus.
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4.3.1 Macrophage Infection with the Pre-Selected Clones.
All 53 selected M.bovis BCG Pasteur, with the addition of clone 295, were 
subcultured into selective 7H9 liquid medium. Each clone was to be used in 
macrophage infection experiments of both human and mouse cell lines. However, 12 
clones were found not to be viable upon subculture making further study not possible. 
These clones were numbers 5, 62, 137, 173, 174, 194, 220, 229, 240, 282, 297 and 
313. Despite repeated attempts at reculture, it was not possible to re-start growth with 
any of these clones or to recover the clones from the frozen cultures. These clones 
were therefore not tested further. Therefore the number of clones used in infection 
studies in human and murine macrophages totalled 42-41  clones up-regulated by in 
vivo mimicking stressing conditions and clone 295.
Each well of a six well microtitre™ plate containing macrophage cells was 
inoculated with an individual clone (MOI=10) and was also subcultured in complete 
Dulbecco's modified Eagles medium and into selective 7H9 liquid medium as a 
control. All cultures were incubated at 37°C. At 2, 12 and 24 hours post-infection 
macrophages were washed and lysed. Control samples of BCG clones in complete 
Dulbecco's modified Eagles medium were taken at 2 and 24 hours whilst one liquid 
7H9 control sample was taken at 24 hours. For each time point, a lOOpl aliquot of the 
macrophage lysates and the M.bovis BCG Pasteur clone incubated in both complete 
Dulbecco's modified Eagles medium and liquid 7H9 media were serially diluted and 
selective plates (kanamycin) inoculated with a range of dilutions. These plates were 
incubated at 37°C for 21 days and colony numbers counted.
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0.5ml of the remaining lysate was added to a Hybaid Ribolyser™ blue. Each 
ribolyser tube was ribolysed immediately, cooled on ice for 1 minute and stored at 
-80°C. The lysis of the macrophages, addition of the lysate to the ribolyser tubes and 
ribolysation was carried out as quickly as possible to minimise any protein 
degradation.
Each of the 42 M.bovis BCG Pastern* clones was assayed in triplicate after 
inoculation into macrophage cell lines. As two cell lines were infected with each 
clone for three different lengths of time and that each liquid 7H9 media control was 
conducted twice (once for each macrophage cell line), this infection experiment was 
conducted once. As with the in vivo mimicking condition experiments described in 
Chapter 3, these initial infections provided a means of screening clones for use in 
further detailed macrophage infection studies.
When using mammalian cell lines, the Galacto-Light Plus assay buffer has 
been designed to discriminate between any endogenous p-galactosidase enzyme and 
the bacterial form of the enzyme. The buffer is supplied at pH 8.0 which enables 
sensitive detection even in cell lines with relatively high levels of endogenous 
P-galactosidase activity (described in protocol supplied with Galacto-Light Plus 
assay). In order to ensure that the macrophage p-galactosidase is not affecting the 
detectable P-galactosidase being generated by each clone, each cell line was cultured 
for 24 hours, not infected, lysed and assayed using Galacto-Light Plus to measure the 
macrophage basal P-galactosidase activity, p-galactosidase enzyme activity could not 
be detected in either of the macrophage types.
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Figure 4.1 is a graphical depiction of Light Units (LU)/ 106 bacterial cells for 
4 different clones, and the negative control harbouring pUS1800, post-infection of 
both macrophage types. The clones in question were selected as they represent a 
number of key points. The results obtained from the infections of both macrophage 
types with all 42 clones can be seen in Appendix 4. The graph for each clone is 
almost the same regardless of the macrophage type infected -  the graph of expression 
during the infection of a clone into murine macrophages is in general similar to that in 
THP-1 cells. Importantly each clone has a fairly consistent level of expression in each 
of the controls at the different time points.
It is clear from Figure 4.1 that, as before, the clones show a wide range of 
levels of expression of lacZ. The negative control (M.bovis BCG Pasteur harbouring 
the basal plasmid pUS1800) has a very low level of lacZ expression. Clone 180 
appears to have greater expression of lacZ post-infection in both murine and human 
macrophages. In both macrophage types, lacZ expression from clone 180 has 
generated more LU/ 106 bacterial cells than both the controls. The greater the length 
of time that the clone is within the macrophage the higher the level of lacZ 
expression. This suggests that clone 180 potentially contains a promoter whose 
activation is increased during infection.
Clones 233 and 254 have been included in Figure 4.1 as examples of clones 
which do not appear to be up-regulated during infection. Clone 233 shows a little 
up-regulation of expression of lacZ after 2 hours when infected in murine 
macrophages but shows no induction after 12 and 24 hours infection, compared to the 
complete Dulbecco’s modified Eagles medium controls. Conversely when infected
Chapter 4: Macrophage Cell-Line Infections with Mycobacterium hovis BCG Pasteur Library.
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into human macrophages, clone 233 is induced after 12 and 24 hours infection 
compare to the complete Dulbecco’s modified Eagles medium control at 24 hours but 
there is no up-regulation after 2 hours compared to the control. The graphs 
representing clone 254 show a similar trend.
Expression from clone 239 is perhaps the most straight forward to inteipret. In 
both macrophage types, there is a considerable induction (about 2 logs) of lacZ 
expression 2 hours post-infection compared to the complete Dulbecco’s modified 
Eagles medium control at 2 hours. The expression of lacZ at the subsequent time 
points decreases in both murine and human macrophages, whilst the lacZ expression 
of the clone grown in the complete Dulbecco’s modified Eagles medium control is 
induced after 24 hours growth.
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It is evident that the interpretation of Figure 4.1, and Appendix 4, requires 
great care to identify any clones that should be investigated further. The increase in 
LU/ 106 bacterial cells of clones 180 and 239 post-infection of both macrophages, 
compared to the clone incubated in complete Dulbecco’s modified Eagles medium for 
the same length of time, suggest that they may be up-regulated during infection. 
Figure 4.1 also suggests that the expression of lacZ in clones 233 and 254 are not 
up-regulated.
Clone 295 was included within the clones for further investigation as an 
example of a clone whose expression of lacZ could not be detected when not stressed 
but could be detected when the clone was grown in stressing media. The clone 
exhibits relatively low levels of p-galactosidase activity when incubated in the control 
media and in the complete Dulbecco’s modified Eagles medium after 2 hours growth 
(see Appendix 4). However during the infection of both murine and human 
macrophages the lacZ expression of clone 295 is increased during the initial stages of 
the infection, up to 12 hours. At 24 hours post-infection, the expression of the clone 
within the macrophages is similar to the expression of the clone incubated in 
complete Dulbecco’s modified Eagles medium after 24 hours. This indicates that 
clones showing elevated expression of lacZ when grown in low pH and/or raised 
nitric oxide intermediates but have undetectable levels of expression when not 
stressed merit investigation via macrophage infection.
There are a number of clones which exhibit high levels of lacZ expression 
when incubated in complete Dulbecco’s modified Eagles medium, compared to the 
liquid 7H9 control medium. Taking clone 279 as an example, the expression of lacZ
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after 2 hours incubation in complete Dulbecco's modified Eagles medium and at all 
time points during the infection is not dissimilar to the lacZ expression of the clone 
when grown in the liquid 7H9 control medium. However, after 24 hours incubation in 
complete Dulbecco's modified Eagles medium, the p-galactosidase activity of clone 
279 is considerably elevated compared to the growth in the liquid 7H9 control 
medium. This may be a significant stress response to serum factors as mycobacteria 
are not thought to grow in complete Dulbecco's modified Eagles medium.
The results of the infection experiments, shown in Appendix 4, were not 
considered in themselves sufficient to decide which clones should be selected for 
further investigation, therefore a second criterion of selection was introduced. The 
ultimate aim of this work was to identify promoters, and therefore their genes, which 
are up-regulated during infection. The best way of identifying clones carrying 
genuine putative promoters responsible for up-regulation is to sequence the 
M.tuberculosis H37Rv DNA inserted at the Narl site of pUS1800. Therefore all 42 
clones were sequenced in both directions and homology to the Mycobacterium 
tuberculosis H37Rv genome, held at the Sanger centre, determined 
(http://www.sanger.ac.uk/Projects/M_tuberculosis/). This is discussed in more detail 
in Chapter 5
Once the homologies of the 42 clones had been identified, a number of clones 
were identified in which P-galactosidase expression was more likely to be due to an 
artefact of the cloned piece of DNA rather than a genuine promoter. In one clone the 
insert contains a potential promoter that is in the wrong orientation for driving the 
expression of lacZ, compared to its genomic orientation. Another clone contains an
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intergenic region between two converging genes and is there for unlikely to contain a 
potential promoter sequence. When sequenced, 15 clones were identified as 
containing MJuberculosis H37Rv DNA internal to genes, which would suggest that 
they are unlikely to be promoters. A further 25 clones were identified as containing 
potential promoter sequences. These clones contain MJuberculosis H37Rv DNA in 
the correct orientation directly up-stream of a gene, contain the end of one gene and 
the start of the next gene or contain regions of MJuberculosis H37Rv DNA covering 
more than two genes (and therefore potentially contained two or more promoters).
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I decided that 5 clones was a suitable number for further investigation and 
those selected were clones 169, 175, 176, 180 and 239. These clones were selected on 
the basis of containing only one promoter-like sequence whilst still exhibiting 
up-regulation of lacZ post macrophage infection compared to the complete 
Dulbecco’s modified Eagles medium controls. Table 4.1 gives brief descriptions of 
the MJuberculosis H37Rv DNA inserted within these clones but a more detailed 
description can be seen in Chapter 5.
Clone
Number
MJuberculosis H37Rv DNA inserted at the Narl site of pUS1800.
169 Intergenic between genes Rvl043 and Rvl044 through to within 
gene Rvl044
175 Internal to gene Rv0301 through to within gene Rv0302
176 Internal to gene Rv2710 through to within gene Rv2711
180 Internal to gene Rvl 164 through to within gene Rvl 165
239 Intergenic between genes Rvl264 and Rvl265 through to within 
gene Rvl265
Table 4.1: The clone number is shown against the M.tuberculosis H37R.V DNA inserted into the Narl 
site of pUS1800 harboured within the clone. The harboured plasmid was sequenced across the inserted 
M.tuberculosis DNA bi-directionally and homologies identified against die M.tuberculosis H37Rv 
genome held at the Sanger centre. The Rv numbers correspond to the annotations of Cole et al. (1998).
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4.3.2 Re-Infection of 5 Clones Showing Up-Regulation during Initial Infection.
The five clones above, selected on the basis of apparent up-regulation during 
infection of murine and human macrophages and due to the fact that the sequence 
data suggested the presence of a genuine promoter, were re-infected into human 
macrophages and studied in greater detail. As the data in Appendix 4 suggests that the 
type of macrophage infected with a clone makes little difference to the level of 
expression of lacZ by that clone, only one macrophage type was used subsequently. 
M.tuberculosis is a human pathogen and it was therefore decided that human THP-1 
macrophages would be used in the more detailed study.
Each clone was either infected or subcultured (in complete Dulbecco’s 
modified Eagles medium or liquid 7H9 medium) in triplicate for 2, 4, 6, 12 and 24 
hour's. If a gene is responsible, in part, for survival within a macrophage, it would be 
expected to be up-regulated soon after phagocytosis and therefore the time scale is 
concentrated towards the initial stages of infection. Infections and sample collection 
were carried out as described previously and each sample was assayed in triplicate. 
Following are Figures 4.2-4.6 which are bar charts that show the Light Units/ 106 
bacterial cells against time of growth or time of infection for the Clones 169, 175, 
176,180 and 239.
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Figure 4.2: Bar Chart of Light Units/ 106 bacterial cells against time of infection in human THP-1 
macrophages for clone 169. Each bar represents the average of three independent infections or 
subcultures. Error bars represents triplicate samples assayed in triplicate using the Galacto-Light Plus 
assay as standard deviations. 2 hour infection P<0.05, 24 hour infection P<0.01.
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Figure 4.3: Bar Chart of Light Units/ 106 bacterial cells against time of infection in human THP-1 
macrophages for clone 175. Each bar represents the average of three independent infections or 
subcultures. Error bars represents triplicate samples assayed in triplicate using the Galacto-Light Plus 
assay as standard deviations. 2 hour and 24 hour infection P<0.001, 12 hour infection P<0.01.
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Figure 4.4: Bar Chart of Light Units/ 106 bacterial cells against time of infection in human THP-1 
macrophages for clone 176. Each bar represents the average of three independent infections or 
subcultures. Error bars represents triplicate samples assayed in triplicate using the Galacto-Light Plus 
assay as standard deviations. 4 hour and 6 hour infection P<0.005, 12 hour infection P<0.01.
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Figure 4.5: Bar Chart of Light Units/ 106 bacterial cells against time of infection in human THP-1 
macrophages for clone 180. Each bar represents the average of three independent infections or 
subcultures. Error bars represents triplicate samples assayed in triplicate using the Galacto-Light Plus 
assay as standard deviations. 4 hour infection P=0.02.
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Figure 4.6: Bar Chart of Light Units/ 106 bacterial cells against time of infection in human THP-1 
macrophages for clone 239. Each bar represents the average of three independent infections or 
subcultures. Error bars represents triplicate samples assayed in triplicate using the Galacto-Light Plus 
assay as standard deviations. 6 hour infection P=0.02.
Figures 4.2-4.4 and figure 4.6 suggest that the clones 169, 175, 176 and 239 
show evidence of up-regulation of the reporter gene lacZ at some of the time points 
during the course of infection. The interpretation of the data in figure 4.5 is 
complicated although there is some suggestion of up-regulation of lacZ expression at 
12 hours. Figure 4.3 represents the expression of lacZ for clone 175, which appears to 
be up-regulated at most time points during the infection in the order of at least a log 
of LU/ 106 bacterial cells compared to the complete Dulbecco’s modified Eagles 
medium control. Clone 175 exhibits only a very small level of up-regulation during 
the first 12 hours of the infection but by 24 hours post-infection the expression of 
lacZ of the clone from within the macrophage is at least 2 logs greater than that of the 
clone grown in the complete Dulbecco’s modified Eagles medium control. 
Conversely, Figure 4.6 shows that clone 239 exhibits considerably more
■  239 THP-1 ■  239 Serum D 239 7H9
2 4 6 12 24
T ime of Infection (Hours)
up-regulation of lacZ expression during the first 4 hours of the infection with 
complete Dulbecco’s modified Eagles medium control expression rising towards the 
end of the infection time scale. There was also an apparent sudden increase of lacZ 
expression at 12 hours post-infection with clone 180. Clone 176, whose expression is 
depicted in Figure 4.4, indicates up-regulation of the promoter throughout the time 
scale of the macrophage infection.
The expression of lacZ in the liquid 7H9 control medium for all clones, except 
clone 169, is reasonably consistent. The reason for the considerable variation in the 
liquid 7H9 control medium for clone 169 is unclear but does need further 
investigation since it may be due to growth phase. However the lacZ expression of 
clone 169 post-infection also fluctuates but when studied as a whole Figure 4.2 
suggests that the clone may well indeed be up-regulated during infection. M  bovis 
BCG Pasteur harbouring pUS1800 and M.bovis BCG Pasteur were used to infect the 
human macrophage cell line but did not generate any LU/ 106 bacterial cells and 
therefore no data is shown. Un-infected macrophage controls were also carried out as 
controls and p-galactosidase could not be detected as found previously.
4.3.3 Replicate Assays for Clones carried out at Different Times.
The Galacto-Light Plus assays carried out for each clone grown in control 
7H9 control medium during the in vivo mimicking (Chapter 3) and macrophage 
infection studies (this chapter) exhibited varying levels of lacZ expression. This was 
an unexpected observation. It would be expected that a clone subcultured in the same
( 'hct/Ner 4: Macrophage Cell-Line Infections with Mycobacterium hovis BC 'G Pasteur Library.
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growth medium over a long period and assayed for lacZ expression at different times 
would exhibit similar levels of lacZ expression.
The luminometer, (Packard Lumicount Model AL10001) and PlateReader 
Software (v2.1) measures the quantity of P-galactosidase enzyme present, by 
scanning the 96 well microtitre™ plate to find the well producing the greatest amount 
of light. Once this well has been identified, the plate reader and software set this well 
as the maximum light emission. The main benefit of this internal adjustment is to 
broaden the linear range of the luminometer and thus makes the equipment more 
versatile. If multiple 96 well microtitre™ plates are being read, and it is expected that 
all readings will fall within the set linear range, then the maximum reading of the first 
96 well microtitre™ plate can be used for all subsequent 96 well microtitre™ plate 
readings. This makes the Galacto-light Plus assay a quick assay when analysing a 
large number of samples.
Within this study, three Galacto-light Plus assays were carried out at different 
times, described in sections 3.3.3, 4.3.1 and 4.3.2. Therefore each assay was carried 
out with a different internal setting on the luminometer and its software. This means 
that without the inclusion of a positive control, the three different experiments can not 
be compared. The obvious positive control to be included would be pure 
p-galactosidase enzyme. However, the inclusion of a positive control would be 
difficult because, for each concentration of the standard, a separate 96 well 
microtitre™ plate would have to be set up.
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During each assay, in order to account for the effect of the PBS and DTT that 
the M.bovis BCG Pasteur lysates where stored in, each 96 well microtitre™ plate was 
assayed with a negative control of 0.5mM DTT in PBS. This allowed the Light Units/ 
106 bacterial cells for each sample to be calculated to take account of the presence of 
PBS and DTT. Therefore all Light Units/ 106 bacterial cells shown in Chapters 3 and 
4 have been corrected so as to indicate only the level of p-galactosidase enzyme 
present.
Therefore despite the fact that the assays were carried out in the same manner, 
each of the results have to be viewed separately (see Figures 3.4, the graphs in 
Appendix 4 and Figures 4.1 -  4.6). The graphs in Chapters 3, Appendix 4 and 
Chapter 4 can not be compared. If they are compared it soon becomes apparent that 
there is one key problem. If an individual M.bovis BCG Pasteur clone were to be 
cultured over a long period of time it would be expected that the Light Units/ 106 
bacterial cells would remain relatively constant, ignoring the effect of growth phase 
on expression. Figure 4.7 is a graph that shows the Light Units/ 106 bacterial cells for 
liquid 7H9 controls for clone 169 taken during the three different studies. Figure 4.7 
suggests that clone 169 is not expressing the same amount of p-galactosidase protein 
over the period of this entire study.
This apparent difference in lacZ expression is due to the Galacto-Light Plus 
assays for each of the studies being carried out at different times and therefore with 
different internal settings on the luminometer. The reason for different internal 
settings in the luminometer is that different numbers of cells are being assayed.
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This being the case, if all samples were to be re-assayed at the same time it 
would be expected that the liquid 7H9 controls for each clone assayed at different 
times should exhibit similar levels of Light Units/106 bacterial cells. In order to show 
that this is indeed true, the liquid 7H9 controls were re-assayed on a small scale. 
Since only 5 clones had been studied at every stage of the second screening process 
one of these clones was selected for this comparison -  clone 169. Samples containing 
the lysate of clone 169 grown in liquid 7H9 control medium were diluted, where 
necessary, so that roughly the same number of cells were assayed for p-galactosidase 
activity with the Galacto-Light Plus assay.
l.E+06  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
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in vitro stress J774 THP-1 THP-1 2 Hour THP-1 4 Hour THP-1 6 Hour THP-1 12 Hour THP-1 24 Hour
Indication of which experient liquid 7H9 control came from
Figure 4.7: Bar chart showing a comparison of the Light units/ 106 bacterial cells for clone 169 when 
assayed at different times. Clone grown in liquid 7H9 medium during the three separate studies 
described in Sections 3.3.3, 4.3.1 and 4.3.2. P-galactosidase assays carried out at the same time are 
shown in the same colour, with pink, blue and purple representing sections 3.3.3, 4.3.1 and 4.3.2 
respectively.
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Figure 4.8 represents all of the liquid 7H9 medium samples for clone 169 
collected during the studies described in sections 3.3.3, 4.3.1 and 4.3.2. The important 
overall picture is that, when assayed at the same time, clone 169 grown in liquid 7H9 
medium on different occasions does in fact exhibit a similar level of lacZ expression.
The three different studies described in Sections 3.3.3, 4.3.1 and 4.3.2 can not 
be directly compared with one another. However it is possible to compare the results 
of each study relative to the level of lacZ expression of the clone grown in the 7H9 
control medium.
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Figure 4.8: Bar chart comparing clone 169 samples grown in liquid 7H9 medium and assayed at the 
same time. Assayed samples taken from sections 3.3.3, 4.3.1 and 4.3.2. The colour scheme for lanes 1-
8 is as in Figure 4.7 - pink, blue and purple representing sections 3.3.3, 4.3.1 and 4.3.2 respectively. 
Samples 1-8 were assayed with Galacto-Light Plus at the same time with the same luminometer 
settings. Lane 1 is a 10'2 dilution of the sample described in section 3.3.3. Lane 2 and 3 are the 
undiluted in vitro controls for the initial infections of murine and human macrophages, respectively, 
described in Section 4.3.1. Lanes 4-8 are 0.2, 0.2, 10'1, 0.25 and 10'2 dilutions of samples taken at 2, 4, 
6, 12 and 24 hours post-infection of human macrophages, respectively, described in section 4.3.2. Lane
9 is an average LU/106 bacterial cells for lane 1-8.
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4 . 4  D i s c u s s i o n
Both human and murine macrophages were infected with the 42 library clones 
(identified as appearing to have greater promoter activity when stressed by in vivo 
mimicking conditions). The level of lacZ expression, driven by the cloned 
M.tuberculosis H37Rv DNA, of each phagocytosed clone was compared with the 
lacZ expression of the clone incubated in complete Dulbecco’s modified Eagles 
medium and 7H9 control medium.
It is clear from Appendix 4 that care must be taken in the interpretation of the 
results as intra-experiment comparisons are extremely complex. There are some 
clones where post-macrophage infection expression of lacZ is greater than its 
expression of lacZ in the liquid controls (for example see clone 180). However, the 
majority of clones appear to be up-regulated at certain times during the length of the 
infection but show no difference in expression, compared to the complete Dulbecco’s 
modified Eagles medium control, at other times -  such as clone 239. A further 
complexity is added by using two different macrophage types. For example, infecting 
murine macrophages with clone 292 appears to causes the expression of lacZ to be 
up-regulated toward to end of the infection time scale, compared to the complete 
Dulbecco’s modified Eagles medium control. However, when used to infect the 
human macrophage cell line THP-1, clone 292 shows no significant up-regulation 
compared to the complete Dulbecco’s modified Eagles medium control.
To summarise the data of this Chapter, of the 42 clones used to infect 
macrophages 20 clones appear to be up-regulated when used to infect both
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macrophage cell lines, 8 clones are apparently down-regulated and 4 clones indicate 
that there is no alteration in the level of expression of lacZ once internalised within 
macrophages, compared to the complete Dulbecco’s modified Eagles medium 
control. Whether the other 11 clones are up-regulated or down-regulated is unclear 
because the clones appear to be up-regulated during the infection of one macrophage 
cell line and down-regulated during the infection of the other. These clones require 
further more detailed investigation as to their specific pattern of expression during 
infection of cultured macrophages.
With the promoter activity of the 42 clones characterised, each clone was 
bi-directionally sequenced and homology against the M.tuberculosis H37Rv genome 
determined (see Chapter 5). Two criteria, the initial infection data and the sequence 
data, were used in conjimction to select a small number of clones for further 
investigation -  the clones numbered 169, 175, 176, 180 and 239. These clones appear 
to show up-regulation of lacZ expression during the initial murine and human 
macrophage infection study and the sequence data indicates that a genuine promoter 
sequence had been cloned (see Chapter 5).
The re-infection data supported the initial findings that these clones contained 
promoter sequences that are up-regulated during infection. Table 4.2 links these 5 
clones with the in vivo mimicking study in Chapter3 and shows that these clones 
appear to exhibit relatively high ratios of induction in both the low pH and the low pH 
containing sodium nitrite media. Interestingly, all of these 5 clones have been 
identified as being potentially up-regulated in both media types.
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The ability to be able to link the second in vitro screen and the two macrophage 
infection studies is not critical and, due to the way that the light units are measured by 
the luminometer, difficult. Each study has to be viewed as a separate entity and data 
from either of the other two studies can not be used to validate the other experimental 
observations. However, the second in vitro screen and both macrophage screening 
processes contained controls of each clone grown in liquid 7H9 liquid medium. This 
being the case and ignoring any growth phase differences, it would be expected that 
the expression levels of lacZ would be relatively constant for each clone. Figure 4.8 
clearly shows that this is indeed the case. There are minor differences in the level of 
expression of lacZ but this would be expected. It is clear from figure 4.8 that, despite 
the considerable differences in LU/ 106 bacterial cells assayed during each study, the 
controls in the three different studies do actually express similar levels of 
p-galactosidase expression.
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Clone
Number
LU/Million bacterial 
cells in control medium
Ratio of LU for Low 
pH to control
Ratio of LU for High 
sodium nitrite to control
169 264.9 7.6 4.8
175 121.6 4.4 2.9
176 240.7 3.9 2.4
180 29.5 3.2 3.9
239 267.0 3.8 7.4
Table 4.2: A copy of the data from Appendix 3 showing the ratio of apparent up-regulation exhibited 
by clones 169, 175, 176, 180 and 239. All clones exhibit up-regulation of lacZ in both stressing media 
types compared to the control medium. The ratios have been generated by dividing the LU/ 106 
bacterial cells for the clone grown in low pH medium and raised nitric oxide medium by the LU/ 106 
bacterial cells for the clone grown in the control medium.
The data of lacZ expression in the clones 169, 175, 176, 180 and 239 thus far 
must be viewed with caution. The sequence data (in Chapter 5) suggests that these 
clones contain MJuberculosis H37Rv promoters cloned in the correct orientation to
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drive lacZ expression, but flanking regions of DNA were also cloned. Promoters, 
which are cloned out of their natural environment, can exhibit drastically different 
expression levels compared to the expression from the genome. Therefore the genes 
associated with the promoters cloned in the five clones need to have their expression 
studied when being driven from the genome. This will be done using the real time 
reverse transcriptase PCR (see Chapter 6).
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Chapter 5. DNA Sequence Analysis
The sequencing of the entire Mycobacterium tuberculosis H37Rv genome has 
led to significant advancements in the study of this organism and tuberculosis as a 
disease. It is an enormously powerful tool. As all previously identified genes have 
been annotated and a considerable number of previously unknown genes have been 
identified (Cole et al., 1998). Where possible, homologies to genes from other 
organisms have been used in order to predict the function of M.tuberculosis H37Rv 
genes. However there are still a number of hypothetical genes that do not show 
homology to any previously identified genes from other organisms. Sequence 
homologies of a gene to those of other bacteria can give some suggestion to potential 
function of unknown proteins.
5.1 In troduction
5.1.1 Strategy
All 42 clones that were identified by previous screenings and infected into 
murine and human macrophages were bi-directionally sequenced, across the Narl 
cloning site of pUS1800, and were identified by sequence searching against the 
Mycobacterium tuberculosis H37Rv genome held at the Sanger centre 
(http://www.sanger.ac.uk/Projects/M_tuberculosis/). A number of other clones that 
were identified during the in vivo mimicking study as having elevated levels of lacZ 
expression when stressed were also sequenced for comparison.
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5.2.1 Oligonucleotide Primers
5.2 M aterials and  M e th o d s
Primer Sequence (5’-3’) Details
RH20 CGGTTT AC AAGC AT AAAG pUS 1800 (and subsequent 
plasmids) nt 109-126
RJH1800REV GGACCACTTCTGCGCTCGG pUS 1800 (and subsequent 
plasmids) nt 239-221
5.2.2 DNA amplification for sequencing
Primers RH20 and 1800REV were used to amplify across the Narl restriction 
site of the pUS1800-based plasmids harboured within the M.bovis BCG Pasteur 
clones. Reaction conditions consisted of an initial denaturation at 95°C for 5 minutes, 
followed by 35 cycles with denaturation 95°C, primer annealing at 55°C and 
extension at 72°C for 1 minute, 1 minute and 2 minutes respectively. The final cycle 
was extension at 72°C for 5 minutes. The amplified DNA fragments were visualised 
as described in Appendix 2 (Agarose gel electrophoresis).
5.2.3 Plasmid recovery from M.bovis BCG Pasteur clones
When sequencing of PCR products was unsuccessful, cultures of individual 
clones (10ml) were centrifuged at 3000g for 10 minutes. The supernatant was 
discarded and the pellet resuspended in 1ml water. Each of the M.bovis BCG Pasteur 
clones were transferred to a Hybaid Ribolyser™ blue tube and processed in a Hybaid 
Ribolyser™ at speed 5.0 for 40 seconds. Each of the lysates were subjected to phenol/ 
chloroform extraction of the total DNA, including the plasmid, which was 
subsequently subjected to DNA precipitation (see Appendix 2). The precipitated
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DNA was resuspended in 30 pi water. Each DNA preparation was used to transform 
E.coli DH5a, then individual clones were subjected to PCR analysis with primers 
RH20 and 1800REV, as described in section 5.2.2, to ensure that the selected clone 
did in fact contain the pUS1800 based plasmid. Plasmid preparations were then 
carried out from the transformed E.coli DH5a cells as described in Appendix 2 and 
were subsequently sequenced using the plasmid as the template.
5.2.4 Automated DNA sequencing
DNA was sequenced by the Core Sequencing Facility at Glaxo Wellcome 
Research and Development PLC, Stevenage, England. All sequencing was carried out 
on Perkin-Elmer ABI Prism 377 Sequencers with BigDye Terminator Sequencing 
Chemistry. All chemicals were supplied by Perkin-Elmer. BigDye 3 cycling 
conditions consist of DNA denaturing at 96°C 5 minutes and 25 cycles of primer 
annealing at 56°C for 15 seconds, primer extension at 64°C for 4 minutes and DNA 
melting at 95°C for 30 seconds. The sequencing reaction mixture consisted of 8pi 
neat BigDye premix, 5pmol of primer, 2pl of template, lpl DMSO to final volume of 
20pl. Samples were purified after sequence cycling using 96 well filtration blocks 
(manufactured by Glaxo Wellcome Research and Development PLC, Stevenage, 
England) containing hydrated sephadex G50, dried, then 2 pi of formamide/blue 
dextran added to dissolve the DNA. The DNA was denatured at 96°C for 2 minutes 
before 1.5 pi loaded onto the sequencing gel.
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Sequence alignments of MJuberculosis library clones were performed on the 
world wide web using the Mycobacterium tuberculosis genome sequence held at the 
Sanger centre (http://www.sanger.ac.uk/Projects/M_tuberculosis/) and the BCM 
Search Launcher located at the Human Genome Center, Baylor College of Medicine, 
Houston Texas (http://kiwi.imgen.bcm.tmc.edu:8088/search-launcher/launcher.html). 
Sequence comparisons were also performed using a BLAST search 
located at the National Centre for Biotechnology Information 
(http://www.ncbi.nlm.nih.gov/BLAST/). Additional sequence analysis was carried out 
using bioinformatics computer programs specifically written for use with the 
MJuberculosis H37Rv genome at Glaxo Wellcome Research and Development, 
Stevenage, England.
5.2.5 Sequence analysis
I l l
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All 42 clones used to infect murine and human macrophages in Chapter 4 
were PCR amplified across the Narl cloning site of pUS1800, with the primers RH20 
and 1800REV. An additional 8 clones from the 333 clones shown in Appendix 3 were 
also subjected to PCR in the same manner. Each amplicon was bi-directionally 
sequenced with the same primers (RH20 and 1800REV). The majority of sequences 
obtained from the pUS1800-based plasmids covered the entire insert sequence. 
However the sequences obtained from 12 clones did not noticeably overlap and 
therefore the entire M.tuberculosis H37Rv DNA sequence cloned into these plasmids 
had to be deduced from database sequences. A number of clones generated multiple 
PCR products, which were gel purified (see Appendix 2) and when sequenced 
independently each of the PCR products from each clone generated the same 
sequence. The M.tuberculosis H37Rv DNA insert in 6 clones proved very hard to 
amplify and/or sequence from the PCR product. The plasmids from these clones were 
recovered into E.coli and subsequent plasmid preparations were bi-sequenced with 
the primer RH20 and 1800REV, as outlined previously.
The sequences obtained in either direction from each clone, with the primers 
RH20 and 1800REV, were paired then independently identified against the complete 
genome sequence of M.tuberculosis H37Rv held at the Sanger institute 
(http://www.sanger.ac.uk/Projects/M_tuberculosis/). In all cases, except clone 188, 
the pairs of sequences identified the same region of cloned DNA confirming a single 
fragment insert. The M.tuberculosis H37Rv genome sequences that were identified in
5.3 R esu lts
5.3.1 Sequence Analysis and the Genome.
112
each clone were copied from the Sanger institute. These M.tuberculosis H37Rv DNA 
sequences are shown in Appendix 5. In addition, information regarding the sequences 
and die clones harbouring the sequences is also given, such as the size of the 
M.tuberculosis H37Rv DNA insert for each clone. The genome co-ordinates of the 
insert have also been included. All sequences are shown in the orientation that they 
appear in pUS1800 and therefore the translational start site of lacZ is at the 3’ end of 
all sequences shown. The restriction enzyme sites (Acil, Hpall or Taql) used to 
generate each of the clones are identified, as are the translational start and stop codons 
of any genes or portions of genes. Appendix 5 shows that 27 of the MJuberculosis 
H37Rv DNA inserts have been cloned using the restriction enzyme Acil. Digestion of 
genomic MJuberculosis H37Rv DNA with restriction enzymes Hpall and Taql have 
generated 12 and 10 clones, respectively. The average size of the cloned 
MJuberculosis H37Rv DNA inserts is 370bp.
Figure 5.1 is a depiction of the MJuberculosis H37Rv genome (Cole et al., 
1998). The circle represents the MJuberculosis H37Rv genome with the position of 
all of the sequences in Appendix 5 represented by the clone number and red arrows to 
identify their position on the genome. It can be clearly seen that the positioning of the 
sequences is well spread through out the genome. However there are three portions of 
the genome which have not been represented by the sequenced clones. The genome 
co-ordinates for these 3 portions are 2101154-2614036, 2623969-2925356 and 
3698200-3967697. In addition there are some small clusters of hits on the genome, 
the reason for this are not known. The 4800 clones picked, and subsequently assayed, 
to date represent 15% of the total number of clones required to statistically cover 95% 
of the MJuberculosis H37Rv genome. Thus this study represents a small scale pilot
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study to investigate the feasibility of this technology in identifying mycobacterial 
promoters and should not be viewed as a definitive study to cover the differential 
expression of all known reading frames.
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Figure 5.1: Map of the M.tuberculosis H37Rv genome. The red arrows indicate the position of DNA 
inserted at the Narl site of the plasmid pUSl 800 and harboured within each of the numbered clones.
It has been argued that bacterial genes involved in virulence are grouped 
together in ‘pathogenicity islands’ (Hacker et al., 1997). Pathogenicity islands have
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been identified in a number of bacteria including uropathogenic Escherichia coli 
(Ritter et al., 1997; Dobrindt et a l, 1998; Ritter et a l, 1995), Shigella flexneri (Vokes 
et a l, 1999; Moss et a l, 1999), Staphyloccus aureus (Lindsay et a l, 1998), Yersinia 
pseudotuberculosis (Buchriesser et a l, 1998) and in Salmonella spp. (Wood et a l, 
1998). If pathogenicity islands were to be present in MJuberculosis, then the small 
clusters and 3 portions of the genome not covered in figure 5.1 may not be entirely 
surprising, as this study should only have identified genes associated with 
intracellular survival, a key requirement of the pathogenicity of MJuberculosis.
As previously stated, each clone contains a different random segment of 
cloned M.tuberculosis H37Rv DNA including different genes, parts of genes or 
intergenic regions. During the identification of the DNA contained within each clone, 
the sequence position on the MJuberculosis H37Rv genome and the annotation of 
each sequence was noted. This included the Rv numbers, which have been given to 
each gene by Cole et al. (1998) as well as indicating any genes or intergenic regions. 
All cloned genes or parts of cloned genes are identified in the sequences of Appendix 
5 by their translational start and stop positions. This has enabled the identification of 
potential promoters that may be contained within each library clone. The criterion for 
deciding what was and what was not a potential promoter was dependent on whether 
any intergenic DNA directly up-stream of a gene was cloned in the correct orientation 
to drive the expression of lacZ.
Figure 5.2 represents all sequenced clones diagrammatically. Rectangles 
represent MJuberculosis H37Rv genes containing the Rv numbers, with the direction 
of translation being represented by the red arrowheads. The green arrows represent
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the DNA cloned within the plasmid pUS1800 harboured within each clone with the 
arrowhead pointing towards the start of the promoterless reporter gene lacZ contained 
within pUS 1800. The size of all rectangles and arrows is not representative of relative 
size.
Of all of the clones sequenced, 16 clones contain M.tuberculosis H37Rv DNA 
that is internal to genes and are therefore unlikely to contain promoters. Clone 90 
contains intergenic DNA situated between 2 M.tuberculosis H37Rv genes where the 
direction of transcription of the two genes converges and is therefore unlikely to 
contain a potential promoter. Two clones (5 and 302) contain potential promoter 
fragments where the orientation with regard to lacZ expression is opposite to that 
driving gene expression on the genome. Six clones contain potential promoters cloned 
into pUS 1800 in the correct orientation to drive lacZ expression but are missing part 
of the 3’ putative promoter DNA. Clone 188 contains a double insert whilst clone 13 
contains 2 potential promoter fragments and one complete gene. The remaining 23 
clones all contain probable M.tuberculosis H37Rv promoters in the same orientation 
that they appear in the M.tuberculosis H37Rv genome and the promoters are in 
corr ect orientation to drive the expression of lacZ.
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Chapter 5: DNA Sequence Analysis
DNA cloned into pUS1800, which appears in the M.tuberculosis H37Rv 
genome positioned within a gene, was considered unlikely to contain potential 
promoters. In total 16 clones contained M.tuberculosis H37Rv DNA internal to genes.
To ensure that cloning of a promoter was unlikely in these fragments, the 
M.tuberculosis H37Rv genome in the close vicinity of the cloned DNA was checked 
for the presence of any other open reading frames. If a second gene had been 
identified in the near vicinity, and its orientation on the M.tuberculosis H37Rv 
genome had been the same as the cloned DNA in pUS1800, it would have been 
feasible that the promoter for the down-stream gene was contained within the coding 
region of the first gene. In all cases where DNA internal to M.tuberculosis H37Rv 
genes was cloned, other genes in the near vicinity were either in the wrong orientation 
or were too distant to be likely to have their expression driven by the fragment of 
cloned DNA.
As an example, clone 7 contains a portion of the coding region for the 
M.tuberculosis H37Rv gene Rvl508c. The genes directly up and down-stream of 
Rvl508c are both situated on the direct strand of the genome. Figure 5.3 is a 
diagrammatic representation of the portion of the M.tuberculosis H37Rv genome 
containing genes Rvl507, Rvl508c and Rvl509. Despite the ability of tlie cloned 
DNA in clone 7 to drive the expression of lacZ, due to its location and orientation it is 
unlikely that the cloned DNA contains a true M.tuberculosis H37Rv promoter for any 
of the genes depicted in Figure 5.3.
5.3.2 Cloned DNA Interna 1 to M .tubercu losis  H37Rv Genes.
118
Chapter 5: DNA Sequence Analysis
R vl 507 l>- Rvl508c
Figure 5.3: Diagrammatic representation of DNA in the vicinity of cloned DNA contained within clone 
7. Genes are represented by hollow rectangles containing the respective gene numbers. Red 
arrowheads indicate the direction of translation of individual genes. The green arrow represents the 
region of M.tuberculosis H37Rv DNA contained within pUS1800. The direction of the arrow indicates 
Hie direction of cloning with the arrowhead representing the start of lacZ.
5.3.3 Clones 5, 90 and 302
Clone 5, 90 and 302 all contain intergenic M.tuberculosis H37Rv DNA. Clone 
90 contains part of the intergenic region between the M.tuberculosis H37Rv genes, 
Rv0609 and Rv0610c (see Figure 5.2). Due to the fact that these two genes converge, 
it is unlikely that the cloned DNA contains a putative promoter. Clones 5 and 302 are 
different to clone 90 in that they do contain the potential promoters for the genes 
Rv0822c and Rvl853, respectively (see Figure 5.2). However, in both cases, the 
cloned putative promoters in pUS1800 are orientated to drive expression away from 
the start of lacZ. Figure 5.4 shows this diagrammatically for clone 302.
lacZ<-----
I Rvl 852 15
Figure 5.4: Diagrammatic representation of DNA in the vicinity of cloned DNA contained within clone 
302. Genes are represented by hollow rectangles containing the respective gene numbers. Red 
arrowheads indicate the direction of transcription of individual genes. The green arrow represents the 
region of M.tuberculosis H37Rv DNA contained within pUS1800 and the direction of the arrow 
indicates die direction of cloning with the arrowhead representing the start of lacZ. The blue arrow 
represents the potential promoter fragment responsible for the expression of Rvl853.
Rvl853
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Clone 188 requires special note as it is unusual and a cloning artefact. The 
amplicon spanning the Narl insert site of this clone has been generated by DNA 
amplification a number of times and each amplification has been bi-directionally 
sequenced. The plasmid was also recovered from the M.bovis BCG clone and 
transformed into E.coli and the purified plasmid also being bi-directionally sequenced 
several times. On every occasion, sequence homology with two separate regions of 
the M.tuberculosis H37Rv genome sequence were identified, suggesting that clone 
188 contains a double insert. The primer sequencing up-stream of lacZ (1800REV) 
identifies a 344bp insert with the MJuberculosis H37Rv genome co-ordinates being 
4328658 -  432900lbp. The sequence obtained using the RH20, which reads towards 
lacZ, identifies a 482bp insert with the M.tuberculosis H37Rv genome co-ordinates 
being 1623341 -  1623822bp. Both of the MJuberculosis H37Rv DNA fragments 
have been generated by Acil digests and both of the sequences, obtained from 
pUS1800 with RH20 and 1800REV, carried the junction sequence between the two 
fragments.
Figure 5.5 is a graphical representation of the MJuberculosis H37Rv DNA 
fragment in clone 188. It shows that the putative promoter for Rv1444c is cloned in 
the correct orientation to drive the expression of lacZ. However, between the end of 
the potential promoter and the translational start site of lacZ, there are portions of 
both Rvl444c and Rv3856c. This has the effect of putting 699bp between the 
potential promoter of Rv1444c and the translational start site of lacZ. However, the 
translation start codons for Rvl444c and lacZ are in frame and therefore a
5.3.4 Clone 188
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translational fusion has been generated. The fusion protein would consist of the initial 
portion of Rvl444c, a middle section of Rv3856c reading into the entire 
p-galactosidase protein. The function of the protein coded for by Rvl444c is 
unknown.
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Figure 5.5: Diagrammatic representation of M.tuberculosis H37Rv DNA in tlie plasmid pUS1800 
harboured within clone 188. Genes are represented by hollow rectangles containing the respective gene 
numbers. Red arrowheads indicate the direction of translation of individual genes. The green arrow 
represents the region of M.tuberculosis H37Rv DNA contained within pUS1800 and the direction of 
the arrow indicates the direction of cloning with the arrowhead pointing towards the start of lacZ. The 
stait of gene Rvl444c and the middle of gene Rv3856c are between the potential promoter of Rvl444c 
and tlie translational start of lacZ.
5.3.5 Clone 233
Clone 233 is also worthy of special note. The cloned M.tuberculosis H37Rv 
DNA is located at co-ordinates 1446292 — 1446456 and has been cloned such that the 
complementary strand of the M.tuberculosis H37Rv genome is driving the expression 
of lacZ. The cloned DNA includes the first 79bp of gene Rvl292, argS, which codes 
for an arginyl-tRNA synthase, in the opposite orientation to that of lacZ in the 
plasmid. Up-stream of Rvl292 is argV”, which is an arginyl-tRNA, which is located 
on the complementary strand of the M.tuberculosis H37Rv genome. The end of the 
cloned DNA directly up-stream of lacZ is probably part of the promoter for argV
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However there are 24bp missing between the end of the cloned DNA and the start of 
argV. This is diagrammatically represented in figure 5.2.
5.3.6 Clone 13
Clone 13 contains two potential promoter sequences and one complete gene, 
Rv0460, and is diagrammatically represented in Figure 5.2. The M.tuberculosis 
H37Rv DNA cloned into pUS1800 straddles 3 genes -  Rv0459, Rv0460 and Rv0461 
and has the genome co-ordinates 551479-552343. The 5’ portion of the gene Rv0459 
and the 3’ end of gene Rv0461 have not been cloned. Gene Rv0459 has an unknown 
function but is similar to unidentified open reading frames in Xanthobacter 
autotrophicus (gene: AF029733 2 - 139aa) and Rhodococcus erytkropolis (gene: 
REREUTPBC1 - 186aa) ~ these open reading frames have been linked to aldehyde 
dehydrogenase genes. Both Rv0460 and Rv0461 are unknown hydrophobic proteins 
with the start site of Rv0461 being uncertain.
The two intergenic regions that have been cloned probably contain the 
promoters responsible for driving the expression of the two genes Rv0460 and 
Rv0461 from the MJuberculosis H37Rv genome. The second potential promoter 
cloned, that of gene Rv0461, is 320bp away from the transcriptional start site of lacZ. 
However the transcriptional start sites of gene Rv0461 and lacZ are in frame and 
therefore a translational fusion has been formed. Whether the transcriptional start site 
of gene Rv0460 is in frame with the start site of lacZ is unclear since the start site of 
gene Rv0460 is uncertain.
Chapter 5: DNA Sequence Analysis
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The plasmid pUS1800 is a transcriptional promoter trap vector and therefore 
does not require MJuberculosis H37Rv promoters and down-stream genes to be in 
frame with the translational start site of lacZ. However a cloned promoter would be 
required to supply both the transcription initiation signals as well as the ribosome 
binding site (RBS) in order to initiate translation.
The potential promoters in seven of the clones (clones 166, 220, 233, 278, 
289, 291 and 330) have been cloned so that not all of the intergenic region between 
two genes has been cloned. Clone 233 has been discussed previously. Clone 330 
harbours part of the 5’ coding region of the MJuberculosis H37Rv gene Rv2338c as 
well as part of the intergenic region between Rv2338c and Rv2339. However the 
cloned DNA stops 59bp short of the start site of gene Rv2339. Both the transcription 
initiation signals and the RBS may be contained within the portion of the intergenic 
region that has been cloned. However this would position the RBS a considerable 
distance from the start point of translation of the gene Rv2339. The gene Rv2339 
codes for a probable membrane protein with strong similarities to other proteins in 
M.leprae and MJuberculosis.
The DNA within clone 289 contains a portion of the intergenic DNA between 
the MJuberculosis H37Rv genes Rv2401 and Rv2402. The intergenic region between 
these two genes is orientated on the genome to drive the expression of gene Rv2402, 
which codes for a hypothetical 74.5KDa protein and contains a helix-turn-helix motif 
(helix-tum-helix motifs are routinely found in DNA binding proteins such as
5.3.7 Incomplete Promote rs
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repressors and activators). The portion of the intergenic region of DNA that has been 
cloned into pUS1800 is orientated, with respect to lacZ, in the same orientation that it 
is on the genome to drive the expression of Rv2402. However, not all of the 
intergenic region between Rv2401 and Rv2402 has been cloned, a 132bp region 
between the end of the cloned DNA and the start of the gene Rv2402 has not been 
cloned. This M.tuberculosis H37Rv DNA fragment may contain transcription 
initiation signals. This is diagrammatically represented in Figure 5.2.
The clones 166, 220, 278 and 291 all contain inserts of DNA up-stream of the 
gene Rv0440 (groELZ) and are diagrammatically represented in Figure 5.2. Clone 
166 harbours an insert containing the 3’ end of the gene Rv0439c and the DNA 
up-stream of the gene Rv0440, but the cloned DNA does not contain the first lObp of 
DNA directly up-stream of the gene. The M.tuberculosis H37Rv genome co-ordinates 
of this cloned DNA fragment are 528230-528690. Clones 220, 278 and 291 harbour 
identical inserts (the M.tuberculosis H37Rv genome co-ordinates of the cloned DNA 
are 528230-528532) containing the 3’ end of the gene Rv0439c and the up-stream 
region of the M.tuberculosis H37Rv gene Rv0440. However, in these latter clones, 
the DNA stops 68bp short of the gene Rv2339. Both the transcription initiation 
signals and the RBS may well be contained within the portion of the intergenic region 
that has been cloned.
It is possible that during the transformation with the plasmid library and 
subsequent recovery of M.bovis BCG Pasteur that sibling transformants could have 
been generated, since clones 220, 278 and 291 all contain identical regions of cloned 
M.tuberculosis H37Rv DNA. All clones were selected and arrayed at random but
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clones 278 and 291 were arrayed in the same 96 well microtitre™ plate, at positions 
E8 and D ll. Clone 220 was arrayed at a much earlier time and is arrayed in a 96 well 
microtitre™ plate that appears much earlier on in the 96 well microtitre™ plate 
numbering system. As more that one transformation of M.bovis BCG Pasteur, using 
the same plasmid library preparation, was earned out to generate the 4800 clones that 
have been arrayed, clones 278 and 291 were probably generated by the same 
transformation and are more than likely sibling clones with clone 220 being generated 
by a separate transformation and is therefore an independent clone. However in the 
context of this study the presence of sibling clones may be expected but is not 
particularly significant.
Clone 220 was not used during the infection of murine and human 
macrophages but there is expression data for clones 166, 278 and 291. Clones 278 
and 291 contain an identical section of M.tuberculosis H37Rv DNA and do exhibit 
similar levels of lacZ expression (see Appendix 4). Clone 166, harbouring more of the 
probable promoter region for Rv0440, exhibits a greater level of expression than 
clones 278 and 291.
It is interesting to note that the gene Rv0440 codes for the chaperonin 
GroEL2. In Chapter 2, not only was the promoter probe vector pUS1800 constructed 
but pUS1808 was also constructed. pUS1808 was constructed as a positive control 
plasmid for pUS1800 and has the promoter of a heat shock protein (hsp60) cloned at 
the Narl site directly up-stream of the promoterless lacZ reporter gene. The gene 
hsp60 and Rv0440 (groELl) are different nomenclature for the same gene.
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In Figure 5.2, there are 22 clones that contain intergenic DNA, between two 
MJuberculosis H37Rv genes, which is in the correct orientation within pUS1800 to 
drive the expression of lacZ. These promoters can be divided into two groups. In all 
cases, not only was an intergenic region cloned but also a portion of the gene directly 
down-stream of the intergenic region and in most cases a portion of the up-stream 
region.
Clone 63 is the first clone in Figure 5.2 that fits in to the group of cloned 
potential promoters that are flanked, within the plasmid pUS1800, by portions of both 
the up- and down-stream MJuberculosis H37Rv genes. It contains the intergenic 
region between genes Rv0940c and Rv0941c as well as the 3’ coding region of 
Rv0941c and the 5’ coding region of Rv0940c. Both genes are situated on the 
complementary strand of the MJuberculosis H37Rv genome and the intergenic region 
of DNA is orientated in pUS1800 to drive the expression of lacZ. Gene Rv0940c has 
been annotated as being similar to several MJuberculosis H37Rv hypothetical 
proteins whilst Rv0941c has an unknown function. Therefore clone 63 probably 
contains the promoter for the gene Rv0940c which is driving the expression of lacZ in 
the promoter trap vector. In addition to the intergenic region of DNA, the initial bases 
of gene Rv0940c are also present in clone 63. Indeed 121bp of Rv0940c have been 
cloned between the intergenic region and the translational start site of lacZ. The start 
sites of Rv0940c and lacZ are in frame and thus a translational fusion between the 
start of Rv0940c and lacZ has been created.
5.3.8 Clones containing Probable Promoters
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The second group of clones is typified by clone 174 (see Figure 5.2). Clone 
174 contains a section of the intergenic regions between the M.tuberculosis H37Rv 
genes Rv0129c and Rv0130 and a portion of the 5’ coding region of gene Rv0130. 
The intergenic region between Rv0129c and Rv0130 is 249bp however, only 161bp, 
before the start of Rv0130, of this region has been cloned into pUS1800 along with 
the first 139bp of gene Rv0130. The cloned intergenic region in pUS1800 is in the 
correct orientation to drive the expression lacZ. As in clone 63, a translational fusion 
has been generated between the 5’ coding region of Rv0130 and the start position of 
lacZ. The function of the protein coded for by Rv0130 is uncertain but it does have a 
44% homology to nodulation proteins from Rhizobium ssp. and is also similar to a 
monoamine oxidase regulatory protein from Archaeoglobus fulgidus.
Of the 22 clones that contain cloned intergenic regions of M.tuberculosis 
H37Rv DNA and down-stream genes, 13 of the down-stream genes are in frame with 
the translational start site of lacZ and have therefore formed translational fusions. 
Since pUS1800 is a transcription promoter trap vector the presence or absence of 
translational fusions is not critical. However the absence of a translational fusion with 
lacZ means that the distance between the potential promoter sequence and the start of 
lacZ becomes more important since the promoter may have become too distal to be 
responsible for the transcription of lacZ.
5.3.9 Sequenced Clones not used during Infection Studies.
Clones 5,137,173, 174,194, 220, 229 and 282 were identified in Chapter 3 as 
being potentially up-regulated during exposure to in vivo mimicking conditions but
Chapter 5: DNA Sequence Analysis
111
were not used during any infection studies. All clones are diagrammatically 
represented in Figure 5.2. Of these clones, only clones 5 and 194 are unlikely to 
contain promoters. Clone 5 has been described previously. The M.tuberculosis 
H37Rv DNA that is cloned into pUS1800 of clone 194 is internal to gene Rv3530c, 
which is similar to cis-1,2-dihydroxy-3,4-cy clohexadiene-1 -carboxylate
dehydrogenase coding genes.
However, interestingly, the rest of these clones contain probable promoters. 
Clones 137, 173, 174 and 282 contain the probable promoters for genes with no 
known function. As previously stated, clone 220 contains the promoter for Rv0440, 
(groELl or hsp60). The probable promoter in clone 229 is directly up-stream of gene 
Rv3077 (atsF), which is similar to aryl- and steryl-sufatases. Clones 173 and 229 are 
worthy of special note since both inserts are internal to two over-lapping genes.
5.3.10 Analysis of Cloned M.tuberculosis H37Rv DNA in the 5 Library Clones
used in Second Round of Macrophage Infection.
The 5 clones (169, 175, 176, 180 and 239) used to re-infect human 
macrophages in section 4.3.2 are of special interest in this study. They were studied in 
detail and the expression of the MJuberculosis H37Rv genes, whose expression may 
be driven by the cloned potential promoter fragments, was additionally investigated 
with the use of quantitative reverse transcribed PCR (see Chapter 6).
Clone 169 contains the putative promoter region (163bp) for the 
M.tuberculosis H37Rv gene Rvl044 and the first 360bp of this gene. The portion of
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the gene that has been cloned is out of frame with the translational start site of lacZ. 
There is no portion of the DNA fragment containing the up-stream gene, Rvl043c. 
The gene Rvl044 has no suggested function but is similar to another hypothetical 
MJuberculosis H37Rv protein.
Clone 175 contains cloned MJuberculosis H37Rv DNA that includes the end 
of Rv0301, the start of Rv0302 and the region of DNA separating the two genes. The 
cloned end of the gene Rv0301 is 242bp long and the cloned region of Rv0302 is just 
14bp. However all of the 139bp separating the two genes has been cloned. The 
translational start site of the cloned Rv0302 is in frame with the translational start site 
of lacZ. Gene Rv0302 has an unknown function but is similar to several repressors 
and regulatory proteins. Rv0302 has a 22.7% identity with the E.coli repressor acrR 
which modulates the acrAB operon when stressed by ethanol, high sodium chloride 
and in stationary phase growth (Ma et al., 1996). Rv0302 also has a similarity to the 
N-terminus of another M.tuberculosis H37Rv hypothetical regulator and contains a 
probable helix-tum-helix.
Clone 176 contains a fragment of MJuberculosis H37Rv DNA that includes 
the end of Rv2710, the start of Rv2711 and the region of DNA separating the two 
genes. The cloned end of gene Rv2710 is 67bp long and the cloned region of Rv2711 
is 55bp long. However all of the 136bp separating the two genes has been cloned. The 
translational start site of the cloned Rv2711 is in frame with the translational start site 
of lacZ. The gene Rv2711 codes for the iron dependent repressor ideR, which has 
strong homology to dtxR coding for the diptheria toxin repressor (Schmitt et al., 
1995).
Chapter 5: DNA Sequence Analysis
129
Chapter 5: DNA Sequence Analysis
Clone 180 contains cloned M.tuberculosis H37Rv DNA that includes the end 
of Rvll64, the start of Rvll65 and the region of DNA separating the two genes. The 
cloned end of the gene Rvll64 is 234bp long and the cloned region of Rvll65 is just 
11 bp. However all of the 25bp separating the two genes has been cloned. The 
translational start site of gene Rvll65 out of frame with the translational start site of 
lacZ. Rvll65 is similar to hypothetical proteins from a number of other organisms, 
such as the hypothetical protein GTP-binding protein from Syneochocystis sp. and to 
the elongation factor G from Micrococcus luteus. However no function has been 
assigned to Rvl 165.
Clone 239 is particularly interesting since the cloned M.tuberculosis H37Rv 
DNA spans only 17bp of DNA up-stream of gene Rvl265 and the first 235bp of the 
gene Rvl265. The translational start site of the cloned Rvl265 is in frame with the 
translational start site of lacZ. The number of base pairs cloned containing the 
potential promoter is veiy small and therefore the fact that the clone shows 
up-regulation during the infection of human macrophages may be fortuitous. The 
function of the protein translated from gene Rvl265 is unknown.
Of the five clones used to re-infect human macrophages, three clones (175, 
176 and 239) have formed translational fusions between a cloned 5’ portion of the 
cloned gene and lacZ. The other two clones, 169 and 180, contain a portion of the 
start of a gene, Rvl 044 and Rvl 165 respectively, that has not formed a translational 
fusion with lacZ. This may not be relevant in clone 180 since the end of the putative 
promoter for Rvl 165 ends 13 bp before the start of lacZ. The presence of 13bp is
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unlikely to interfere with the initiation of transcription of lacZ. This may not be the 
case with clone 169 since there are 362bp between the start of Rvl 044 and lacZ. The 
presence of 362bp between a putative promoter and lacZ may generate a 
transcriptional fusion, with RNA polymerase generating a transcript containing both 
the 362 bases of the cloned Rvl 044 gene and the lacZ gene. Ribsomes could attach to 
the transcript at both the TTG of Rvl 044 and the ATG of lacZ.
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Sequence comparison of cloned DNA with the M.tuberculosis H37Rv genome 
database shows that this promoter probe library has a good coverage of the 
M.tuberculosis H37Rv genome despite the fact that the library was not generated 
randomly. Indeed there are only 3 gaps in the genome coverage of the M.tuberculosis 
H37Rv of any real significance with the genome co-ordinates are 2101154-2614036, 
2623969-2925356 and 3698200-3967697. The reason for these 3 gaps is unclear but 
may be entirely due to the statistically small number of cloned sequences analysed to 
date. Sequencing of other clones may identify cloned regions within these portions of 
the genome.
Interestingly there are only 2 sequences that have been cloned more than once. 
Clones 303 and 311 contain exactly the same section of the MJuberculosis H37Rv 
genome, with the genome co-ordinates 4306285 -  4306610. These co-ordinates place 
the DNA fragments within gene Rv3822c and these two clones may be siblings. The 
second sequence that has been repeated is the probable promoter sequence for gene 
Rv0440, groEL2, which is harboured in clones 166, 220, 278 and 291. Clones 220, 
278 and 291 contain identical fragments cloned into pUS1800 whilst clone 166 
contains a slightly larger fragment. It is important to point out that these 4 clones 
were originally selected as being potentially up-regulated in Chapter 3 from 3 
different 96 well Microtitre™ plates. Clones 278 and 291 were both originally arrayed 
in the same 96 well Microtitre™ plate but were arrayed in different wells. The protein 
coded for by groELl is a chaperonin that has previously been annotated as Hsp60 -  a 
heat shock protein with a molecular weight of 60KDa.
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The hsp60 promoter has been cloned into pUS1800 to generate pUS1808 (see 
Chapter2). A M.bovis BCG Pasteur clone harbouring the plasmid pUS1808 was 
subjected to in vivo mimicking conditions (see Chapter 3), but was not used during 
macrophage infection studies. The reason that this clone was not used during the 
macrophage infection studies was that gene Rv0440 had been shown to be 
up-regulated during infection and therefore would not be a good constitutive promoter 
positive control (Batoni et al., 1998). In a number of other investigations designed to 
study differential expression, heat shock proteins are routinely found to have an 
elevated expression during infection (Monahan et a l, 1994; Lee and Horwitz, 1998; 
Garbe etal., 1996).
Sequence alignments, using ClustalW multiple sequence alignements 
(http://dot.imgen.bcm.tmc.edu:9331/multi-align/clustalw.html), have been carried out 
in order to identify any consensus sequences. The alignments were carried out using 
M.tuberculosis H37Rv sequences contained within all clones, only the sequences of 
clones containing potential promoters or with cloned intergenic regions. No 
consensus sequences could be identified. It has been suggested that M.tuberculosis 
does not have a conserved -35 transcription signal but the sequence for the conserved 
-10 signal is T(80%), A(90%), Y(60%), G(40%), A(60%) and T(100%), where Y 
indicates a pyrimidine residue (Bashyam et al., 1996). Mulder et al. (1997) have 
reviewed mycobacterial promoters and have calculated the mycobacterial consensus 
sequences to be: -35: T(91.7%), T(52.9%), G(62.3%), A(44.4%), C(56.9%) and 
G(3 0.6%)/A(26.4%); and the -10: T(68.4%), A(75.8%), T(41.1%),
A(35.8%)/G(26.3%), A(33.7%)/C(28.5%) and T(75.8%).
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The clones identified in Chapter 3 and 4 and sequenced within this chapter 
contain M.tuberculosis H37Rv DNA that has been identified as being potential 
promoter sequences that appear to cause up-regulated gene expression during 
infection. However it is necessary to determine that the identification of these 
probable promoter fragments has not occurred via random events but rather by the 
ordered rational selection described therein.
In order to show that the M. tuberculosis H37Rv DNA was not isolated due to 
random events it was necessary to generate 50 random, virtual clones. 50 numbers 
between 1 and 4411529 were randomly generated (using Excel). (4411529 is the 
number of nucleotide bases contained with the M. tuberculosis H37Rv genome.) The 
average insert size of the library has been identified as being about 400bp. To 
continue the randomness of these virtual clones, half of the initial virtual co-ordinates 
had 400bp added to generate a second related virtual co-ordinate whilst the other half 
had 400bp deducted to generate the second co-ordinate. This generated 50 random 
virtual clones each containing 400bp. Half of the 50 clones were designated as having 
the direct strand of the cloned M.tuberculosis H37Rv DNA driving the expression of 
lacZ on the pUS1800-based plasmid whilst the other half were designated as having 
the lacZ expression driven from the complementary strand. The genes and 
intergenic regions contained within these virtual clones were then determined 
from the M.tuberculosis H37Rv genome held at the Sanger centre 
(www.sanger. ac.uk/projects/M_tuberculosis/).
Of these randomly generated virtual clones, 27 contained M.tuberculosis 
H37Rv DNA situated internal to genes and 3 contained M.tuberculosis H37Rv
Chapter 5: DNA Sequence Analysis
134
situated between converging genes. These clones are therefore unlikely to contain 
potential promoter fragments. 20 of the virtual clones contain intergenic 
MJuberculosis H37Rv DNA between genes that may contain potential promoter 
sequences. However of these 20 virtual clones, 10 would have been cloned into 
pUS1800 in an orientation to drive the expression away from lacZ. Therefore only 10 
of these virtual clones contain potential promoter sequences that are in the correct 
orientation to drive the expression of lacZ. This is in contrast to the 33 clones that 
contain probable promoter sequences, identified during this work.
Over half of the 50 clones sequenced to date contain probable promoters in the 
correct orientation to drive the expression of lacZ, i.e. regions of MJuberculosis 
H73Rv DNA directly up-stream of a known gene. Table 5.1 gives data describing the 
function of proteins whose putative promoters or parts of putative promoters have 
been cloned into pUS1800 and are diagrammatically depicted in Figure5.2. Of the 
genes contained in Table 5.1, 9 code for proteins with no known function, 5 code for 
proteins with some homologies to proteins with known functions, 8 genes code for 
proteins with an identified function, 4 genes code for proteins with described possible 
functions and 3 genes code for proteins that are described as ‘similar to hypothetical 
proteins’.
Of the clones used to re-infect human macrophages in Chapter 4, only one 
contains the probable promoter for a gene with a known function. Clone 176 contains 
the promoter for the gene Rv2711, which is the non dependent repressor ideR 
(Schmitt et a l , 1995). Clone 169 contains the probable promoter for the hypothetical 
protein Rvl044. Clones 175, 180 and 239 contain the probable promoters for genes
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Rv0302, Rvl 165 and Rvl 265, all of which code for proteins with no known function. 
Recent searches for homologies for any of the hypothetical proteins or proteins with 
unknown functions against proteins with known functions stored in various databases 
have failed to identify any new homologies. Further analysis and discussion of the 
promoters of these 5 clones are contained in Chapter 6.
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Gene
Number
Clone
Number
Protein Function
Rv0130 Clone 174 Unknown function, similar to nudulation protein in from 
Rhizobium ssp. and is also similar to a monoamine 
oxidase regulatory protein from Archaeoglobus fulgidus.
Rv0183 Clone 254 Possible oxidoreductase.
Rv0302 Clone 175 Unknown function -  similar to repressors and regulatory 
proteins.
Rv0347 Clone 292 Unknown function
Rv0440 Clone 166, 
220, 278, 
291
GroEL2, chaperonin.
Rv0457c Clone 320 Probable peptidase
Rv0460 Clone 13 Unknown hydrophobic protein.
Rv0461 Clone 13 Unknown hydrophobic protein.
Rv0596c Clone 137 Unknown function, has chaperonin signature.
Rv0613c Clone 173 Unknown function.
Rv0767c Clone 205 Unknown function.
Rv0940c Clone 63 Similar to hypothetical protein
Rvl044 Clone 169 Similar to hypothetical protein.
Rv1109c Clone 325 Unknown function
Rvll65 Clone 180 Similar to hypothetical proteins from different organisms, 
ie gtp-binding protein SLR1105 from Synechocystis sp.
Rvl265 Clone 239 Unknown function.
Rv1444c Clone 188 Unknown function.
Rvl630 Clone 279 RpsA, ribosomal protein SI.
Rvl658 Clone 281 ArgG, argininosuccinate sythase.
Rvl852 Clone 302 UreG, mease accessory protein.
Rv2339 Clone 330 Probable membrane protein.
Rv2345 Clone 277 Probable membrane protein.
Rv2402 Clone 289 Unknown function, contains helix-tum-helix motif.
Rv2594c Clone 226 Holliday junction resolvase.
Rv2711 Clone 176 IdeR, iron dependent repressor.
tRNAArgV Clone 233 tRNA
Rv2921c Clone 234 FtsY, probable cell division protein.
Rv3077 Clone 229 AtsF, similar to aryl- and steryl- sufatases.
Rv3174 Clone 222 Unknown oxidoreductase.
Rv3603c Clone 282 Unknown function
Table 5.1: Table o f  all genes whose putative promoters or parts o f  putative promoters have 
been cloned into pUS1800. The function o f  proteins is stated where possible. All gene and protein 
details obtained from the Sanger institute MJuberculosis H7Rv genome site 
(http://www.sanger.ac.uk/Projects/M_tuberculosis/).
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The data presented in Chapter 4 suggests that the promoters harboured within 
tlie clones 169, 175, 176, 180 and 239 (representing the putative promoters for the 
M.tuberculosis H37R.V genes Rvl044, Rv0302, Rv2711, Rvl 165 and Rvl265, 
respectively) are up-regulated during infection. However this needs to be viewed with 
a certain amount of caution. These promoters have been cloned out of their natural 
environment and therefore may not behave as they would do in vivo. It is therefore 
feasible that the 5 promoters, contained within Clones 169, 175, 176, 180 and 239, 
will behave differently driving the expression of lacZ on a plasmid rather than the 
expression of their own genes on the M.tuberculosis H37Rv genome. This being the 
case, the activity of these promoters needs to be studied when driving expression of 
their own open reading frames. Since M.tuberculosis H37Rv genomic DNA was used 
to create the library harboured in M bovis BCG Pasteur, this strain should therefore be 
used to study endogenous expression from these promoters.
There are several methods available to study the relative amount of mRNA 
being expressed from potentially differentially regulated genes. Northern blots or 
reverse transcriptase PCR (RT-PCR) could be used but both methods are unsuitable. 
Northern blotting, it would appeal*, would be ideal for measuring and comparing the 
amount of mRNA being expressed under different growth conditions. This is true 
provided that sufficient mRNA can be recovered from each growth condition. In 
order to measure the level of mRNA being expressed from any of the 5 promoters 
identified in Chapter 4, a comparison of mRNA levels in vitro and in cultured human 
macrophages needs to be carried out. Gathering sufficient mRNA from in vitro grown
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M.tuberculosis H37Rv is relatively simple. However, recovering mRNA from 
M.tuberculosis H37Rv post-infection is difficult and yields are low. This would mean 
that enormous numbers of human macrophages (in excess of lO10) would need to 
infected in order to recover sufficient MJuberculosis H37Rv mRNA for Northern 
blotting.
RT-PCR could also be used to measure the level of mRNA being expressed by 
the 5 genes identified as being potentially up-regulated in Chapter 4. Despite the fact 
that RT-PCR is sequence specific and thus unambiguous, it is only semi-quantitative 
and therefore can not be used to irrefutably show that these 5 genes are indeed 
up-regulated during infection.
6.1.1 Fluorogenic 5’ Nuclease Assay
Fluorogenic 5’ Nuclease assay, commonly called Taqman®, is a relatively
novel method of following DNA amplification during the PCR reaction. Holland et
al. (1991) first utilised the 5’—>3’ exonuclease activity of the DNA polymerase from
Thermus aquaticus (Taq) in the detection of specific PCR products. The
5’-+3’exonuclease activity of Taq cleaves 5’ terminal nucleotides of double-stranded
DNA and releases mono- and oligonucleotides but preferentially cleaves displaced
single-stranded DNA. If an additional complementary probe with a radioactive
phosphate (32P) at the end of a non-complementary 5’ tail is added to a PCR mix then
the 5’ tail, and therefore the 32P, is removed from the probe by the Taq. The amplified
DNA and the 5’ tail of the radioactive probe can be separated by thin layer
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chromatography. The amount o f probe degradation products can be measured and
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thus the amount of product DNA measured. Holland et a l envisaged “the use of this 
technique to create a truly homogeneous assay, in which amplification and actual 
detection (of DNA) occur in one tube”. This has indeed become the case however the 
theory is now more complex but generates more specific results.
Currently, Taqman® routinely utilises a probe, internal to the amplification 
primers, called a molecular beacon which carry labels at both 5’ and 3’ ends of the 
DNA. The 3’ end of the probe is labelled with a quencher dye whilst the 5’ end of the 
DNA carries a fluorescent reporter molecule. When the probe is single-stranded but 
coiled, the quencher and fluorescent molecule are sufficiently close for the quencher 
dye to suppress the fluorescence of the reporter molecule. If the target sequence is 
present, the probe anneals down-stream of one of the primer site and is cleaved by the 
5’ nuclease activity of Taq DNA polymerase as the primer is extended. This cleavage 
of the probe separates the reporter dye from the quencher dye, increasing the reporter 
dye signal. Cleavage removes the fluorescent reporter molecule and the quencher dye 
from the probe associated with the target strand, allowing the primer extension to 
continue to the end of the template strand. The inclusion of the probe during the 
extension of the primer does not inhibit the over all PCR process. An increase in 
fluorescence intensity is proportional to the amount of amplicon produced.
Taqman® PCR has a number of different applications. It was initially used for 
the detection of bacterial DNA sequences (Whitham et a l, 1996; Livak et a l, 1995; 
Bassler et a l, 1995). Taqman® has subsequently been used in assessing the 
development of hereditary diseases, such as familial breast and ovarian cancer (Chen
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et a l, 1997). Reverse transcriptase PCR (RT-PCR) can also be used to measure the 
level of mRNA in a sample using Taqman® (Manganelli et a l, 1999).
6.1.2 Quantitative Real Tim e PCR without the use of Molecular Beacons.
An adaptation of the quantitative real time PCR process allows the DNA to be 
measured, in a similar manner but without the use of a probe. In 1992, Higuchi et a l 
(1992) noted that if ethidium bromide was included in a PCR, the amplification of 
target DNA could be continuously monitored because ethidium bromide only 
fluoresces in the presence of double-stranded DNA. Progress has allowed the removal 
of the carcinogenic compound ethidium bromide from the PCR tube, to be replaced 
by another fluorescent chemical, such as SYBR Green (Perkin Elmer).
The use of an internal probe during real time PCR is more sequence specific 
than the use of SYBR Green (Perkin Elmer) by reducing any mis-priming of the 
amplification primers. However, provided that the amplification primers do not mis- 
prime, there is little difference in sensitivity between the two methods. Due to the 
increased sequence specificity, Taqman® utilising the internal probe is generally 
preferred.
6.1.3 Positive Control Selection
When using real time PCR, a positive control must be used and the selection 
of the positive control is critical especially if using cDNA as a template. The samples 
being subjected to real time PCR will obviously contain differing amounts of starting
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template. When using cDNA as a template, a constitutively expressed gene whose 
expression is unaltered by different growth conditions is an ideal candidate as a 
control. In MJuberculosis H37Rv the ideal candidate gene for use as a control is sig A 
(Rv2703 or rpoV), believed to be the essential housekeeping sigma factor for 
MJuberculosis. Indeed, using Taqman®, the expression of Rv2703 (sigAI rpoV) was 
shown to be unaltered in M.tuberculosis when grown in a number of different 
stressing environments (Manganelli et a l, 1999). This makes Rv2703 (sigAI rpoV) an 
excellent control when comparing the expression of Rv302, Rvl044, Rvl 165, 
Rvl265, and Rv2711 grown in vitro and post-infection of cultured human 
macrophages.
6.1.4 Strategy
mRNA was isolated from MJuberculosis H37Rv incubated in control 7H9 
liquid medium and complete Dulbecco's modified Eagles Medium. mRNA was also 
isolated from MJuberculosis H37Rv post-infection of human macrophages. cDNA 
was generated via reverse transcription of the isolated mRNA. Primers for each of the 
5 genes, identified in Chapter 4 as being potentially up-regulated, and the control 
gene Rv2703 (sigAI rpoV) were designed. Internal probes, for Fluorogenic 5’ 
Nuclease assay, were not designed due to potential problems over ownership rights 
with Perkin Elmer (who own the Taqman® licence). Quantitative reverse 
transcriptase PCR amplification of the 6 genes using cDNA from each of the growth 
conditions was subsequently followed using SYBR Green (Perkin Elmer).
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6.2 Materials and Methods \  \ |U  IS?
6.2.1 Primers
Primer Sequence (5’-3’) Details
302FOR GGGAGAGGTCACGAGAATCG M.tuberculosis genome nt 
364637-364657. Rv0302
302REV AGCCCTTGGTCGCCATC M.tuberculosis genome nt 
364700-364680
(complementary strand). 
Rv0302
1044FOR GTCGACGGAATACCCGTCAC M.tuberculosis genome nt 
1167471-1165491. Rvl044
1044REV TAAGGATCCGTGCCCGTCT M.tuberculosis genome nt 
1165542-1165523 
(complementary strand). 
Rvl044
1165FOR TTGTTCTGCGTAAAGCGCTG MJuberculosis genome nt 
1294506-1294526. Rvll65
1165REV GCCGGTCTGTCTTGTTGACC MJuberculosis genome nt 
1294569-1294549 
(complementary strand). 
Rvll65
1265FOR GACTGGTTCGACGGCGAC MJuberculosis genome nt 
1413483-1413501. Rvl265
1265REV GCTTGCCAATCACCGTAATTTC MJuberculosis genome nt 
1413547-1413525 
(complementary strand). 
Rvl265
271 IFOR AGCACGTGATGAGCGAGGAC MJuberculosis genome nt 
3023875-3023895. Rv2711
2711REV TGGTCGGGTTGTTGAGCAC MJuberculosis genome nt 
3023935-3023916 
(complementary strand). 
Rv2711
SIGAFOR TTCGCGCCTACCTCAAACAG MJuberculosis genome nt 
3018514-3018534. Rv2703 
(sigA/ rpoV)
SIGAREV GCTAGCTCGACCTCTTCCTCG M.tuberculosis genome nt 
3018581-3018560 
(complementary strand). 
Rv2703 (sigA! rpoV)
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6.2.2 Mycobacterium tuberculosis H37Rv RNA Extraction In Vitro
10 ml mid-exponential phase Mycobacterium tuberculosis H37Rv incubated 
in liquid media (either 7H9 or complete Dulbecco's modified Eagles medium) were 
harvested by centrifugation at 3000g for 10 minutes. The media was discarded and 
the cells were resuspended in 500pl 4M guanidinium isothiocyanate. The bacteria 
were added to a Hybaid Ribolyser™ blue tube containing 500pl acid phenol, 100 pi 
chloroform/isoamyl alcohol (24:1 (v/v)) and 200 pi acidified Divolab No.l (Diversey 
Ltd., UK). The cells were processed immediately in a Hybaid Ribolyser™ at speed
4.0 for 40 seconds and cooled on ice for 1 minute. Cell debris was removed by 
centrifugation at full speed in a microcentrifuge for 5 minutes. The aqueous layer was 
removed to a fresh tube and re-extracted with an equal volume of chloroform/isoamyl 
alcohol (24:1 (v/v)). The aqueous layer was again removed to a fresh tube and the 
RNA precipitated with 500 pi isopropanol/salt solution (0.3ml 3M sodium acetate 
pH4.0, 49.7 ml isopropanol) and 50ng linear acrylamide at -70°C for at least 1 hour. 
The RNA sample was pelleted by microcentrifugation for 20 minutes, air-dried and 
resuspended in an appropriate volume of DEPC-treated water (Hybaid Ribolyser™ 
Kit -  blue protocol).
6.2.3 Mycobacterium tuberculosis H37Rv RNA Extraction Post-infection of 
Cultured Human Macrophage.
THP-1 human macrophage cell line was infected with Mycobacterium 
tuberculosis H37Rv as described in section 4.2.1.2 and lysed with the addition of 4M 
guanidinium isothiocyanate. Mycobacterium tuberculosis H37Rv were separated
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from the monocyte cell debris by micro centrifuge for 10 minutes. The macrophage 
cell debris was discarded, and the pelleted Mycobacterium tuberculosis H37Rv 
pooled and resuspended in 500 pi guanidinium isothiocyanate. RNA was isolated 
from mycobacteria as described in section 6.2.2
6.2.4 Primer Design
All primers for Taqman PCR were designed on Primer Express software v. 1.0 
(Perkin Elmer), which is specifically designed for Taqman® primer design.
6.2.5 Reverse Transcription of Bacterial RNA
8ng of RNA were incubated at 37°C with RNase-free DNase for 30 minutes. 
The enzyme was subsequently inactivated at 65°C for 10 minutes. Reverse 
transcription was carried out described by the manufacturer (Gibco BRL). 5ng of 
RNA was added to 3 mM each dNTP (dATP, dGTP, dCTP, dTTP), lx DTT, lx  
buffer and 100 fmol random hexamers (Roche). Incubation of the mixture at 72°C and 
cooling on ice caused the random hexamers to anneal to the RNA. Superscript II 
reverse transcriptase (Gibco BRL) was then added and the mixture incubated at 42°C 
for 1 hour. The efficacy of the reverse transcription was checked by PCR.
6.2.6 Real Time PCR
All reactions were carried out using the SYBR Green (Perkin Elmer) reporter
system as described by the manufacturer. All PCRs were carried on an ABI PRISM
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7700 Sequence Detection System (Perkin Elmer) using MicroAmp® Optical 96-Well 
Reaction Plate and Optical Caps (PE Biosystems). The SYBR Green PCR Master 
Mix is 2X in concentration and contains sufficient reagents to perform 200 50-mL 
reactions. The mix is optimized for SYBR Green reactions and contains SYBR Green 
I Dye, AmpliTaqGold® DNA Polymerase, dNTPs with dUTP, Passive Reference 
(ROX), and optimized buffer components. The Passive Reference (ROX) is a dye 
included in the SYBR Green PCR Master Mix that does not participate in the PCR 
amplification and provides an internal reference to which the SYBR Green/dsDNA 
complex signal can be normalized during data analysis. Initial calibration experiments 
were carried using Mycobacterium tuberculosis H37Rv genomic DNA so as not to 
utilise valuable reverse transcribed cDNA. PCR reaction conditions consist of an 
initial AmpliTaqGold® DNA Polymerase activation at 95°C for 5 minutes followed 
by 40 cycles with primer annealing and extension at 60°C for 30 seconds and 
denaturation at 95°C for 30 seconds.
6.2.6.1 Calculation of Standard Curves for DNA Template
Using the optimal concentration of each set of primers, the amount of template 
Mycobacterium tuberculosis H37Rv genomic DNA added to each primer set was 
altered as follows: 10 ng, 1 ng, 0.5 ng, 0.2 ng, 0.1 ng, 0.05 ng, 0.02 ng and O.Olng. A 
standard curve of comparative threshold (Ct) values against amount of DNA added 
was calculated. See figures 6.3 and 6.4.
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6.2.6.2 Measurement of Levels of mRNA Present in Different Growth 
Conditions of Mycobacterium tuberculosis H37Rv
Constant amounts of reverse transcribed cDNA (0.4 ng) from each of the 
growth conditions were amplified with each set of primers. Comparative threshold 
(Ct) values were plotted against growth conditions. See figure 6.5.
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6.3 Resuite §f
6.3.1 mRNA Isolation and Reverse Transcription
Total RNA was extracted from M.tuberculosis H37Rv incubated in liquid 7H9 
control media, complete Dulbecco's modified Eagles Medium and in cultured human 
macrophages. The quality of the total RNA extracted was determined visually via 
denaturing gel electrophoresis and is shown in Figure 6.1.
Isolating large quantities of mRNA from MJuberculosis H37Rv incubated in 
liquid 7H9 media and complete Dulbecco's modified Eagles Medium is relatively 
simple because large numbers of mycobacterial cells can be cultured. This is not the 
case with mRNA isolated from MJuberculosis H37Rv harvested from within cultured 
human macrophages. Not only does the isolation of MJuberculosis H37Rv from the 
macrophage lysate complicate matters but also gathering sufficient mycobacterial 
cells post-infection is dependant on the number of macrophages used during the 
infection process and the number of bacilli ingested.
Figure 6.1 clearly identifies the problems associated with isolation of total 
RNA from MJuberculosis H37Rv post-infection of cultured human macrophages. 
Lanes 2 and 3 are 4 hour post-infection samples collected at the same tune and lane 4 
is a 4 hour complete Dulbecco’s modified Eagles Medium control. Lanes 5, 6 and 7 
are post-infection, complete Dulbecco’s modified Eagles Medium control and 7H9 
control samples collected after 24 hours growth, respectively.
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Lanes 2, 3 and 5 are the total RNA extracted from M.tuberculosis H37Rv 
post-infection of lx l08 cultured human macrophages infected with a multiplicity of 
infection of 10. Despite the fact that lx l0 8 cultured human macrophages were used 
for each infection, the samples in lanes 2, 3 and 5 contain virtually undetectable levels 
of total RNA.
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Figure 6.1: Denaturing gel o f total RNA isolated from M.tuberculosis H37Rv grown under different 
culture conditions. RNA visualised with SYBR gold. Lane 1 is RNA marker (0.28-6.58kb) (Promega). 
Lanes 2 and 3 are independent M.tuberculosis H37Rv total RNA samples obtained 4 hours 
post-infection o f cultured human macrophages. Lane 4 is M.tuberculosis H37Rv total RNA sample 
isolated after 4 hours incubation in complete Dulbecco's modified Eagles medium. Lane 5, 6 and 7 are 
total RNA samples isolated after 24 hours incubation post-infection o f cultured human macrophages, in 
complete Dulbecco’s modified Eagles medium and in liquid 7H9 medium, respectively.
Knowing that 3pg of marker was loaded into lane 1, it was estimated that 
lanes 6 and 7 contained Ipg of total M.tuberculosis H37Rv RNA, lane 4 contained 
lOOng of total RNA and lane 5 contained lOng of total RNA. This means that the total 
RNA concentrations of the 4 hour complete Dulbecco's modified Eagles Medium 
control, the 24 hour infection, the 24 hour complete Dulbecco's modified Eagles 
Medium control and the 24 hour 7H9 liquid medium control are approximately 20
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ng/|.il, 2 ng/pl, 1 pg/ftl and 1 pg /pi, respectively. Since the total RNA in lanes 2 and 3 
can not be detected, the total RNA concentration of the two 4 hour infections can not 
be estimated and it was therefore assumed that the concentration of total RNA was no 
more than lng /pi. As there was no difference between the conditions used to infect 
the human macrophages, the two M.tuberculosis H37Rv total RNA samples collected 
at 4 hours were pooled together. Each of the 5 samples was subjected to reverse 
transcription as described in Section 6.2.5.
Due to the fact that the M.tuberculosis H37Rv total RNA obtained from the 
7H9 liquid medium control was most plentiful, a PCR, using the pairs of primers to 
amplify Rv0302, Rvl044, Rvl 165, Rvl265, Rv2711 and Rv2703 (sigAl rpoV), was 
carried out to check the efficacy of the reverse transcription. Amplification products 
were seen with the primer sets for Rv0302, Rvl265, Rv2711 and Rv2703 (sigA! 
rpoV), but was absent with the primer sets for Rvl044 and Rvl 165. Despite the lack 
of amplification of genes Rvl044 and Rvl 165, reverse transcription was considered 
sufficiently successful for use with real time PCR. The reason for the failure to 
amplify DNA with the primers for Rvl044 and Rvl 165 is not known. This could be 
due to a problem with the reverse transcription of the total RNA or with the 
amplification of the target sequences. Alternatively the level of expression of these 
genes could be expressed at very low levels when M.tuberculosis is grown in liquid 
7H9 medium.
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6.3.2.1 Calculation of Optimal Prim er Concentration
When using real time PCR and SYBR Green to analyse PCR amplification, 
the first requirement is to minimise any primer dimers. Since DNA preferentially 
forms double stranded molecules, single stranded primers that are heated and cooled 
during the amplification cycles can form dimers, even if the DNA is not homologous. 
SYBR Green is similar to ethidium bromide in that it only chelates to double stranded 
DNA. Any primer dimers present would therefore interfere with detection of the 
required DNA sequences following amplification.
Therefore the pairs of primers (e.g. 302FOR and 302REV, 1044FOR and 
1044REV, etc) were mixed at a range of different concentrations. The concentrations 
were 50nM:50nM, 50nM:300nM, 50nM:900nM, 300nM:50nM, 300nM:300nM, 
300nM:900nM, 900nM:300nM and 900nM:900nM, with the initial concentration 
representing the forward primer. Full 40 cycle amplifications were carried out with 
and without lng of MJuberculosis H37Rv genomic DNA template, in order to 
identify the mixture of primers concentrations that generate the least number of 
primers dimers, using SYBR green to measure both the amplification of the target 
sequence and the number of primer dimers. With all pairs of primers, the optimal 
concentration of primers pairs, generating the least number of primer dimers and the 
greatest amplification of target sequence, was 900nM:900nM.
The primers designed to amplify genes Rvl044 and Rvll65 formed a greater 
number of primer dimers than the primers designed to amplify genes Rv0302,
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Rvl265, Rv2711 and Rv2703 (sigAI rpoV). In addition to the increased number of 
primer dimers, amplification of the target DNA was not seen. The reason for the lack 
of amplification with the primers for Rvl 044 and Rvl 165 is not known. Quantitative 
RT-PCR analysis of the genes Rvl 044 and Rvl 165 was therefore not conducted.
6.3.2.2 Calculation of Standard Curves for DNA Template
With the ideal concentration of mixed primers identified, the efficiency of 
amplification with each set of primers had to be determined. As previously stated, in 
order to relate RNA samples containing different amounts of starting template, a 
constitutively expressed gene which is not up- or down-regulated is required as a 
control. This control is called a comparator and in this case Rv2703 (sigAlrpoV) was 
selected.
MJuberculosis H37Rv genomic DNA was used to calculate the efficiency of 
amplification with each primer set. The genomic DNA was diluted to 10 ng, 1 ng, 0.5 
ng, 0.2 ng, 0.1 ng, 0.05 ng, 0.02 ng and O.Olng of template and PCR amplification 
was carried out with each set of primers at their optimal concentration. Figure 6.2 is a 
copy of the immediate output from the Taqman® equipment and analysis software. It 
shows a series of graphs that are generated during the amplification process with the 
range of diluted MJuberculosis H37Rv genomic DNA with the primers set designed 
to amplify a short region of the gene Rv2711. All of the graphs are horizontal during 
the initial stages of the amplification, until sufficient template DNA has been 
generated. Once sufficient template DNA has been generated, the signal accelerates 
exponentially and each of the graphs curves away from the baseline, shown with the
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dark black line close to 0.000. The point where each graph leaves the baseline is 
called the Cj value. The Cj value represents the point in time when there is sufficient 
template for the detection of the exponentially increasing signal. The lower the Ct 
value the greater the number of template molecules present at the start of the 
amplification. Taking the dark blue and the red graphs as examples, which are at 
opposite ends of the scale, the dark blue graph has a much lower Ct value than the red 
line. This means that PCR represented by the dark blue graph contains more starting 
template that the PCR represented by the red line. The dark blue line depicts the 
amplification of M.tuberculosis H37Rv genomic DNA with lOng of DNA and the red 
line represents 0.0 lng of starting genomic DNA.
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Figure 6.2: Graph taken directly from Taqman® analysis software. The dark blue, dark green, blue, 
pink, light blue, yellow, light green and red lines represent PCR amplifications with 10 ng, 1 ng, 0.5 
ng, 0.2 ng, 0.1 ng, 0.05 ng, 0.02 ng and 0.01 ng o f  M.tuberculosis H37Rv genomic DNA, respectively. 
The dark black horizontal line close to 0.000 represents the threshold at which DNA amplification 
accelerates exponentially.
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Figure 6.3 shows Ct value for each genomic DNA concentration for 4 sets of 
primers designed to amplify regions of the genes Rv0302, Rvl265, Rv2711 and 
Rv2703 (sigAI rpoV). These graphs show the efficiency each of the amplifications.
If the amplification of cDNA from MJuberculosis H37Rv grown in different 
growth conditions is to be related, the efficacy of PCR, with each set of primers, 
needs to be similar. The efficacy of a PCR is related to the slope of the standard curve 
for the primer sets used in the amplification. Thus, if the linear best-fit trendlines are 
correct, in Figure 6.3, the yellow, dark blue and pink curves which show the 
amplification from the MJuberculosis H37Rv genes Rv2711, Rv0302 and Rvl265, 
respectively, are quite close to being parallel meaning that the amplification 
efficiency is roughly the same. However, the amplification of the gene Rv2703 (sigAI 
rpoV), which is represented by the pale blue line, is not parallel to the other 3 lines 
and the angle of the slope is shallower. This means that the PCR represented by the 
green line (the amplification of Rv2703) is less efficient than the PCRs of the genes 
Rv0302, Rvl265 andRv2711.
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M.tuberculosis H37Rv DNA added (ng)
 Rv0302  Rv 1265 Rv2711  sigA
Figure 6.3: Graph o f CT value against amount o f  M.tuberculosis H37Rv genomic DNA added to each 
real time PCR. M.tuberculosis H37Rv DNA added was 10 ng, 1 ng, 0.5 ng, 0.2 ng, 0.1 ng, 0.05 ng, 
0.02 ng and 0.01 ng. Each line represents a linear best-fit trendline. Individual amplifications are 
represented by dots.
Since the amplification efficacy of the comparator (Rv2703 (sigA/ rpoV)) is 
lower than the efficacy of the other 3 PCRs (Rv0302, Rvl265 and Rv2711 -  the 
samples), the amplification from cDNA generated from M.tuberculosis H37Rv grown 
in different growth conditions for these genes can not be accurately compared. It is 
known that the expression of Rv2703 (sigA/ rpoV) is unaltered by the growth of 
M.tuberculosis H37Rv in different conditions (Manganelli et al., 1999). Therefore if 
the efficiencies of the 4 amplifications had been comparable, it would have been 
possible to definitively calculate a ratio of the level of expression of each sample gene 
in each of the growth conditions, with Rv2703 (sigA! rpoV) being used as a standard 
control.
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It is clear from figure 6.3 that the linear best-fit trendlines do not accurately 
represent the observed data, which is non-linear over this range of DNA 
concentrations. However, the range of template concentrations and Cx values shown 
in figure 6.3 is wider than the actual range used subsequently to generate in figure 
6.5; it is therefore possible to examine the effect of re-plotting figure 6.3 without the 
lOng point, which otherwise has an excessive influence on the slope of the line 
plotted. Figure 6.4 indicates that over this range the PCR efficiencies of the sigA 
(Rv2703/ rpoV) and Rvl265 amplifications are similar. With this in mind, it may be 
possible to use figure 6.4 to extrapolate greater significance from quantitative PCR 
using M.tuberculosis H37Rv cDNA as a template.
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M.tuberculosis H37Rv DNA added (ng)
 Rv0302  Rv 1265 Rv2711  sigA
Figure 6.4: Graph o f CT value against amount o f M.tuberculosis H37Rv genomic DNA added to each 
real time PCR. M.tuberculosis H37Rv DNA added was 1 ng, 0.5 ng, 0.2 ng, 0 !  ng, 0.05 ng, 0.02 ng 
and 0 .0Ing. Each line represents a linear best-fit trendline. Individual amplifications are represented by 
dots.
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6.3.2.3 Measurement of Levels of mRNA Present in Different Growth
Conditions of Mycobacterium tuberculosis H37Rv
Although the absence of a standard control was a limitation, it was still 
possible to carry out a semi-quantitative comparison of real time RT-PCR with the 
four sets of primers. In order to generate some consistency, a constant amount of 
cDNA was added to each amplification. This was difficult since the amount of cDNA 
produced can not be accurately measured. It was assumed that the reverse 
transcription of all M.tuberculosis H37Rv RNA samples were equally successful and 
therefore the amount of cDNA present was related to the starting amount of mRNA. 
For each cDNA preparation, the amount of starting mRNA was adjusted to be 
constant.
Therefore cDNA (0.4 ng) generated from each of the RNA preparations from 
M.tuberculosis H37Rv after 4 and 24 hour macrophage infections and 24 hours 
incubation in complete Dulbecco's modified Eagles Medium and liquid 7H9 medium 
was amplified independently with each primer set. Each set of primers was used to 
amplify each of the cDNA samples in triplicate. In Figure 6.5, the average Ct value 
for each primer set with each cDNA sample is.depicted graphically.
It is apparent from figure 6.5 that the aforementioned problem with the 
comparator is significant. It would be expected that different preparations of mRNA 
would be at different concentrations. Despite the fact that Rv2703 (sigA! rpoV) is not 
up- or down-regulated during infection, the proportion of the sigA molecules, 
compared to the total mRNA molecules, would be expected to change. Therefore the
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number of sigA molecules in each of the RNA samples would be different. This is 
indeed the case since the Ct values for the 4 cDNA preparations are different.
Normally, if the real time PCR comparator exhibits a similar PCR 
amplification efficiency to the sample amplifications (in this case Rv0302, Rvl265 
and Rv2711), the Ct values can be adjusted so that the comparator Ct value is 
constant. This would mean that the number of initial template molecules for the 
comparator are constant in all samples. This would also have the effect of altering the 
Ct values for all other sample amplifications.
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As previously discussed this type of comparison can not be carried out 
because the PCR efficiencies are not similar. Therefore the only method available to 
suggest any relationship between the generation of mRNA, from the genes in 
question, in the different growth conditions is to amplify DNA from constant amounts 
ofcDNA.
Figure 6.5 suggests that, with constant amounts of cDNA at the start of the 
amplification, the M.tuberculosis H37Rv expresses both Rvl265 and Rv2711 at a 
higher rate post-infection than it does when grown in vitro since the Ct values during 
infection are lower than the Ct values generated by in vitro cDNA. However, as in 
Chapter 4, the MJuberculosis H37Rv incubated in complete Dulbecco's modified 
Eagles medium is the direct control for MJuberculosis H37Rv grown in 
macrophages. In the case of Rvl265, the expression of the gene appears to be greater 
during both the 4 and the 24 hour infections compared to the level of expression of 
the gene in the complete Dulbecco’s modified Eagles medium control. This is also the 
case in the expression of Rv2711, but to a lower extent. It appears that the expression 
of Rv2711 is also up-regulated during the incubation of MJuberculosis H37Rv in 
complete Dulbecco's modified Eagles medium compared to growth in liquid 7H9 
medium. Figure 6.5 suggests that the expression of Rv0302 is not up-regulated during 
macrophage infection or incubation in complete Dulbecco's modified Eagles medium.
However figure 6.4, which shows the PCR efficiencies within the range of 
MJuberculosis H37Rv cDNA concentrations being amplified, suggests that the 
amplification efficiencies of Rv2703 (sigA or rpoV) and Rvl265 are in fact similar. 
This enables a greater interpretation of the results in figure 6.5 with respect to the
Chapter 6: Real time PCR using Taqm an®  Technology.
161
potential induction of Rvl265. Since the expression of sigA is unaltered during 
infection (Manganelli et a l, 1999), there is a strong case suggesting that Rvl265 is 
induced during infection. Quantitative RT-PCR calculations for fold induction of 
Rvl265 require the accommodation of the sigA expression and the expression of 
Rvl265 in vitro (grown in liquid 7H9 medium). This suggests that Rvl265 is induced 
after 24 hours post-macrophage infection by 10-20 fold.
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Total RNA was extracted from M.tuberculosis H37Rv incubation in liquid 7H9 
medium, complete Dulbecco's modified Eagles Medium and in cultured human 
macrophages. Reverse transcription of the isolated mRNA was carried out and the 
efficiency of the reverse transcription tested by PCR with each of the 6 sets of 
primers.
The primers designed to amplify short regions of Rvl044 and Rvll65 failed to 
amplify any DNA during the test of the efficiency of cDNA generation. There was 
also no amplification from genomic MJuberculosis H37Rv DNA during the 
calculation of optimal primer concentration and the primers designed to amplify the 
genes Rvl044 and Rvll65 also generated a greater number of primer dimers than 
expected. There are 2 possible reasons for the lack of amplification of the genes 
Rvl044 and Rvll65. The first is that each of the primer pairs may not be very good 
primers and therefore may need to be re-designed. Secondly, the dimerization of each 
primer set may be strong enough to interfere with the annealing of the primer to the 
target sequence.
It is disappointing that the amplification efficiencies of PCRs for Rv0302, 
Rvl265, Rv2711 and Rv2703 (sigA! rpoV) are not similar in figure 6.3. Since the 
efficiency of the Rv2703 (sigA) PCR is low, in order to cause the 4 PCRs to have 
similar efficiencies, the efficiencies of PCRs for Rv0302, Rvl265 and Rv2711 would 
have to be reduced. Due to the short length of time available it was not possible to 
alter the efficiencies of any of the PCRs.
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Since the efficiency of the Rv2703 (sigA) PCR (the comparator) in figure 6.3 is 
lower than the efficiencies of the PCRs for Rv0302, Rvl265 and Rv2711 (the 
samples), a definitive quantitative measurement of the up-regulation of the sample 
genes is not possible. In this instance, quantitative RT-PCR can only be used to 
suggest any possible up-regulation. However, using figure 6.4 to suggest comparable 
PCR efficiencies between the Rv2703 (sigA) and Rvl265 primers and an 
extrapolation of the cDNA amplification results in figure 6.5, there is strong evidence 
that Rvl265 is indeed up-regulated 10-20 fold during infection. However, the 
truncation of the graph in figure 6.3, to generate figure 6.4, can not be used to 
calculate definitive quantitative values of the degree of up-regulation of Rvl265.
It has been shown that Rv2711 is the gene responsible for the production of an 
iron dependent repressor (which has been annotated as ideR) and is a homologue for 
the diphtheria toxin repressor (dtxR) (Schmitt et al., 1995). An interesting result of 
this work is that the detection of the Rv2711 mRNA is greater in both samples 
obtained post-infection and the sample obtained from incubation in complete 
Dulbecco's modified Eagles Medium than it is the sample grown in liquid 7H9 
medium. This is interesting since the protein product of gene Rv2711 is an iron 
dependent repressor. Not only is the iron availability low within a macrophage but it 
is also limited in complete Dulbecco's modified Eagles Medium.
Iron is required by almost every living organism as a protein cofactor. In 
response to low iron availability in the environment, microorganisms have developed 
a number of methods for iron uptake. Microorganisms are known to secrete 
siderophores, which are low molecular weight, high-affinity non chelators that
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solubilize non complexed in the environment or bound to compounds from their host, 
such as transferrin and lactoferrin. It has been shown that the IdeR protein is 
responsible for repressing siderophore biosynthesis in the presence of iron and that 
M.smegmatis ideR mutants are more sensitive to oxidative stress (Dussurget et al., 
1996). Therefore Dussurget et al. suggested that IdeR couples non metabolism to the 
oxidative stress response. It has subsequently been suggested that IdeR positively 
controls the expression of JxbA (Dussurget et al., 1999), which encodes a putative 
formyltransferase necessary for exochelin biosynthesis. Exochelins are siderophores 
found in fast growing mycobacteria. Dussurget et al. suggested that IdeR could act 
directly as a positive regulator for the JxbA gene or as an activator of a second 
activator for this gene. Alternatively, IdeR could act as a repressor of a repressor. Any 
of these potential positive functions of IdeR could provide a reason for the 
up-regulation of Rv2711 during infection. IdeR is a homolog of the Corynebacterium 
diphtheriae DtxR protein and a similar cascade mechanism has been hypothesised for 
the induction of a heme oxgenase (Schmitt, 1997).
The genes Rv0302 and Rvl265 have been annotated by Cole et al. (1998) as 
coding for proteins with unknown functions. However the gene Rv0302 has sequence 
similarity to a number of repressors and regulatory proteins from other organisms 
including the E.coli acrAB operon repressor (Ma et a l, 1996). The gene Rvl265 has 
no homologies to any currently known proteins. The results for the amplification of 
the gene Rv0302 are unclear since the error bars of the triplicate amplifications 
overlap and suggest that the expression of this gene is not up-regulated during 
infection compared to the expression during incubation in complete Dulbecco’s
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modified Eagles medium and liquid 7H9 medium. The expression of gene Rv0302 in 
different growth condition does need further investigation.
The evidence of the up-regulation of Rvl265 and Rv2711 contained within 
this chapter needs to be carefully considered. There is undoubtedly evidence of 
up-regulation but certain assumptions had to be made in order to generate data. The 
amount of RNA present in preparations obtained from M.tuberculosis was estimated 
as opposed to measured. To compound this issue, the M.tuberculosis RNA isolated 4 
hours post-macrophage infection could not be detected using denaturing gel 
electrophoresis and therefore a maximum quantity of RNA present was estimated. It 
was also assumed that different mRNA preparations, containing different quantities of 
mRNA, were reverse transcribed with equal efficacy. These assumptions may well be 
affecting the detected up-regulation of Rvl265 and Rv2711. However, the apparent 
up-regulation of Rvl265, in particular*, is considerable and therefore, despite the 
assumptions mentioned above, the evidence strongly suggests that this gene is indeed 
up-regulated during infection.
The potential power of real time PCR has not been fully realised with analysis 
on these particular genes. However, these results do suggest that the genes Rvl265 
and Rv2711 may be up-regulated during the infection of cultured human 
macrophages, which supports the p-galactosidase assay results in Chapter 4. Further 
investigation of the genes Rvl265 and Rv2711 is required to obtain quantitative 
estimates of the degree of up-regulation of these genes during infection.
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^  .  p r o ,7.1 General Discussion
The aim of this study was to identify genes that are potentially involved in the 
virulence of M.tuberculosis and are therefore up-regulated during the infection of the 
host. This study has shown that it is possible to mimic in vitro the conditions that 
M.tuberculosis may be exposed to in vivo and use them to identify potentially 
up-regulated genes. In this study, the in vivo mimicking conditions used were a 
reduced pH (pH 5.4) and a reduced pH (pH 5.4) with sodium nitrite. Sodium nitrite at 
a reduced pH decomposes to generate reactive nitrogen intermediates (Taylor et al., 
1927). Therefore the intention of this study was to identify gene expression responses 
to acidification and/or reactive nitrogen intermediates. However the true 
environmental conditions that M.tuberculosis is exposed to during infection are 
unclear and gene expression will undoubtedly respond to other signals, such as 
reactive oxygen intermediates, not covered in this study.
The clones that were identified as up-regulated by the in vivo mimicking 
conditions were subsequently used to infect human and murine macrophages and 
these experiments identified a number of clones whose expression of lacZ appeared to 
be up-regulated inside the macrophage compared to in vitro. Sequence data showed 
that over half of the clones used to infect macrophages contained cloned 
M.tuberculosis H37Rv DNA that contained potential promoters. mRNA analysis, 
using Taqman® technology, of a small number of these potentially up-regulated 
genes supported the findings of up-regulation in two of the five genes tested.
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The MJuberculosis genes Rvl 265 and Rv2711 (ideR) do appeal* to be 
up-regulated during infection and the quantitative reverse transcriptase PCR findings 
are consistent with this interpretation if not fully conclusive. Superficially, it may be 
regarded as not surprising if the ideR gene were to be up-regulated during infection as 
its role as an expression regulator would probably be required during the process of 
infection, especially considering its potential activator role in siderophore 
biosynthesis (Dussurget et a l , 1996). However, the real significance of an 
up-regulation of the repressor itself, as opposed to the genes that it controls, remains 
to be investigated. The apparent up-regulation of Rvl265, which codes for a protein 
with an unknown function is perhaps more intriguing, especially considering the 
strong evidence, obtained using real time PCR, of its macrophage-infection induction. 
The possible intra-macrophage up-regulation of genes Rv0302, Rvl044 and Rvl 165 
needs to be re-examined.
The strongest evidence supporting the success of the gene fusion methodology 
employed here to identify genes up-regulated during mycobacterial infection was the 
repeated finding of the promoter sequence for Rv0440 (groELl) in 4 independently 
tested clones. Other studies designed to investigate differential gene expression in 
mycobacteria have identified the gene Rv0440 (groEL2) as being up-regulated during 
infection or exposure to stressing conditions (Monahan et a l, 1994; Lee and Horwitz, 
1998; Garbe et a l, 1996). The groEL2 gene codes for a chaperonin heat shock protein 
with a molecular weight of 60KDa. The up-regulation of the gene Rv0440 (groEL2) 
may be a general stress response rather than a specific response to acidification or 
reactive nitrogen intermediates.
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7.2 Direct Comparison of Promoter Probe Methodology with Alternative 
Techniques.
During this study, a number of clones were identified as being apparently 
up-regulated during infection but upon sequencing were found to contain portions of 
M.tuberculosis H37Rv DNA that are unlikely to contain promoter sequences, such as 
regions internal to genes. These false positive results are to be expected, as they are 
also found in other studies using technologies such as differential display PCR 
(DD-PCR) (Garbe et al., 1996; Lee and Horwitz, 1998; Monahan et al., 1994; Ragno 
et al., 1997; Rivera-Marrero et al., 1998). However the fact that approximately half of 
the sequenced, potentially up-regulated genes contain probable promoter sequences 
suggests that the presence of these false positives is acceptable as they are easily 
identifiable.
During the use of subtractive hybridization to identify the mig gene of M. avium 
as induced during phagocytosis, Plum and Clark-Curtiss (1994) commented that their 
protocol would be especially useful in identify induced genes “for organisms that do 
not presently have a well-defined genetic system, such as the mycobacteria”. This 
may well be the case but perhaps the biggest problem with using RNA based 
procedures, such as subtractive hybridization, microarrays and the real-time 
reverse-transcriptase PCR used during this study, to identify potential virulence 
factors is whether they have the ability to identify genes with transient expression or 
low level expression. The expression of a particular virulence factor may be 
extremely short lived and, unless mRNA is extracted during this spike of expression, 
it may not be reverse transcribed and therefore can not subsequently be amplified. If a 
gene were to be expressed in small quantities, it may be difficult to generate sufficient
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amplicon to detect it during the hybridization step of subtractive hybridization or 
micro array s. An additional consideration is the half-life of mRNA. Some mRNAs 
have veiy short half-lives and therefore, despite considerable levels of expression, 
detection of these mRNAs can be difficult.
The completion of the MJuberculosis H37Rv genome sequence (Cole et al., 
1998) is undoubtedly an enormous advancement in mycobacterial research in general 
and the study of tuberculosis specifically. The use of techniques such as high density 
DNA arrays and proteome analysis, which exploit the availability of the genome 
sequence to great effect, are ideally suited to identifying virulence factors. However 
the huge cost involved in this state of the art technology precludes a significant 
portion of the research community from making use of these techniques. The work 
described here is very labour intensive but does not require expensive laboratory 
equipment, apart from the Taqman® equipment, which can be replaced with lower 
technology, lower cost alternatives. Although cost should not an argument for or 
against a specific technique, the availability of that technique is. However, perhaps 
more importantly, the methodology described here is not only capable of identifying 
novel virulence factors but could also be used to support data obtained from genomic 
techniques, such as high density DNA arrays and proteome analysis. Genomics and 
proteomics are undoubtedly one of the main methods that will be employed to 
identify virulence factors in the future, not only of MJuberculosis but of other 
organisms as well, such as the causative agent of malaria, Plasmodium falciparum 
(Hayward et al., 2000).
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It is important to note that genomics and proteomics can detect all of the 
changes in gene control but do have certain limitations. Transcriptional methods, such 
as the promoter probe methodology described here and genomics, are not capable of 
identifying any post-transcriptional regulation, such as mRNA stability, mRNA 
secondary structure or initiation and termination of translation. Problems can be 
caused by post-translational modification when using proteomics. Proteins that are 
post-translationally modified (i.e. glycosylated) during certain growth conditions will 
occupy different positions in a two dimensional polyacrylamide gel to the 
un-modified protein and therefore appear to be de novo synthesised proteins. The 
detection of low abundance proteins, such as repressors, is particularly difficult using 
proteomics. One advantage that the promoter probe methodology has over genomics 
and proteomics is that it can be used in advance of the availability of genome 
sequence data. This methodology could therefore be used to identify virulence 
determinants of other microbial pathogens.
Both in vivo expression technology (IVET) and signature-tagged mutagenesis 
(STM) have an enormous advantage over the methodology used here to identify 
potential virulence factors. During these two techniques all of the screening for 
virulence factors is carried out in vivo. The use of animal models, as opposed to 
cultured macrophages, would expose M.tuberculosis to an environment that could 
never be reproduced in vitro -  such as serum proteins, the presence or absence of 
chemicals (such as iron availability) and die effect of these on the macrophage. An 
additional advantage of STM and IVET are that gene expression is studied in situ on 
the chromosome. This negates any alteration in gene expression experienced when 
studying expression with a plasmid construct. The methodology described here could
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be adapted to use animal models by altering the reporter gene used (lacZ) to a 
selectable reporter gene and mutant strain of M.tuberculosis (as in the IVET 
methodology). However, the problem of expression of the reporter gene still being 
initiated from the plasmid, as opposed to the chromosome, would still exist.
There is little doubt that each of these methods are capable of identifying 
potential virulence factors or generating additional data regarding potential virulence 
factors. Identification of virulence factors via one technique will require the support 
of data generated by other techniques, such as allelic exchange mutagenesis. Allelic 
exchange mutagenesis was first carried out in the M.tuberculosis complex by Norman 
et al. (1995), with viable mutants being reported later that year (Reyrat et al., 1995). 
However, allelic exchange mutagenesis is not, in itself, capable of identifying 
virulence factors but is better suited to identifying the effect on mycobacteria of 
removal of virulence factor proteins identified via other methods. This being the case, 
allelic exchange mutagenesis is well suited to validating virulence factor expression 
data previously identified via other means. Allelic exchange mutagenesis will 
probably be most useful in the mutation of specific genes in M.tuberculosis, if an 
alternative live vaccine to BCG were ever to be created.
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The clones that were sequenced and identified as containing the probable 
promoters of genes potentially up-regulated during infection need further 
investigation. Perhaps the simplest method of definitively identifying which genes are 
up-regulated during infection is using Taqman® technology, as described in Chapter 
6, provided that an appropriate positive control can be utilised. Other 
lower-technology techniques could be used identified which genes are up-regulated 
during infection, such as Northern blotting or RT-PCR. The problem with these two 
techniques is that Northern blots require large amounts of mRNA, which is difficult 
to obtain and RT-PCR is only semi-quantitative. There are currently 23 sequenced 
clones from this work, in addition to those already used during quantitative RT-PCR 
experiments, containing potential promoters whose genes should be investigated 
further.
7,3  F u tu re  W ork  § S H  \  /
As stated above the overall process of promoter library generation, in vitro 
selection, in vivo selection and sequencing has been successfully used to identify 
potentially up-regulated promoters. Therefore the size of the library, currently at 4800 
clones, should be increased in order to identify other M.tuberculosis H37Rv genes 
up-regulated during infection. Ideally it would be increased to the 32951 clones 
required to statistically cover the entire M.tuberculosis H37Rv genome. In addition to 
increasing the size of the library, it may also be profitable to use different in vitro 
stimuli designed to mimic the intra-macrophage conditions, such as reactive oxygen 
intermediates, or anaerobic conditions. The library could also be used to identify
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genes expressed during different growth conditions in vitro, or expressed at different 
stages of growth, such as stationary phase.
The logical progression of the separate studies carried out during this work was 
to mimic the effect of in vivo conditions on each clone, a study of the expression 
levels of each clone post-infection, sequence analysis and ultimately quantitative 
RT-PCR. With a complete view of the work carried out here and in retrospect, this 
may not have been the best utilisation of resources. In future, having carried out the in 
vivo mimicking study, I think that the next step should be the sequence analysis. This 
would further reduce the number of clones to be used in macrophage infection studies 
since only clones containing potential promoters would need to be infected. Since a 
low number of clones would then to used to infect macrophages, not only could each 
clone be studied in greater detail (i.e. with more time points and in triplicate 
infections), but the macrophages could also be pre-activated with interferon y. 
Pre-activated macrophages are more capable of suppressing MJuberculosis infections 
(Sato e ta l , 1998).
This study was designed to identify genes that are up-regulated during infection 
and are therefore likely to be associated with the pathogenicity of MJuberculosis. 
Clearly the immediate requirement of the bacterium post-infection internalisation 
within the macrophage is survival. The effect of long-term infection has not been 
investigated during this study. However the methodology described here could easily 
be adapted to measure the level of lacZ expression over a greater number of days. 
This may have identified different clones associated with the longevity of the 
M.tuberculosis infection.
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The identification of further virulence factors will better our understanding of 
M. tuberculosis infection and potentially lead to an alternative and better vaccine than 
the current BCG vaccine. The methodology described here has identified genes that 
are potentially up-regulated during infection and a continuation of this work will 
consolidate the findings described here.
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Appendix I: Materials
A p p en d ix  1 -  M ateria ls
All media were obtained from Difco and chemicals from Sigma unless 
otherwise stated. Appropriate media and chemicals were manufactured using double 
distilled water and autoclaved at 121°C under 15 psi pressure for 15 minutes. 
Alternatively, solutions were sterilised by filtration through a 0.2 pm Ministart filter 
unit.
Growth Media
LB broth: Bacto tryptone 1.0% (w/v), yeast extract 0.5% (w/v), NaCl (85 mM) pH7.5. 
LB agar: As LB broth with bacteriological agar 1.5% (w/v).
7H9 broth: 5.2g/l in water, with tween and glycerol.
7H11 agar: 21g/l in water, with glycerol.
SOC: Bacto tryptone 2.0% (w/v), yeast extract 0.5% (w/v), NaCl (8.0 mM) KC1 (2.5 
mM) MgS04 (20 mM) glucose (20 mM) pH7.5. Sterile MgCl2 (10 mM) prior to use. 
Dulbecco's modified Eagles medium (Life-Tech)(DMEM GMAX): 4 mM 
L-glutamine adjusted to contain 1.5 g/1 sodium bicarbonate, 4.5 g/L glucose and
1.0 mM sodium pyruvate.
Media Supplements
Xgal (5-bromo-4-chloro-3-indolyl-p-D-galactopyranoside): 40 pg ml'1 dissolved in 
dimethyl formamide. Filter sterilised, stored at -20°C in the dark.
Tween 80: 0.05% (v/v).
Glycerol: 0.02% (v/v).
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Kanamycin: 50 pg ml'1 for Escherichia coli, 15(ig ml"1 for Mycobacterium bovis 
BCG. Filter sterilised, stored at -20°C.
Heat inactivated Foetal Calf Serum (Life-Tech): 10% (v/v)
Phorbol Myristate Acetate (PMA): lOmg/ml in DMSO. Stored at -20°C.
General Buffers
6X Loading buffer: 40.0% (w/v) sucrose, 0.25% (w/v) Orange G, 5mM EDTA. 
Buffered phenol/ chloroform: 50:50 ratio (v/v).
Phosphate-buffered saline: 137 mM NaCl, 2.7 mM KC1, 4.3 mM Na2HP04, 1.4 mM 
KH2PO4 (pH7.3).
50X TAE: 270 mM tris, 7.0 mM EDTA, 1.15% (v/v) glacial acetic acid.
TE: 10 mM tris/HCl pH8.0,1 mM EDTA pH8.0.
10X MOPS: 0.2 M 3-(N-morphmo) propanesulfonic acid, 50 mM sodium acetate, 
5 mM EDTA
Buffers Required for RNA Isolation
guanidinium Isothiocyanate (GITC): 4M guanidinium isothiocyanate, 20mM Tris 
(pH7.6), lOmM EDTA, 2% Sarkosyl and 1% Beta mercaptoethanol.
Acidified Divolab Detergent: 9.6ml Divolab Nol (Diversy Lever), 24ml 500mM 
sodium acetate (pH 4.0), 66.4ml RNAse free water.
Acid phenol: Pro analysis phenol (Merck) saturated with water and equilibrated with 
50mM sodium acetate (pH 4.0).
RNA denaturant: Glyoxal/DMSO (1.5mls/2.5mls). Stored at -80°C.
SYBR Gold (Cambridge Bioscience): diluted 1:10000 in MOPS
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Solution 1: 50 mM glucose, 25 mM tris/HCl pH8.0,10 mM EDTA.
Solution 2: 0.2M NaOH, 1% (whr) SDS.
Solution 3: 60% (v/v) 5M potassium acetate, 11.5% (v/v) glacial acetic acid.
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Bacterial Strains
Strain Details
Escherichia coli DH5a supE44, AlacU169 (§80lacZAl5), hsdR17, recAl 
endAl, gyrA96, thi-1, relAl (Hanahan 1983).
Epicurian Coli® XL2-Blue 
ultracompetent cells
recAl, endAl, gyrA96, thi-1, hsdR17, supE44, 
relAl, lac [F5 proAB laclqZAM15 TnlO (Tef) 
Amy Cam1]
Mycobacterium bovis BCG 
Pasteur
ATCC Number: 35748
Mycobacterium tuberculosis 
H37Rv
ATCC Number: 27294
Macrophage Ceil Lines
Macrophage Cell Line Reference
J774 (Unkeless, 1979) ATCC Number: HB-197
THP-1 (Auwerx, 1991) ATCC Number: TIB 202
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P la sm id s
Plasmid Details Reference
pALSOOO Mycobacterial origin of replication Labidi et aL, 1985
pUC18 bla, colEl, lacZa Yanisch-PeiTon et al., 1985
pUC19 bla, colEl, lacZa Yanisch-Perron etal., 1985
pUS 1781 Stewart, G. R. (Pers. Comm.)
pMC1871 Promega
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General molecular biology techniques were performed according to Current 
Protocols in Molecular Biology unless stated otherwise (1998).
Small Scale Preparation of Plasmid DNA
Plasmid DNA was routinely extracted from E.coli by alkaline lysis. A 3 ml 
16-18 hour culture was centrifuged at 1400g for 10 minutes and the supernatant 
discarded. The remaining pellet was resuspended in 150 pi of solution I followed by 
addition of 300 pi of freshly prepared solution II. The contents were mixed by 
inversion and placed on ice for 5 minutes. Subsequent addition of 225 pi of solution 
III was followed by inversion mixing and incubation on ice for a further 5 minutes. 
The mixture was centrifuged at 15000g for 5 minutes to remove precipitate. The 
supernatant was extracted and incubated with RNAseA (final concentration 
20 pg ml"1) at 37°C for 20 minutes. Plasmid DNA in solution was purified by phenol/ 
chloroform extraction precipitated and resuspended in 30 pi water (stored at -20°C).
Plasmid DNA to be used for sequencing or for transformation of M.bovis 
BCG Pastern* was extracted using commercially available kits (Hybaid Recovery™ 
Plasmid Midi Prep kit or Qiagen Mini and Midi kits) according to manufacturers’ 
instructions.
182
Appendix 2 - Methods
A 10 ml culture of M.tuberculosis H37Rv was grown at 37°C to late 
exponential phase after which cycloserine was added to a final concentration 
of lmg ml'1 and the culture grown for a further 12 hours. The bacteria were pelleted 
by centrifugation at 3000g for 15 minutes then the supernatant discarded. The 
remaining pellet was resuspended in 400 pi 0.3M sucrose/TE and incubated at 80°C 
for 1 hour to heat kill the bacteria. Freshly prepared lysozyme was added to a 
concentration of 2 pg ml'1 and incubated at 37°C for 1 hour. EDTA (50mM), SDS 
(l%v/v) and pronase (0.2mg ml"1) were and the mixture incubated at 55°C for 1 hour. 
This was followed by 2 phenol/chloroform extractions and treatment with RNAseA 
(final concentration 20 pg ml"1). After incubation at 37°C for 1 hour, chromosomal 
DNA in solution was again purified by phenol/chloroform extraction, ethanol 
precipitated and resuspended in an appropriate volume of water.
Agarose Gel Electrophoresis
Routine DNA analysis was performed using agarose gel electrophoresis. Gels 
of appropriate concentration (w/v) were prepared in IX TAE and subjected to 
electrophoresis at 1-5 V cm'1 in a horizontal submarine gel tank (BioRad). Gels were 
then stained in an ethidium bromide bath (0.5 pg ml'1 in IX TAE). DNA was 
observed using an ultra-violet transilluminator and photographed on gel 
documentation systems Imagestore 5000 (UVP) or ImageMaster® (Pharmacia 
Biotech)
Chromosomal DNA Extraction from Mycobacteria
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Formaldehyde Gel Electrophoresis
RNA was mixed 1:10 with RNA denaturant loading buffer and incubated at 
50°C for 30 minutes. Gels of appropriate concentration (w/v) were prepared in IX 
MOPS (10X MOPS added post agarose melting in water) and subjected to 
electrophoresis at 1-5 V cm'1 in a horizontal submarine gel tank (BioRad). Gels were 
then stained in a SYBR Goldbath (1:20000 MOPS). RNA was observed an 
ultra-violet transilluminator and photographed on a gel documentation system (UVP 
Imagestore 5000) or ImageMaster® (Pharmacia Biotech)
Purification of DNA from Agarose Gels
Specific DNA fragments were excised from agarose under UV 
transillumination and purified using the QIAEX II Gel extraction kit (Qiagen) or 
Advantage™ PCR-Pure Kit (Clonetech) according to manufacturer’s instructions.
Phenol/Chloroform Extraction of DNA
Phenol/chloroform and DNA solution were mixed in equal volumes. Samples 
were centrifuged at 15000g for 5 minutes. The upper aqueous layer containing the 
DNA was extracted and retained.
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To a given volume of DNA in solution, was added 0.1 volume 2M NaCl and 2 
volumes 100% (v/v) ethanol. Samples were placed at -20°C for 18-24 hours and 
centrifuged at 15000g for 10 minutes at 4°C. The supernatant was discarded and the 
DNA pellet was washed with 70% (v/v) ethanol. The resulting pellet was air dried 
and resuspended in an appropriate volume of water.
Restriction Endonuclease Digestion of DNA
DNA was digested with the required restriction endonuclease in the 
appropriate IX restriction buffer and incubated at the enzyme’s optimum temperature. 
The total reaction volume was altered according to the amount of DNA to be 
digested. Restriction endonucleases and buffers were supplied by Roche and New 
England Biolabs.
Dephospliorylation of DNA
DNA was dephosphorylated using calf intestinal alkaline phosphatase (CIP) in 
the supplied IX buffer (Roche). The reaction was first incubated at 37°C for 15 
minutes and then at 55°C for a further 15 minutes. Another 1 unit of CIP was added 
to the reaction and the fust two incubation steps repeated. The reaction was 
terminated by inactivation of the enzyme at 75°C for 10 minutes.
DNA Precipitation
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DNA fragments were ligated in a 3:1 molar ratio of insert DNA to vector 
using T4 DNA ligase (Bethesda Research Laboratories) in the supplied IX buffer. 
The reaction was incubated at 14°C for 18-24 horns.
Synthesis of Oligonucleotides
Synthetic oligonucleotides were purchased from Sigma Genosys Limited.
Polymerase Chain Reaction (PCR)
PCR amplification was performed using the Perkin Elmer GeneAmp 9700 
thermal cycler. A standard reaction contained 200 pM each dNTP (dATP, dGTP, 
dCTP, dTTP), 0.5 pM each oligonucleotide primer, 0.5 ng DNA template and 1U Taq 
DNA polymerase in IX PCR buffer (Stratagene). Typical PCR reaction conditions 
consisted of an initial denaturation step at 95°C for 5 minutes, followed by 35 cycles 
with denaturation at 95°C, primer annealing at a temperature appropriate for the 
primers and extension at 72° for a time dependant on the length of the expected 
product. The final cycle was extension at 72°C for 5 minutes.
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Preparation of Competent Cells 
E.coli for Routine Transformations.
E.coli DH5a cells were cultured in 100 ml LB broth at 37°C with shaking at 240 rpm 
to an ODeoo of 1.0 and chilled to 4°C for 20 minutes. Cells were harvested at 1400g 
for 15 minutes at 4°C and washed in 50 ml sterile water. This procedure was repeated 
twice and the cells resuspended in 2 ml 10% (v/v) glycerol. Aliquots were stored at 
-70°C.
M.bovis BCG Pasteur
M.bovis BCG Pasteur cells were prepared for transformation as described by 
Wards and Collins (Wards and Collins, 1996). Aliquots were either used immediately 
or stored at -70°C.
Transformation of Competent Cells 
E.coli -  Routine Transformations
Up to 10 ng of DNA was added to 20 pi of competent E.coli DH5a cells and 
placed in ice for 45 minutes. Cells were then heat-shocked at 42°C for 45 seconds and 
immediately placed in ice for 2 minutes. Recovery of cells was achieved by addition 
of 80 pi SOC and incubation at 37°C with shaking for 60 minutes prior to selection of 
transformants on LB agar supplemented with the appropriate selective antibiotics.
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Epicurian Coli® Ultracompetent Cells (Stratagene) were used according to 
manufacturer’s instructions with selection of transformants on LB agar supplemented 
with the appropriate antibiotics.
M.bovis BCG Pasteur
An aliquot (100 pi) of competent M  bovis BCG Pastern* cells were 
electroporated with 0.1-1 pg of plasmid DNA using the BioRad GenePulser (voltage
2.5 kV, capacitance 25 pFD, resistance 600Q). Cells were then recovered in 900 pi of 
7H9 broth at 37°C for 6-12 hours and transformants selected at 37°C on 7H11 agar 
supplemented with the appropriate antibiotics.
p-galactosidase Assay with Galacto-Light Plus Substrate
Galacto-Light Plus (Tropix Inc.) is a Chemiluminescent Reporter Gene Assay 
System for the detection of P-galactosidase which exhibits thr ee orders of magnitude 
greater sensitivity compared to colourimetric p-galactosidase assays. The 
Galacto-Light Plus assay was used according to manufacturer’s instructions but with 
one alteration. Due to the nature of the mycobacterial cell wall, the lysis solution 
supplied with the kit does not disrupt the mycobacteria sufficiently. In order to cause 
sufficient cell disruption, 0.5ml of mycobacterial culture (unless otherwise stated) 
was added to a Hybaid Ribolyser™ blue tube containing 0.5ml PBS, with fresh 
Dithiothreitol (DTT) to 0.5mM, and ribolysed in a Hybaid Ribolyser™ at speed 5.0
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for 45 seconds. The Ribolyser tubes, containing the lysed bacteria, were cooled on ice 
for 1 minute and then stored at -80°C to be used at a later date. The lysed bacteria 
were thawed slowly at 4°C and then centrifuged at 15000g for 5 minutes to sediment 
the cell debris. In all cases the Galacto-Light Plus assay was carried out using 20pi of 
lysed bacteria and the reaction was carried out in a microtitre plate incubated at 25°C. 
After 1 hour the luminescence of each well was measured using Packard Lumicount 
(Model AL10001) and analysed with PlateReader Software (v2.1). In all cases a cell 
count was carried out (by either measuring the absorbance at 600nm (46oo) or by 
plating out small samples of cultures on selective 7H11 media) and the light units 
expressed as Light Units (LU) per lxlO6 bacterial cells.
Cell Culture 
J774 Mouse Macrophage Cell Line (Unkeless, 1979)
Start cultures at 2x105 cells/ml were incubated at 37°C with 5% CO2 and 
maintained between lx l05 and lx l0 6 cells/ml. Eveiy 3 days the complete Dulbecco’s 
modified Eagles medium was discarded and the attached cells washed twice with 
10ml Versine (Gibco BRL), which was discarded. Adherence of the macrophages was 
reduced with the addition of 5mg/ml Tiypsine in Versine. Complete Dulbecco’s 
modified Eagles medium was added to inactivate the trypsin and scraping brought the 
cells into suspension. The cells were centrifuged at lOOOg for 5 minutes, the 
supernatant discarded and the cells resuspended in a small volume, counted and the 
cultures restarted.
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Start cultures at 2x105 cells/ml were incubated at 37°C with 5% C02 and 
maintained, by addition or replacement of fresh medium. Cell numbers were not 
allowed to exceed lx l0 6 cells/ml. Every 3 days the cells were passaged by 
centrifugation at lOOOg for 5 minutes, the media discarded and the cells resuspended 
in a small volume, counted and the cultures restarted.
To cause differentiation, THP-1 cells were passaged, restarted at lxlO6 
cells/ml and incubated at 37°C with 5% C02 for 3 days in Dulbecco's modified Eagles 
Medium containing 5 ng/ml Phorbol Myristate Acetate (PMA) to induce monocyte 
differentiation. After this incubation time had elapsed the medium was discarded, the 
adherent monocytes were washed twice with PBS to remove any residual PMA, then 
fresh Dulbecco's modified Eagles medium containing 10% foetal calf serum was 
added and tlie cells incubated at 37°C with 5% C02.
Statistical Analysis
All statistical analysis was carried out using SPSS for Windows (SPSS Inc.) 
and are analysis of variance (AnoVa) tests.
Appendix 2 - Methods
THP-1 Human Macrophage Cell Line (Auwerx, 1991)
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Appendix 3 -  Tables of p-galactosidase Assays of All Clones Exposed to 
Stressing Conditions In Vitro in the Second Round of Screening.
Shown overleaf is a table depicting the Light Units (LU)/ 106 bacterial cells, 
indicating the level of lacZ expression of the 333 M.bovis BCG Pasteur library clones 
and the negative and positive control plasmids of pUS1800 and pUS1808, harboured 
within M.bovis BCG Pasteur, grown in selective 7H9 broth media at pH 6.6 (control). 
Columns 3 and 4 are ratios of the LU/ 106 bacterial cells generated by the clone 
grown in liquid media at pH 5.4 and liquid media at pH 5.4 containing sodium nitrite 
divided by the LU/ 106 bacterial cells generated by the clone grown in the control 
media. Therefore column 3 and 4 represent the factors of activation/ repression of 
each of the clones when grown in the stressing media compared to the control media.
The clones shown in red have a factor of ‘up-regulation’ in either the low pH 
and/or the high nitric oxide media greater than 3 compared to the expression of the 
clone grown in the control medium. These clones were used in subsequent 
macrophage infection studies. Figures in green are the LU/ 106 bacterial cells 
generated by clones grown in the low pH and/or the high nitric oxide media - a factor 
of ‘up-regulation’ can not be calculated for these clones since the clone grown in the 
control media did not generate measurable LU/106 bacterial cells.
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Clone Number RLU/Million bacterial cells in control medium Low pH:control High sodium 
nitrite:control
1 684.8 0.4 0.1
2 697.6 0.6 2.3
3 2773.8 0.1 0.0
4 620.3 2.1 1.3
5 1066.8 3.4 3.1
6 313.0 0.0 0.1
7 5945.7 4.0 1.6
8 173.5 1.4 1.3
9 1188.3 1.9 0.7
10 885.9 0.7 0.9
11 2784.9 0.8 0.7
12 33.4 0.3 1.1
13 2195.1 3.3 2.5
14 773.7 0.4 0.3
15 5223.9 0.5 0.8
16 739.9 0.3 0.2
17 1494.4 0.2 0.1
18 1573.3 0.1 0.1
19 1329.3 0.1 0.0
20 2377.7 0.1 0.0
21 975.8 0.0 0.0
22 1857.7 0.1 0.1
23 263.8 0.7 0.0
24 0.0 0.0 0.0
25 7265.2 0.0 0.0
26 273.2 0.3 0.0
27 918.8 0.0 0.1
28 130.1 0.4 0.7
29 2285.9 0.1 0.2
30 797.8 0.1 0.0
31 434.5 0.0 0.0
32 1124.7 0.2 0.3
33 6630.4 0.2 0.1
34 753.5 0.2 0.2
35 1044.2 0.2 0.2
36 3173.3 0.3 0.1
37 4597.1 0.1 0.0
38 4403.1 0.1 0.0
39 976.2 0.5 0.5
40 4780.4 0.0 0.0
41 20.8 0.3 2.5
42 422.4 0.0 i 0.1
43 86.3 0.4 0.5
44 70.6 2.4 1.0
45 889.5 0.2 0.3
46 823.7 0.1 0.2
47 1165.9 0.5 0.4
48 744.7 0.0 0.2
49 281.5 1.7 0.6
50 81.3 0.7 I 1.8
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Clone Number RLU/Million bacterial cells in control medium Low pHrcontrol High sodium 
nitrite:control
51 279.8 1.2 0.4
52 70.6 0.0 0.2
53 1395! 0.7 0.3
54 30.4 0.4 0.3
55 17.0 1 ! 0.0
56 3 5 ! 2.0 0.6
57 202.8 1.4 0.5
58 223.2 0.3 1.5
59 31.3 1.7 1.9
60 104.9 0.6 1.5
61 483.6 0.5 0.4
62 74.8 3.4 0.7
63 652.5 0.8 3.2
64 219.8 0.0 0.0
65 0.0 0.0 0.0
66 47.8 0.8 0.4
67 0.0 0.0 0.0
68 171.4 0.3 2.0
69 11.7 0.0 0.0
70 0.0 0.0 10.3
71 0.0 5.53 16.86
72 0.0 0.0 0.0
73 0.0 13.58 0.0
74 456.3 0 ! 0.0
75 2 2 1 ! 0 ! 0.0
76 0.0 0.0 0.0
77 49.6 0.9 0.0
78 36.6 0.2 0.4
79 21.2 2 ! 0.9
80 427.9 1.2 0.2
81 120.8 1.0 0 !
82 117.6 2.0 1.0
83 0.0 43.82 0.0
84 632.7 0 ! 0 !
85 0.0 0.0 0.0
86 0.0 0.0 0.0
87 809.9 0.6 0.4
88 47.5 1.9 2.6
89 4 2 ! 4.6 0.7
90 8.9 7.4 3.8
91 259.0 0.4 0.0
92 770.7 0.2 0 !
93 956.6 0.0 0.0
94 1444.3 0.9 0.5
95 1673.0 0,3 0 !
96 587.9 0 ! 0.0
97 5821.8 0 ! 0.0
98 2 8 8 5 ! 0.2 0.0
99 39.7 0.2 0.9
100 166.3 0.4 0 !
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Clone Number RLU/Million bacterial cells in control medium Low pH:control High sodium 
nitrite: control
101 385.7 2.0 0.6
102 370.5 0.1 0.0
103 243.0 0.1 0.2
104 325.1 0.1 0.0
105 0.0 24.19 0.0
106 675.8 0.0 0.0
107 1342.0 0.3 0.0
108 0.0 5.74 0.0aso 0.0 18.99 0.71
110 0.0 0.0 0.0
111 0.0 0.0 0.0
112 0.0 0.0 0.0
113 0.0 0.0 0.0
114 0.0 0.0 0.0
115 1604.2 0.1 0.0
116 2009.7 0.1 0.2
117 113.4 0.9 0.6
118 96.3 1.2 0.5
119 107.0 2.6 1.2
120 2144.4 0.2 0.1
121 406.2 0.8 0.4
122 48.6 1.4 1.5
123 308.6 1.8 0.9
124 413.5 0.7 0.8
125 460.7 0.0 0.4
126 1103.8 1.5 1.0
127 9219.5 1.3 0.8
128 78.4 0.2 0.0
129 0.0 12.82 9.66
130 1109.7 1.5 0.8
131 194.6 0.8 1.0
132 2071.3 0.1 0.0
133 547.1 0.8 0.5
134 6866.6 0.6 1.1
135 2120.0 0.6 0.3
136 493.8 1.5 1.2
137 1559.9 2.3 3.0
138 2877.0 2.1 1.9
139 504.3 1.2 1.3
140 2319.1 1.4 1.5
141 215.1 1.4 1.6
142 2568.1 2.1 2.3
143 283.5 0.8 0.9
144 2337.0 2.2 2.0
145 378.8 1.0 2.4
146 1068.9 1.1 0.8
147 2368.9 1.5 1.8
148 1726.0 2.3 1.9
149 822.7 1.4 2.0
150 28.8 0.4 1.0
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Clone Number RLU/Million bacterial cells in control medium Low pH:control High sodium 
nitriteicontrol
151 0.0 0.0 1.80
152 19.1 0.9 0.9
153 40.7 2.4 2.5
154 0.0 0.0 0.0
155 0.0 0.94 15.62
156 804.7 1.3 1.1
157 81.3 1.3 1.0
158 0.0 0.0 0.0
159 0.0 0.0 0.0
160 12.8 0.5 0.0
161 0.0 0.0 4.97
162 19.9 0.7 0.6
163 11.6 1.5 2.4
164 380.2 2.1 1.8
165 492.9 0.8 1.0
166 662.4 2.3 3.6
167 103.9 0.6 0.7
168 31.0 1.4 2.2
169 264.9 7.6 4.8
170 102.4 1.6 1.7
171 0.0 6.97 21.94
172 0.0 0.0 0.0
173 83.1 3.2 2.6
174 42.0 2.1 3.4
175 121.6 4.4 2.9
176 240.7 3.9 2.4
177 610.4 2.2 0.9
178 1110.3 2.0 0.9
179 569.6 1.2 0.6
180 29.5 3.2 3.9
181 3677.5 2.8 1.8
182 191.3 1.5 1.1
183 1328.5 2.3 1.6
184 252.5 1.5 2.3
185 0.0 34.01 52.63
186 172.8 1.2 1.7
187 0.0 0.0 2.06
188 873.4 4.5 2.0
189 118.5 2.6 1.1
190 111.1 2.7 1.6
191 207.6 2.3 1.6
192 35.1 1.4 1.1
193 507.7 1.4 0.8
194 2754.8 3.4 1.9
195 310.7 1.4 0.4
196 0.0 0.0 0.0
197 2578.8 2.0 2.3
198 0.0 0.0 0.0
199 26.4 0.6 0.9
200 19.4 2.0 6.5
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Clone Number RLU/Million bacterial cells in control medium Low pH:control High sodium 
nitrite: control
201 2.6 13.5 5.8
202 0.0 0.0 0.0
203 2436.8 2.9 2.5
204 51.9 2.7 2 !
205 581.1 2.9 3.0
206 0.0 0.0 0.0
207 526.3 1.2 1.0
208 610.9 1.5 0.6
209 193.3 2.0 0.8
>—»
 
O 65.5 1 ! 0.6
211 1183.0 2 ! 2.5
212 53.3 1.0 0.2
213 1265! 2.8 0.8
214 1351.5 1.2 1.0
215 0.0 0.0 0.0
216 1 6 ! 1.6 1 !
217 0.0 0.0 0.0
218 0.0 0.0 0.0
219 3 5 8 ! 1.8 1.9
220 2 1 1 8 ! 3.4 0.8
221 823.9 1.6 1.4
222 1094.3 3.9 10.6
223 1689.3 2 ! 1.5
224 1240.2 1.5 0.9
225 0.0 0.0 0.0
226 489.0 2.9 3 !
227 68.6 1.3 0.9
228 1 2 ! 0.7 0.5
229 19.9 3 ! 0.7
230 95.3 3.4 2.8
231 2 0 8 ! 1.7 1.6
232 92.2 2.0 0.8
233 20441.7 4.7 2 !
234 8428.6 9.2 11.7
235 213.4 1.2 2.1
236 144.2 1.2 1.0
237 93.3 2.6 2 !
238 1297.4 2.0 0.6
239 267.0 3.8 7.4
240 917.0 2.9 3.4
241 0.0 0.0 0.0
242 0.0 0.0 0.0
243 0.0 0.0 0.0
244 7563.9 0.2 1.8
245 90.0 0.3 0.0
246 7.8 0.0 2.6
247 24.3 1 0 ! 2.7
248 0.0 5.50 0.0
249 0.0 4.16 8.16
250 0.0 0.0 0.0
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Clone Number RLU/Million bacterial cells in control medium Low pHrcontrol High sodium 
nitritexontrol
251 0.0 2.52 16.28
252 17.9 13.2 3.3
253 461.0 2.1 1.1
254 1674.2 5.2 2.2
255 135.1 0.8 0.7
256 0.0 39.02 30.88
257 65.0 1.2 1.4
258 0.0 0.0 0.0
259 90.0 1.7 1.3
260 90.8 1.4 1.2
261 0.0 0.0 0.0
262 0.0 2.69 17.02
263 0.0 0.0 17.25
264 521.5 1.6 2.8
265 0.0 10.22 0.0
266 3882.6 1.6 0.6
267 84.5 0.7 0.3
268 1884.1 1.9 2.3
269 50.5 0.6 0.4
270 1634.6 2.5 1.7
271 1984.2 1.0 1.2
272 115.4 0.6 0.6
273 190.0 2.7 2.3
274 147.0 1.6 2.2
275 2015.6 2.8 1.2
276 18.9 2.6 2.6
277 273.6 4.0 2.2
278 2359.4 4.3 5.5
279 1592.9 4.3 1.7
280 146.8 2.1 1.4
281 44.9 9.0 15.7
282 239.7 1.4 3.0
283 150.4 1.3 1.5
284 4276.5 1.4 2.4
285 4305.4 0.5 0.6
286 4230.1 0.2 0.1
287 4580.8 0.6 0.9
288 6651.4 0.9 1.7
289 477.1 5.2 3.5
290 29.8 7.6 2.5
291 2837.7 5.4 6.1
292 548.4 2.7 3.4
293 151.0 5.4 3.8
294 79.9 0.9 2.6
295 0.0 810.64 54.25
296 12.4 7.0 7.4
297 194.5 4.8 3.2
298 5153.4 0.1 0.1
299 905.8 0.5 0.5
300 223.4 1.8 0.2
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Clone Number RLU/Million bacterial cells in control medium Low pILcontrol High sodium 
nitrite: control
301 0.0 41.83 62.22
302 22.5 11.1 6.3
303 8.9 5.4 0.0
304 26.1 2.0 1.6
305 95.4 5.3 2.8
306 170.3 2.2 1.2
307 1976.3 0.6 0.5
308 766.0 0.6 0.0
309 143.4 0.3 1.5
310 566.5 0.5 0.9
311 845.8 3.0 2.2
312 3860.5 0.6 0.4
313 142.9 7.1 6.1
314 28.4 1.6 2.1
315 1433.8 1.1 0.5
316 0.0 0.0 0.0
317 940.4 1.0 2.1
318 658.2 1.3 2.8
319 0.0 6.84 8.52
320 0.4 30.2 116.5
321 0.0 36.46 36.28
322 0.0 134.61 245.05
323 395.8 7.6 9.8
324 140.2 1.6 2.5
325 106.0 4.3 2.6
326 822.3 0.5 0.6
327 242.2 0.4 0.5
328 81.0 1.6 2.1
329 98.5 0.6 0.5
330 12.2 3.9 3.9
331 2555.1 2.2 1.5
332 14.0 2.6 2.3
333 0.0 27.86 0.0
pUS 1800 0.0 0.0 0.0
pUS 1808 8945.8 0.1 0.1
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Appendix 4 - Graphs of p-galactosidase Assays of All Clones Post- 
Infection in Murine and Human Macrophages.
Below are bar charts of p-galactosidase activity levels from each of the 42 
M.bovis BCG Pasteur clones, harbouring the M.tuberculosis promoter probe vector, 
and the negative control plasmid of pUS1800, harboured within M.bovis BCG 
Pasteur, obtained post-infection of murine J774 and human THP-1 macrophages. 
Also shown are the p-galactosidase activity levels from each of the 42 M.bovis BCG 
Pasteur clones, harbouring the M.tuberculosis promoter probe vector, and the 
negative control plasmid of pUS1800, harboured within M.bovis BCG Pasteur, 
incubated in either complete Dulbecco’s modified Eagles medium for 2 and 24 hours 
or liquid 7H9 medium for 24 hours. The graphs are Light Units (LU)/ 106 bacterial 
cells against the clone number and are on different logarithmic scales.
Appendix 4: Graphs o f  /3-galactosidase Assays o f  All Clones Post-Infection in Murine and Human
Macrophages
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Appendix 5: Sequence Data
Appendix 5 - Sequence Data
All sequences are shown in the orientation that they are cloned in pUS1800 
with the translational start site of the lacZ reporter gene at the 3’ end of the DNA 
sequence shown. The 37 clones printed in blue are those infected into murine and 
human macrophages. The 5 clones printed in red were screened twice by re-infecting 
human macrophages. The 8 clones printed in black were assayed as described in 
Chapter 3.
The size of the cloned DNA, the M.tuberculosis H37Rv genome bases cloned 
and the restriction site used to digest genomic M.tuberculosis H37Rv DNA for 
cloning in to pUS1800 are detailed prior to the sequence. All genes or parts of genes 
(start or end) are depicted with arrows with the direction of the arrow indicating the 
direction of translation. Shaded regions of the sequence represent intergenic regions.
Clone 5
Size o f cloned M.tuberculosis H37Rv DNA: 499bp
Nucleotides o f M.tuberculosis H37Rv genome cloned: 915974bp-916472bp M.tuberculosis genome base pair before lacZ in pUS1800: 916472bp
Restriction site used to digest genomic M.tuberculosis H37Rv DNA for cloning in to pUS1800: Taql
TCGAGCGAGTGGGCCGGGATGGCGATAGCCTCGGTGTCCTGCTGGTCGTCGGCGTCGTCGTGGACCTTC
GGGCCGCGGCCGGATGGCTCGGGTTCGGGGGCGACATGGCGGTGCGTGGGGAGGTCAGGAAAAGCGGGG
CCGAGCCTGGCGATCAGATCGGCCACACTAACGGCGCCGGTGGCATGACAGCCGACATTCTGGGTGTCC
CGCGGACCCTGGGCTGCCACCCATGTGGCGGGCGGTACCGTGATCCATCGGTCAACACCATCGGGGAAT
Rv0822c<--------- 1
GCTGACTCGGAGAGCCGTGCCCACGGCGCGGCGCTCTCGCCGTCACTCATGTCCTACCGGCCTCCGAGA 
GTCTAGGTGGCGGACGCCCGCGGTGTTGGCTGCGTGTCCTACGCGCACCTTCGCGCAGCACCGCCACGA 
GTCGGCGCCGCACAATGCAGCAAGGCCCACATCGTACTGATTTATCGGTCCAGACGCGATTTCGA 6bp
to stop codon o f Rv0823c
2 0 8
Appendix 5: Sequence Data
Clone 7
Size o f cloned M.tuberculosis H37Rv DNA: 233bp
Nucleotides o f M.tuberculosis H37Rv genome cloned: 1699624bp-1699856bp
M.tuberculosis genome base pair before lacZ in pUS1800: 1699624bp
Restriction site used to digest genomic M.tuberculosis H37Rv DNA for cloning in to
pUS1800: Acil
Sequence internal to Rvl508.
CCGCTCCTGCCGGTCGCTCTTCGCCATGGCATAACGTCGGGGCGTGGCTGTGGGTTCATCCTAGATGTC
GGTGCCCAGCGCCCTTTCGGCAACGACGTCCTGTTGTCGGTTGCCACGAGGAAGATCCGGTCTAGACTG
CCCGGCGACCGCGTTGGCAACCATGGCGCTCTGCTACCGTTTCGCGCAGAACCGAGGAGAATCCAGATG
AAGCGACCCCCGGAGGTGTTGCGCGG
Clone 13
Size o f cloned M.tuberculosis H37Rv DNA: 865bp
Nucleotides o f M.tuberculosis H37Rv genome cloned: 551479bp-552343bpM.tuberculosis genome base pair before lacZ in pUS1800: 552343bp
Restriction site used to digest genomic M.tuberculosis H37Rv DNA for cloning in to pUS1800: Acil
GCGGGTTCAGTCTGGAAGCGCCCGAGGGCGTGCGCTTTCTCAGCAGAGGTCGGGTGTTCAGCGACGCCG
AAAAGGCGATGCGGGAGGCTGCGCCGGTGATCACCGGCGCAGCCTACGAGTGCGGCGAACGACCGTTAG
Rv04 59 > |
TGCGGGGTCTTGTCGTCGATCTCGACGATCCAGATGCCACGCCGGGAGTGTGCCGCGCCAGTCGGCGGT
R v0460 I >
AGCCGCAGTAAGGTCGTAGACCGTGATCCCCCTTCCGCGGTCATGGCAGCTGACCAGCGCGATGCTGGT
TGGTAATGCGATCGGACTGCTAGCGGGGGTGGCGTGCAGCGTGCTGGTGCATGCCCGGATCCGTCCGGA
CATCGTCATCGCAATGGTAGTCGGGATTCCCAGCGCGATCGGGCTGCTGGTCATCCTGTTCTCCGGACG
TCGATGGGTGACGATGCTGGGCGCGTTCATCCTGGCGTTGGCGCCGGGTTGGTTTGGTGTGCTGGTTGC
Rv04 60-------->| Rv04 6 l | --------->
GATCCAGGTGGCGTCCAGTGGCTGACAACGATTACCGGTCGGCACCCGGAACCGAGCCGTTTGTGCCCG
ATTTCGACACCGGCGCACACTCGCAGCGGTTCCTCTCGTTGGCCGGCCAGCAAGACAGGGCGGGGAAAT
CCTGGCCAGGCTCGACGCCGAAGCCGCAGGAGGACCCCGTGGGTGTCGCGCCTTCGGCCAGCGTCGAGG
TGCTGGGGTCCGAGCCGGCCGCCACGCTAGCGCACTCGGTTACAGTACCCGGTCGATATACCTACCTGA
AGTGGTGGAAGTTCGTTCTAGTGGTCCTCGGCGTATGGATCGGTGCTGGCGAGGTCGGCCTGAGCTTGT
TCTACTGGTGGTATCACACACTCGACAAGACGGCCGC
Clone 63
Size o f cloned M.tuberculosis H37Rv DNA: 406bp
Nucleotides o f M.tuberculosis H37Rv genome cloned: 1051336bp-1051741 bp M.tuberculosis genome base pair before lacZ in pUS1800: 1051336bp
Restriction site used to digest genomic M.tuberculosis H37Rv DNA for cloning in to pUS1800: Taql
TCGAAAGCGATGGCCCAACGGCAACCATCGCGGTTTCCGACGGCAGCAGCGCTCCGGCGGTTCGGCTGG
CGTCCCCACCGAAGGGCATCGACGTTTCCGGCCTGGCGATCGTTGCCGCGTTGTCCCGCGCCTGGGGCA
R v 0 9 4 lc  ► |
g c a g t c c c a c t t c g t c g g g c a a g a c g g t c t g g g c a a t t a t t g g g c c g g a g a a c c a a c t c Jt g a c c a a g c c
GTTGCGCCCCGCTTGCACGTCAAATTAGAACACGTTCTAATCTCGTTGGGGACGGCCACTTCGAGGAAG
'  >Rv0940c
GCAATCACfGTGCGGTTCAGCTACGCGGAGGCAATGACCGACTTCACGTTCTACATCCCGCTGGCCAAGG
CAGCCGAAGCGGCGGGATACAGCAGCATGACGATTCCCGACAGCATCGCCTACCCCTTCGA
209
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Clone 89
Size o f cloned M.tuberculosis H37Rv DNA: 243bp
Nucleotides o f M.tuberculosis H37Rv genome cloned: 905242bp-905484bpM.tuberculosis genome base pair before lacZ in pUS1800: 905484bp
Restriction site used to digest genomic M.tuberculosis H37Rv DNA for cloning in to pUS1800: HpaU 
Internal to Rv081 lc
CCGCCGCGCAGCCGCTCGACGGCCCGCCGTCCGGCGCCCACATCGTCGGCGGGCGGCAGCGAGTCGACG
TCGATCACCGCGGCAACCTCGGCTTCCGGACCGGTTACCAGGGCGGTGTCGCCCGGCAGACCCCGTTTG
AGCAGGGCCAGTGCCACCGGCCCTAGCTCTACGTGCTCGACCACCGTTCCCAGTCGTCCCACCGTGCGA
CCGCCGGCCAGCACCGCATCGCCCGTCGACGGCCGC
Clone 90
Size o f  cloned M.tuberculosis H37Rv DNA: 251 bp
Nucleotides o f M.tuberculosis H37Rv genome cloned: 704074bp-704324bpM.tuberculosis genome base pair before lacZ in pUS1800: 704324bp
Restriction site used to digest genomic M.tuberculosis H37Rv DNA for cloning in to pUS1800: HpaU 
Intergenic to Rv0609 and Rv0610c -  converging genes
CCGGCTGGACCCGATACGGCGACGGATCTGTGGCGCAGGTCAAATCGATCTTCGACGCTCCGCGCGGTT
ACCTCAATGCGGCGTGTCGTCGGCGTGTTGTACATTGGGCATCGGGACTCCTGAGAAGGATCCTGTAGG
CCGCAGCCCCACCCACGGGTGGGGCTGACGTGCGTCCAAGGGGGCCAGATCTGGCAGACCTTCATCTTG
TTTGCGACGATGTCCCATAATCGTTGGTGGTCTTCACCGACCGG
Clone 137
Size o f cloned M.tuberculosis H37Rv DNA: 126bp
Nucleotides o f M.tuberculosis H37Rv genome cloned: 69540 lbp-695526bpM.tuberculosis genome base pair before lacZ in pUS1800: 695401 bp
Restriction site used to digest genomic M.tuberculosis H37Rv DNA for cloning in to pUS1800: Taql
I >Rv0597c
TCGAGACGAGGCGGCGCGACAGCAGCTCCGCTACACTCGTAGCATGTCTGCTACGATACCCGCTCGCGA
TCTTCGCAACCACACCGCCGAGGTACTGCGGCGAGTTGCCGCCGGCGAGGAAATCGA
Clone 166
Size o f cloned M.tuberculosis H37Rv DNA: 361bp
Nucleotides o f M.tuberculosis H37Rv genome cloned: 528230bp-528590bpM.tuberculosis genome base pair before lacZ in pUS1800: 528590bp
Restriction site used to digest genomic M.tuberculosis H37Rv DNA for cloning in to pUSl 800: HpaU
CCGGTGACCACAACGACGCGCCCGCTTTGATCGGGGACGTCTGCGGCCGACCATTTACGGGTCTTGTTG 
Rv0439c<---------1
TCGTTGGCGGTCATGGGCCGAACATACTCACCCGGATCGGAGGGCCGAGGACACGGTCGAACGAGGGGC 
ATGACCCGGTGCGGGGCTTCTTGCACTCGGCATAGGCGAGTGCTAAGAATAACGTTGGCACTCGCGACC 
GGTGAGTGCTAGGTCGGGACGGTGAGGCCAGGCCCGTCGTCGCAGCGAGTGGCAGCGAGGACAACTTGA 
GCCGTCCGTCGCGGGCACTGCGCCCGGCCAGCGTAAGTAGCGGGGTTGCCGTCACCCGGTGACCCCCGT 
TTCATCCCCGATCCGG 16bp to Rv0440
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Clone 169
Size o f cloned M.tuberculosis H37Rv DNA: 524bp
Nucleotides o f M.tuberculosis H37Rv genome cloned: 1166888bp-l 167411 bp M.tuberculosis genome base pair before lacZ in pUS1800: 116741 lbp
Restriction site used to digest genomic M.tuberculosis H37Rv DNA for cloning in to pUS1800: AciI
CCGCCGTCACCTCTGCCATGGTCCATCTACGGTATCTGCGACAAGGGCAGCGTCGATGCCTCGACATGC
AGAGTCGGTGTTCGCTTCACGCGAACTAGGCGCGCCTAGCCTGGACGAGTCGCCGGGCCGACATTCGCC
1 ->Rvl04 4
CGAGGCCTTGGCCTCCATCACCTAATTGTGTGCAAAACCGTATCTAATTGATACGATTGCGCACATGGC
TATCTGGGATCGCCTCGTCGAGGTTGCCGCCGAGCAACATGGCTACGTCACGACTCGCGATGCGCGAGA
CATCGGCGTCGACCCTGTGCAGCTCCGCCTCCTAGCGGGGCGCGGACGTCTTGAGCGTGTCGGCCGAGG
TGTGTACCGGGTGCCCGTGCTGCCGCGTGGTGAGCACGACGATCTCGCAGCCGCAGTGTCGTGGACTTT
GGGGCGTGGCGTTATCTCGCATGAGTCGGCCTTGGCGCTTCATGCCCTCGCTGACGTGAACCCGTCGCG
CATCCATCTCACCGTCCCGCGCAACAACCATCCGCGTGCGG
Clone 173
Size o f cloned M.tuberculosis H37Rv DNA: 314bp
Nucleotides o f M.tuberculosis H37Rv genome cloned: 709301 bp-709614bpM.tuberculosis genome base pair before lacZ in pUS1800: 70930lbp
Restriction site used to digest genomic M.tuberculosis H37Rv DNA for cloning in to pUS1800: Acil
CCGCGTCGGCGCCGTCACAACGCCGAACCCTAGGCGAGGCCAGCCCCATCGGCTGGTGCCCGACGTCAA
I >Rv0613c
GCCTCGGCTGGCCGCGGCATAAGGTGGCCACCGTGGCCGAAGCGTTCGATGCGACCCAAGCCGTGGCGA
GAATCCTGGCCGAACATGGCCCATTGAGCGAGGACGACATCGCACGACGCCTGCTGGACAGCGGCGTGG
Rv0614<--------- 1
CCGACCCGGACGCCGTCCTGCGCGCGCTTCGCCTTGAAACGGAATGGCCGGCAAGGCAGTTGGTCGACG
ATCGGTGGGTGTGGCTGCCGACGCTGCTAGCCGGGCGG
Clone 174
Size o f cloned M.tuberculosis H37Rv DNA: 322bp
Nucleotides o f M.tuberculosis H37Rv genome cloned: 157673bp-157984bpM.tuberculosis genome base pair before lacZ in pUSl 800: 157984bp
Restriction site used to digest genomic M.tuberculosis H37Rv DNA for cloning in to pUS1800: Taq\
TCGAATGTCGTGGCCGCAGCGCGAGATCGCGGTTGGCTAACGATTCAGCGTCGGCCCGGACACCTTGGG
CGATTGACACACCCGGGTCACGGCTGGCTCCCGAGCGGCGCAACGACCGCACGCACAACCCCTATGCTT
1 >Rv0130
ACTGCCGACCAGAGGAGAGACCCATGCGCACCTTCGAGTCGGTCGCCGACCTGGCCGCCGCCGCGGGCG
AAAAGGTCGGGCAGAGCGACTGGGTGACCATCACCCAGGAAGAGGTCAATCTGTTCGCCGACGCAACGG
GTGATCACCAGTGGATCCACGTCGA
Clone 175
Size o f cloned M.tuberculosis H37Rv DNA: 395bp
Nucleotides o f M.tuberculosis H37Rv genome cloned: 364222bp-364616bpM.tuberculosis genome base pair before lacZ in pUS1800: 364616bp
Restriction site used to digest genomic M.tuberculosis H37Rv DNA for cloning in to pUS1800: Acil
CCGCCGCTGTCTGCGATGCCCGTGGAATACCTAACCCCGAGAATTGAAGACCGTGCGCTCGAGGTGCAG
ACCTTGCTTGCCGACCGCGGACACCACCGTGGCCCGTCGATCCCGGATCTGCTCATCGCCGCGACAGCC
GAACTGTCGGGCTTGACGGTACTGCACGTCGACAAGGACTTTGACGCCATCGCCGCGCTTACCGGTCAG
Rv0301-------- ► |
AAAACAGAACGGCTCACGCATCGCCCGCCTTCCGCT^AAGGAGCCCGACCAACCCTTGTGATTGGCGTG
GGGGGGCGCTAACGTAACTGTCTGTAACGTTCGATACAGAACTGGCGCCGGGGTGCGGCCGCGACTCTA
I ►Rv0302
cgagccgagacaagccggcgcaaggatggcgcaco | gtgggcgttcccgc
211
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Clone 176
Size o f cloned M.tuberculosis H37Rv DNA: 259bp
Nucleotides o f M.tuberculosis H37Rv genome cloned: 3023359bp-3023617bp M.tuberculosis genome base pair before lacZ in pUS1800: 3023617bp
Restriction site used to digest genomic M.tuberculosis H37Rv DNA for cloning in to pUS1800: TaqI
Rv2710-------- >\
TCGAGCGCGACGTGATGAGTAAGCTGCGGCACGGTGAGCGGGCGGATCGGCTGCGGTCGTACGCCAGC|
GAAGCTGGACATCCTGAGCCAGGTAGCAGACGGTATGCCCGCCGCGCCAGCGGCGGGCATACCGCTGCG
Rv2711 | ----->
GTGGGGCGGCGGGCAACCATTTTCGCAGCTGGCCAAGTAGACTCAGCTGCAATGGAGGGTGCTGA
ACGAGTTGGTTGATACCACCGAGATGTACCTGCGGACCATCTACGACCTCGA
Clone 180
Size o f cloned M.tuberculosis H37Rv DNA: 271 bp
Nucleotides o f M.tuberculosis H37Rv genome cloned: 1293907bp-1294177bp M.tuberculosis genome base pair before lacZ in pUSl 800: 1294177bp
Restriction site used to digest genomic M.tuberculosis H37Rv DNA for cloning in to p U S l800: Acil
CCGCTCGATCTGGATGCTAGCGCCGCGTGGCGATCTGATGGCCCAGGCGACGCTGTACTACCAGGTGCA
TGTGCTGATCGCGCTCGCGCTGTTTGCGCTCTGGCCGTTTACCCGATTGGTGCACGCGTTCAGCGCGCC
GATCGCCTACCTGTTCCGGCCCTACATCGTGTACCGCAGCCGCGAGGTGGCGGCCAAGCACGAATTGAT
R vl 164 >| | --------- » R v ll6 5
CGGTTCCGCGCCGCGTCGTCGTGGGTGGTl
Clone 188
When this clone is bi-directionally sequenced with the two primers and homologies identified against 
the M.tuberculosis H37Rv genome held at the Sanger Centre, different M.tuberculosis H37Rv DNA 
sequences are identified depending on the direction o f the sequencing.
Primer RH20 routinely identifies homology as:
Number o f  base with homology to M.tuberculosis H37Rv genome: 482 bases 
Nucleotides o f M.tuberculosis H37Rv genome cloned: 1623341 bp - 1623822bp M.tuberculosis genome base pair closest to lacZ in pUS1800: 1623341bp
Restriction site used to digest genomic M.tuberculosis H37Rv DNA for cloning in to pUS1800: Acil
GCGGCCATCGGCGGCGCCGATCCGGTTTCGGTACCGGCGGCCGGGGCCGTCGGGCGTCAGAACACGCTC
R v l4 4 5 c  > | |  »R v l4 4 4 c
TGGCTGCTGGACCGCGACGCCGCCGCCAAGCTTCCGAGTjTAACCGCGTCAGGGTCATAATGACCGTCAT
GGCAGACAGAAGCGGCCGCCCCGCGCCCGTGCGACGGCGAATGAAAACCCTCACCCAGGCCGCATTGAA
CGCCGACAAGACGGTGGAGCAGGTCGAAGACGTCCTGGACGGTCTGGGTAAGACCATGGCCGAGCTGAA
CAGCTCGCTGTCACAGCTGAACAGCACCGTGGAGCGCTTGGAGGACGGTCTGGACCATCTCGAAGGTAC
CCTGCACAGCCTGGACGATCTCGCGAAACGGCTCATCGTGTTGGTCGAGCCGGTGGAAGCCATCGTCGA
TCGGATCGACTACATCGTGAGCCTCGGCGAAACGGTGATGTCACCGCTGTCGGTCACCGAGCACGCGG
Primer 1800Rev routinely identifies homology as:
Number o f base with homology to M.tuberculosis H37Rv genome: 344 bases 
Nucleotides o f M.tuberculosis H37Rv genome cloned: 4328658bp -  4329001bp M.tuberculosis genome base pair before lacZ in pUS1800: 4329001 bp
Restriction site used to digest genomic M.tuberculosis H37Rv DNA for cloning in to pUS1800: Acil 
Internal to Rv3856c
CCGCCTCTGCATCGAACTTCGATTCTGGCCGGATGCCACGATTGCCGGCGATCAGCCGGCCGGTGCAGT
GGCCCAGCACGTCGGTGTGACCGTTGGCCACGGCGCGCACCATCCGTCGCGTCATCGCTGCCGAATCCA
TCGACAGCTTGGAGTGCACGCTGGCCACCACGATGTCGAGGCGGTCCAGCATCTCGGGTTCCTGGTCCA
AGCTCCCGTCTTCGAGGATGTCGACCTCGATCCCGGTCAGGATGCGCAGCGGCGCGAACTTCTCGCGCA
GCTCGTCGATCACGTCCAGCTGCTTGCGCAACCGGTCCGGAGACAGGCCGTTGGCGATCGTCAACCGC
212
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Clone 194
Size o f cloned M.tuberculosis H37Rv DNA: 189bp
Nucleotides o f M.tuberculosis H37Rv genome cloned: 3967509bp-3967697bp M.tuberculosis genome base pair before lacZ in pUS1800: 3967697bp
Restriction site used to digest genomic M.tuberculosis H37Rv DNA for cloning in to pUS1800: Acil 
Internal to Rv3530
CCGCTGCTGGCCGGCTACCTGTCGCGGCGGATGACTAGAAGGAGCCGTAGGGCGACGACCGGCCGATGG
ACAGCGCCGCCTACGGCGAAAAGACCAAGGGCCGCAACTGGTATGAATCCCGCTTCCTGCCCAGCCGCT
TTTCTGGTTCCCGGCGTTGACCATACTTAGGGCGAAGGACGGGTAGGTGGGACCGTGGGCGCTCTACGG
TTTGCTGTTCACCATCGTGATTCTCTCCACCCTGGCACCCGCGAGATGCCAAACGACAAGTGGTAGCAC
TAAGAGTTTGCGCTGCAAGGAGATCAGATCACCGGCCGACCGC
Clone 200
Size o f cloned M.tuberculosis H37Rv DNA: 709bp
Nucleotides o f M.tuberculosis H37Rv genome cloned: 987661 bp-988370bpM.tuberculosis genome base pair before lacZ in pUS1800: 987661bp
Restriction site used to digest genomic M.tuberculosis H37Rv DNA for cloning in to pUSl 800: Acil 
Internal to Rv0888
GCGGCCCGCCGAGTTCTGCTGGATGTAGTTGGCGACCTGCGCGAGGTTGGCGTTGGTGGTCGGCCCTCC
ACCGGTGTTGGTATGTAAGTTGTAGACGTCGACCGTGTCACCGCCGGGAAGCCGCATCTGGCTGTAGGT
GAAGCCCTTCAAGGTGAGGCAGTTGTCGGATGTGCACTCATACCATGTCTGCCGGTCCAGCCGCTGCAC
CTTGAACTCCGAGAGGGTATTGAGCCCGTCGGAGAAGGGCACACCGATAGGCCACAGCAAGGTAGGCGG
CTCCGGCGGGGTCTGGCTGGGCATCTTGGATTTCTTGATGAGGAATTGGTGGTAGGCGAAATCCTCCTG
GACGTTCGCGACGTAGTAGGCGTTGAGCCGCTTCCCAATCTCTTTGGTGTAGAAGAACCGGGGCAGAAT
TGCGCTGGATAGCGGGAAGGGCAGCCCCGCGATGTTGTAGGTGAGCATGCTGAAGTCGCCGCTGATGGT
GTCGGTCGGGGTGTTGCCGACGAACACGGTCACGGTGGCGACGTCGTCGTGCCCATGGAACGGACCCAG
GTATCCCGCCAGACCGTGCACGTGCAGGCTGGTGTCATCGCTGACGTTCACACTGAAGGTATCGGTGCC
AACGAAACCCGGATCGGCTGTGTAGATGAAGCTGGCCGTTCGTTGGTCGACGGTCACGATGCCATGCTG
GGGTCCACCGGGTGCACCGC
Clone 201
Size o f  cloned M.tuberculosis H37Rv DNA: 183bp
Nucleotides o f M.tuberculosis H37Rv genome cloned: 4191841bp-4192023bp M.tuberculosis genome base pair before lacZ in pUSl 800: 4191841 bp
Restriction site used to digest genomic M.tuberculosis H37Rv DNA for cloning in to pUS1800: Acil 
Internal to Rv3740
GCGGTGCCGGTCGAGCAGATTGGAGTGTAACCGTGACGTCAGTTCCAGCAGCTCACGCACCCGGCCCGG
CGCCGGCAGGGCAGACCGCCGCGCGTGGTAGCCGAGGTCGACGTCAGCGTCGGTCGACCAGCCGAGGTT
GATGAGTGCACCGTGAAGCGACGTGGGGCGCTTGCGAAATAGCGG
Clone 205
Size o f cloned M.tuberculosis H37Rv DNA: 543bp
Nucleotides o f M.tuberculosis H37Rv genome cloned: 860532bp-861074bpM.tuberculosis genome base pair before lacZ in pUS1800: 860532bp
Restriction site used to digest genomic M.tuberculosis H37Rv DNA for cloning in to pUSl 800: Acil
CCGCGCGGCCTCGATGGCGCGGCCCATGTCCTCGGCATCGGCGTCGGCGGCGACTCCCAGCACTTCCTC 
GGTGGCCGGATTGACCGTCGGGAAGGTGCCCGCACGGCCGTCCGATAGTTTGCCGTCGATGAGCAGCGC 
Rv07 67c<--------- 1
ACTAATTCCGTCGCCCCACAGGGCCATCTACCGCTCCCAACTTCTCCGACTCTCATCATCGATTGGACA
CTTGTCCGATATTGCCTCATCGAGACCGTATCCGCAAGGCCGCTACACCGTCCTGACCGATGCACCAGG
GGCCACGTCGCGTCGCGGACAGTCCCATGTTAGCTGCATGTTTAGCAGACTGGCTTGCCTCCTGCCGCG
I-------- »Rv07 68
ACCATCCGATAGCTTGGACATGTGTCCAGCGATGTACTGGTTACCACCCCGGCCCAGCGCCAAACCGAA
CCCCACGCCGAAGCGGTGTCACGCAACCGCCGCCAGCAGGCAACCTTCCGCAAGGTGCTAGCTGCCGCC
ATGGCGACCCTGCGGGAGAAGTCATACGCCGACCTGACGGTGCGCCTGGTGGCGGCCCGC
2 1 3
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Clone 220
Size o f  cloned M.tuberculosis H37Rv DNA: 303bp
Nucleotides o f M.tuberculosis H37Rv genome cloned: 528230bp-528532bpM.tuberculosis genome base pair before lacZ in pUS1800: 528532bp
Restriction site used to digest genomic M.tuberculosis H37Rv DNA for cloning in to pUS1800: Hpall
CCGGTGACCACAACGACGCGCCCGCTTTGATCGGGGACGTCTGCGGCCGACCATTTACGGGTCTTGTTG
R v0439c+
ATGACCCGGTGCGGGGCTTCTTGCACTCGGCATAGGCGAGTGCTAAGAATAACGTTGGCACTCGCGACC
GGTGAGTGCTAGGTCGGGACGGTGAGGCCAGGCCCGTCGTCGCAGCGAGTGGCAGCGAGGACAACTTGA
GCCGTCCGTCGCGGGCACTGCGCCCGG 74bp to start of Rv0440
Clone 222
Size o f cloned M.tuberculosis H37Rv DNA: 298v
Nucleotides o f M.tuberculosis H37Rv genome cloned: 3541887bp-3542184bp M.tuberculosis genome base pair before lacZ in pUS1800: 3542184bp
Restriction site used to digest genomic M.tuberculosis H37Rv DNA for cloning in to pUS1800: Acil
CCGCTTGGATACCGAAGCCTTGTTCGCAATCAGTTCGACCCCGGTGGCGTTGATGCCCTCGCAGTAGAA 
CAGCTCTGCAGCCGCCTTCAAGATACGCTGACGAGCGCCGCGGCCCCCGCGCCTGGGGGGTTCCGTTGT 
Rv3173c<--------- 1
TCTGGTGACCGGCGGCATAGTGCTGAGTATACCGACCTGTTTACAACACCCCTTAGCGCGTGTACCGTC
I >Rv3174
AAAGCACAAAGTACACCAATCGGTTTACTGTAGGAGGTCTCATGACTTCACTAGCCGAGCGGACCGTGC
TCGTCACCGGCGCCAACCGCGG
Clone 226
Size o f cloned M.tuberculosis H37Rv DNA: 261bp
Nucleotides o f M.tuberculosis H37Rv genome cloned: 2925356bp-2925616bp M.tuberculosis genome base pair before lacZ in pUS1800: 2925356bp
Restriction site used to digest genomic M.tuberculosis H37Rv DNA for cloning in to pUS1800: Hpall
CCGGCTCAATCTCGATGCGCCCATCGCGCTCGGTGATCTCCACCTGGTCGTTCCCGCGCAAGCCAAGGC
Rv2595<--------- 1
GCTCGCGAATCCGCTTGGGAATCACCAGACGTCCTGCGACATCGATGGTTGTTCGCATGGTAGGAAATT
TACCATCGCACGTTCCATAGGCGTGTCCTGCGCGGGATGTCGGGACGATCCGCTAGCGTATCGAACGAT
I ►Rv2594c
TGTTCGGAAATGGCTGAGGGAGCGTGCGGTGCGGGTGATGGGTGTCGATCCCGG
Clone 229
Size o f cloned M.tuberculosis H37Rv DNA: 341bp
Nucleotides o f M.tuberculosis H37Rv genome cloned: 3439365bp-3439705bp M.tuberculosis genome base pair before lacZ in pUS1800: 3439705bp
Restriction site used to digest genomic M.tuberculosis H37Rv DNA for cloning in to pUS1800: Hpall
CCGGCCGATCCTGTAGGCGCGGTGACGGTGGTCACCTTGACCAGCACGATCGAAATCGGCGGCAACCCG
CTGGCGCGTCTGGCCGAACTTGTCGTCGGCCGCGCCATGGCCAAGCGGTCCAACACGATGCTCGCCGGG
Rv307 6-------- >|
I ►Rv3077
CTGGCACAACGATTGGAGGACAAACATGGCTAACCGTCCCGACATCATCATCGTGATGACCGACGAGGA
ACGTGCGGTGCCGCCGTACGAGTCGGCCGAGGTGCTCGCCTGGCGTCAACGCAGCTTGACCGGCCGCCG
TTGGTTCGACGAGCACGGGATCAGTTTCACTCGGCACTACACCGG
214
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Clone 230
Size o f cloned M.tuberculosis H37Rv DNA: 238bp
Nucleotides o f M.tuberculosis H37Rv genome cloned: 4398121 bp-4398358bp M.tuberculosis genome base pair before lacZ in pUS1800: 439812lbp
Restriction site used to digest genomic M.tuberculosis H37Rv DNA for cloning in to pUS1800: Acil 
Internal to Rv3910
GCGGGCAGCGTCGGTTCGCTGCTGCGGCTGTCGGTGCTGGCTCTCATCATGCTGCCAATTCTGGCTGCG
GTCACCCTCTGCGCACGGGTGCCCGAGGCGCGGGCGGCGCTGGATGCCGTGCGAGCCCGAATCAGGAGC
CGGCGCTTGAAGACCGGGCCTCAGACCCAGAATGTCTTGGATCAATCGTCTCGCCCCGGACCGGTCACG
TACCCTGAGCGGAGGCGTTTGGCCCCGCCGC
Clone 233
Size o f  cloned M.tuberculosis H37Rv DNA: 165bp
Nucleotides o f M.tuberculosis H37Rv genome cloned: 1446292bp-1446456bp M.tuberculosis genome base pair before lacZ in pUS1800: 1446292bp
Restriction site used to digest genomic M.tuberculosis H37Rv DNA for cloning in to pUS1800: Acil
GCGGAGGCATCGAGGCCGCGCTCGGCCAGCACCGCGGCCGCGGTCGCTTTGAGCAGCTCAGCCAGGTCA
<---------1 R v l292
Clone 234
Size o f cloned M.tuberculosis H37Rv DNA: 78 lbp
Nucleotides o f  M.tuberculosis H37Rv genome cloned: 3233754bp-3234534bp M.tuberculosis genome base pair before lacZ in pUSl 800: 3233754bp
Restriction site used to digest genomic M.tuberculosis H37Rv DNA for cloning in to pUSl 800: Acil
CCGCCCGCCGGGCAAGAAGATTACCCGACTGTCTTTGCTCTCCGGTGGCGAGAAGGCGCTGACCGCGGT
GGCGATGCTGGTCGCGATCTTTCGTGCCCGTCCATCGCCGTTCTACATCATGGACGAGGTGGAGGCCGC
CCTCGACGACGTGAACCTGCGCCGACTGCTCAGCCTGTTCGAACAGCTGCGAGAGCAGTCGCAGATCAT
CATCATCACCCACCAGAAGCCGACGATGGAGGTCGCGGACGCACTGTACGGCGTAACCATGCAGAACGA
Rv2922<--------
CGGCATCACCGCGGTCATCTCGCAGCGCATGCGCGGTCAGCAGGTGGATCAGCTGGTTACCAATTCCTC
I I------- >Rv2921c
GTAGGGTTCGTCCCTAAGCATCGGGGCAAGCGACCCCTGGAAGGATTGTCAGCGTGTGGGAAGGTTTGT
GGATCGCCACGGCGGTCATCGCCGCCCTGGTCGTCATCGCTGCGCTGACCCTGGGGCTGGTGCTCTACC
GTCGGCGGCGCATCAGTCTGTCGCCTCGGCCCGAGCGCGGCGTTGTCGACCGCTCAGGCGGTTACACCG
CATCGTCTGGCATCACGTTTAGTCAGACGCCGACGACCCAGCCGGCCGAGCGGATCGATACGAGCGGAC
TGCCCGCCGTGGGCGACGATGCGACCGTCCCTCGCGACGCGCCCAAGCGCACGATCGCCGACGTACACC
TTCCCGAGTTTGAGCCAGAACCCCAGGCTCCAGAGGTCCCCGAGGCTGACGCCATCGCGCCGCCCGAAG
GTCGATTGGAACGACTGCGCGG
Clone 239
Size o f  cloned M.tuberculosis H37Rv DNA: 253bp
Nucleotides o f M.tuberculosis H37Rv genome cloned: 1413241 bp-1413493bp M.tuberculosis genome base pair before lacZ in pUSl 800: 1413493bp
Restriction site used to digest genomic M.tuberculosis H37Rv DNA for cloning in to pUS1800: Taql
I >R vl265
TCGAATGGCTGATCACAATGGTTCTCGCCAGGCCGGACGCTGTTTTCGCGCCGGCCAGGAACCGGTGTC
ACGTTTCGCTGCCGGTGAACGCGATGTCATTAAAGATGAAAGTATGTAATCATGTAATTATGAGGCACC
ATCACATGCACGGGCGGCGCTACGGTCGCCCCGGCGGCTGGCAGCAAGCTCAGCAACCAGATGCCAGTG
GGGCGGCGGAATGGTTCGCTGGCCGCCTGCCCGAGGACTGGTTCGA
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Clone 247
Size o f  cloned M.tuberculosis H37Rv DNA: 643bp
Nucleotides of M.tuberculosis H37Rv genome cloned: 3209562bp-3210204bp M.tuberculosis genome base pair before lacZ in pUS1800: 3209562bp
Restriction site used to digest genomic M.tuberculosis H37Rv DNA for cloning in to pUS1800: Hpall 
Internal to Rv2900c
CCGCAGCCACCTTGTCCACGGCGCCACCGCGCTGATCCTGCCGACGCTGGGTCGGACCGATCGCGATAC
CCGCAATGGTCGCAAACAATTGGTGTCGGTTGAGGATTCGATGTCGATGGTGCATCTGTCGCGTGGTAG
CCTGCACCCGCCCAGCGATCAGGTGCGCAGCGAGGTGCAGATCATCTGCCAGCTGGCCCGCGCCTTGTT
CGGCCCCGGACATCCGGTGCCATGGGAACGGTTCGCAGATGACTACGACACCATCCGTGACGCCATCGC
CGCGGTGGTGCCCGGCTGTGACGACTACAACCACAAGGTGCGTGTGCCCGACGGATTCCAATTGCCGCA
CCCGCCGCGCGATGCGCGCGAATTCCGTACCAGCACAGGCAAAGCTAACTTCGCGGTCAATCCGTTGCA
GTGGGTGCCGGTGCCGCCCGGCCGGCTGGTGCTACAGACCCTACGCAGCCATGACCAGTACAACACCAC
GATCTACGGGCTCGACGACCGATATCGCGGCGTGAAGGGCGGACGCCGGGTGGTGTTCATCAACCCGGC
CGACATCGAAACGTTCGGTTTGACGGCGGGTGACCGTGTCGACCTGGTGTCGGAGTGGACCGACGGCCA
AGGCGGTCTGCAAGAACGGCGG
Clone 252
Size o f  cloned M.tuberculosis H37Rv DNA: 390bp
Nucleotides o f M.tuberculosis H37Rv genome cloned: 638179bp-638568bpM.tuberculosis genome base pair before lacZ in pUS1800: 638179bp
Restriction site used to digest genomic M.tuberculosis H37Rv DNA for cloning in to pUS1800: Acil 
Internal to Rv0547c
GCGGGATCGACATCCTGATCAACAATGCCGGCCGGTCGATCCGGCGGCCGCTGGCCGAGTCGCTGGAAC
GCTGGCACGACGTCGAGCGCACCATGGTGCTCAACTACTATGCCCCGCTGCGGCTTATCCGCGGGCTTG
CACCCGGGATGCTCGAGCGTGGCGACGGCCATATCATCAATGTCGCCACCTGGGGCGTGTTGTCGGAGG
CTTCGCCGCTGTTCTCGGTGTACAACGCATCGAAGGCCGCACTGTCGGCGGTGAGCCGGATCATCGAAA
CCGAGTGGGGTAGTCAGGGCGTGCATTCGACGACGCTGTACTACCCGCTGGTGGCAACTCCGATGATTG
CGCCGACGAAGGCCTACGACGGGCTGCCGGCGCTGACCGCCGCGG
Clone 254
Size o f  cloned MJuberculosis H37Rv DNA: 662bp
Nucleotides o f MJuberculosis H37Rv genome cloned: 213879bp-214540bpM.tuberculosis genome base pair before lacZ in pUS1800: 214540bp
Restriction site used to digest genomic MJuberculosis H37Rv DNA for cloning in to pUS1800: Acil
RvO 18 3 |----- »
CCGCGTCGTGCAGCGAGCCAGTCATGCGATAGCAGTGTGCGAGCAGTTCACGCCGGTAGGGCTCGGTGT
GGGCGGAGAAGTCCCCGCGCCGTTCGTCGGCGGGCTCGCGGCCAGAGTTTTCTGCGAGCACACTCACGT
CAATGAGCCTACGCAGAGTCTCCGACACTCTCACCGGAGCAGCCGTTACGCTCCCGGTAATGACTACCA
Rv0182c<---------1
CCCGGACTGAACGGAATTTCGCGGGCATCGGCGATGTGCGCATCGTCTACGACGTCTGGACGCCGGACA
CCGCGCCGCAAGCGGTGGTCGTGCTGGCCCATGGTCTGGGCGAGCATGCCCGCCGCTACGACCATGTCG
CGCAGCGGCTCGGCGCGGCCGGCCTGGTCACCTATGCGCTTGACCACCGCGGGCATGGCCGCTCGGGTG
GCAAACGGGTGCTAGTGAGAGACATCTCCGAGTACACCGCTGACTTCGACACCCTCGTTGGGATCGCCA
CCCGGGAATATCCCGGGTGCAAGCGCATCGTGCTCGGGCACAGCATGGGCGGCGGCATTGTGTTCGCTT
ACGGTGTCGAACGTCCAGACAACTACGACCTGATGGTGCTTTCGGCGCCGGCGGTGGCGGCACAGGACC
TGGTGAGCCCGGTAGTGGCGG
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Clone 277
Size o f cloned M.tuberculosis H37Rv DNA: 261bp
Nucleotides o f  M.tuberculosis H37Rv genome cloned: 2623709bp-2623969bp M.tuberculosis genome base pair before lacZ in pUSl 800: 2623969bp
Restriction site used to digest genomic M.tuberculosis H37Rv DNA for cloning in to pUS1800: Acil
Rv2 334 c<---------1
I ►Rv234 5
CGCACGCCCGTATCCGCCGGCACAGCGTCTAAATTGACGGTATGCGTCTCGTTCGCCTGCTCGGCATGG
TCCTGACTATCCTCGCCGCCGGGCTGCTGCTGGGGCCGCCCGCTGGCGCGCAACCACCTTTCCGGCTGT
CGAACTACGTGACCGACAACGCGGGCGTGCTGACTAGCTCCGGTCGCACCGCGG
Clone 278
Size o f cloned M.tuberculosis H37Rv DNA: 303bp
Nucleotides o f M.tuberculosis H37Rv genome cloned: 528230bp-528532bpM.tuberculosis genome base pair before lacZ in pUS1800: 528532bp
Restriction site used to digest genomic M.tuberculosis H37Rv DNA for cloning in to pUS1800: Hpall
CCGGTGACCACAACGACGCGCCCGCTTTGATCGGGGACGTCTGCGGCCGACCATTTACGGGTCTTGTTG 
Rv0439c<--------- 1
TCGTTGGCGGTCATGGGCCGAACATACTCACCCGGATCGGAGGGCCGAGGACACGGTCGAACGAGGGGC 
ATGACCCGGTGCGGGGCTTCTTGCACTCGGCATAGGCGAGTGCTAAGAATAACGTTGGCACTCGCGACC 
GGTGAGTGCTAGGTCGGGACGGTGAGGCCAGGCCCGTCGTCGCAGCGAGTGGCAGCGAGGACAACTTGA 
GCCGTCCGTCGCGGGCACTGCGCCCGG 74bp to start o f Rv0440
Clone 279
Size o f  cloned M.tuberculosis H37Rv DNA: 316bp
Nucleotides o f M.tuberculosis H37Rv genome cloned: 1833418bp-1833733bp M.tuberculosis genome base pair before lacZ in pUS1800: 1833733bp
Restriction site used to digest genomic M.tuberculosis H37Rv DNA for cloning in to pUS1800: Acil 
CCGCCCTGAGTTCACGCTCGGCGCAATCGGGACCGAGTTTGTCCAGCGTGTACCCGTCGAGTAGCCTCG
I >Rvl630
TCAGGTACCAATCTGTCCCTACGACCCAACCCTGTCCGGAGCAACCCAACAATATGCCGAGTCCCACCG
TCACCTCGCCGCAAGTAGCCGTCAACGACATAGGCTCTAGCGAGGACTTTCTCGCCGCAATAGACAAAA
CGATCAAGTACTTCAACGATGGCGACATCGTCGAAGGCACCATCGTCAAAGTGGACCGGGACGAGGTGC
TCCTCGACATCGGCTACAAGACCGAAGGCGTGATCCCCGC
Clone 281
Size o f  cloned M.tuberculosis H37Rv DNA: 295bp
Nucleotides o f M.tuberculosis H37Rv genome cloned: 1871235bp-1871529bp M.tuberculosis genome base pair before lacZ in pUS1800: 1871529bp
Restriction site used to digest genomic M.tuberculosis H37Rv DNA for cloning in to pUS1800: Acil
CCGCGCGGCCCTGCCCCAGGTCGTCGGCACCATCGCCGGTGATGACACCATCCTGGTGGTGGCCCGCGA
R v l6 5 7  >| |--------->Rvl 658
GTCATCCTGGCCTATTCCGGCGGTCTGGACACCTCGGTGGCGATCAGCTGGATAGGCAAGGAGACCGGC
CGTGAGGTGGTGGCGGTGGCGATCGACCTCGGGCAGGGCGGCGAGCACATGGACGTCATACGGCAGCGG
GCGCTGGACTGCGGCGCGG
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Clone 282
Size o f cloned M.tuberculosis H37Rv DNA: 233bp
Nucleotides o f M.tuberculosis H37Rv genome cloned: 4046042bp-4046274bp M.tuberculosis genome base pair before lacZ in pUS1800: 4046042bp
Restriction site used to digest genomic M.tuberculosis H37Rv DNA for cloning in to pUS1800: Acil
CCGCCCGATTGCCGCCGGCAACCGACACTGTTGGTGTAGTGACCAAATCAGCAGTGCCCCGGGTGGGTC
TTGACGTGCAAATCGACTACAGTCTTGGTGACCGTCCGGTACCCGGGCATGGGACTGGAACGAACCAAG
I »R v3603c
AAACCTGTGAGGCCGTCTGCTATGGAGCGGTTCGACGGTTTGCGTCCGGCCAGGCTCAAGGTGGGGATC
ATCTCGGCTGGCCGGGTCGGCACCGC
Clone 289
Size o f  cloned M.tuberculosis H37Rv DNA: 196bp
Nucleotides o f M.tuberculosis H37Rv genome cloned: 2698200bp-2698395bp M.tuberculosis genome base pair before lacZ in pUS1800: 2698395bp
Restriction site used to digest genomic M.tuberculosis H37Rv DNA for cloning in to pUS1800: Taql 
Intergenic to Rv2401 and Rv2402
TCGACTTGCTCGGCGTCCACTTCACGCCCGGCGCCCGGCGTAGTTGGGTGCGTGCTCAGGTGGGCCTAG 
CAGCCGTGTGCCGTGTCGCGGTTTGGCGTCGGCGGTCACCGTAATCGCGACACACCTGGGGTTTTGCCT 
GCCGGCGCTATAGTGTGGGCCCGATGAACGGGTTCCTGAGTTGGTGGGACGGCGTCGA 132bp t o  
s t a r t  o f  Rv2402
Clone 290
Size o f cloned M.tuberculosis H37Rv DNA: 252bp
Nucleotides o f M.tuberculosis H37Rv genome cloned: 1288947bp-1289198bp M.tuberculosis genome base pair before lacZ in pUS1800: 1288947bp
Restriction site used to digest genomic M.tuberculosis H37Rv DNA for cloning in to pUSl 800: Acil 
Internal to Rvl 161
CCGCGCCGTAGCCGTCGTAGCGCCATTGGTCGGTGTGCGCATACCAGTACGACGCGCCGGGCACCTGAC
GCGGCGGCCGCGACCAGTCGGTGGCCATCGCCATCGTCTGCCACCCGGTCAACGGACGCACCTTCTCCT
GGCCGACGTAGTGCGCCCACCCGCCGCCGTTGCGTCCCATCGATCCGGTCAACATGAGCAGCGCCAACA
CCGAGCGGTACATGACATCGCTGTGGAACCAGTGACAGATTCCGC
Clone 291
Size o f  cloned M.tuberculosis H37Rv DNA: 303bp
Nucleotides o f  M.tuberculosis H37Rv genome cloned: 528230bp-528532bpM.tuberculosis genome base pair before lacZ in pUSl 800: 528532bp
Restriction site used to digest genomic M.tuberculosis H37Rv DNA for cloning in to pUS1800: Hpall
CCGGTGACCACAACGACGCGCCCGCTTTGATCGGGGACGTCTGCGGCCGACCATTTACGGGTCTTGTTG 
Rv0439c<--------- 1
TCGTTGGCGGTCATGGGCCGAACATACTCACCCGGATCGGAGGGCCGAGGACACGGTCGAACGAGGGGC 
ATGACCCGGTGCGGGGCTTCTTGCACTCGGCATAGGCGAGTGCTAAGAATAACGTTGGCACTCGCGACC 
GGTGAGTGCTAGGTCGGGACGGTGAGGCCAGGCCCGTCGTCGCAGCGAGTGGCAGCGAGGACAACTTGA 
GCCGTCCGTCGCGGGCACTGCGCCCGG 74bp to start of Rv0440
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Clone 292
Size o f cloned M.tuberculosis H37Rv DNA: 494bp
Nucleotides o f M.tuberculosis H37Rv genome cloned: 417058bp-417551bpM.tuberculosis genome base pair before lacZ in pUS1800: 41755 lbp
Restriction site used to digest genomic M.tuberculosis H37Rv DNA for cloning in to pUS1800: Acil 
CCGCTTGGCAACCAATCGGAAACAATCGATCGGTCAACGGTGCTTTGTTGTCGTGCCGACCGTCGCGGG 
TGGCCGCGTTGACAGTCGATATTGCGGTCACAGGCTGACGCGCCTGGCCAGCCAGACGCTCGCGAAGTG 
CGGGTCCGTCCTGGCCGCGAGGGTGTCGTAGCCGCGGTCGTAGTGTGAGACTCCGACACCTGATCCGCC
|-------- »Rv034 7
AGCGCAGAGATGTGAGATCAACGGACGGAAGGCGACGGTGCCCGGCGCGCGCGAGTTGACGCTGCGCGT
CGAGCGCGGGGCTCTATTTCGGCGTCGATGGGCAGCATCGGCAGCGTCATCAGCTCGCGCAGCAATTCG
TCGTGATCCGCGGCGCTGCGCGCTGGGTACCCGGCCTCGATGGGTATCATTTTTGGTTATCGTTCTGGT
TATCATGAATGTTGTGACGGCCCATCCCAAGTACCCGAATGACCCTCTTGCGCTGGTATTGATTGAACT
GCGCCATCCGC
Clone 293
Size o f cloned M.tuberculosis H37Rv DNA: 214bp
Nucleotides o f M.tuberculosis H37Rv genome cloned: 1901144bp-1901357bp M.tuberculosis genome base pair before lacZ in pUS1800: 1901357bp
Restriction site used to digest genomic M.tuberculosis H37Rv DNA for cloning in to pUS1800: Acil 
Internal to Rvl676
GCGGAGTTTTGCCATCGGTATGGTATTGGGGTGCCTACTCGATTGGCCCGCGGTGCGACCGTGCCGACT
CGCCGTCTGCAGGACATCAACGATCAACCGGTGGACGTCCCGGCTGCGACCGGAAGGACACACCTGCAG
TTTCGGCGGTTCGCGGCCTGTCCGATCTGCCACCTGCACCTGCGCAGCTTCGCCAACCGGCACCAAGAG
GTTGCGG
Clone 295
Size o f cloned M.tuberculosis H37Rv DNA: 485bp
Nucleotides o f M.tuberculosis H37Rv genome cloned: 3279691bp-3280175bp M.tuberculosis genome base pair before lacZ in pUS1800: 327969lbp
Restriction site used to digest genomic M.tuberculosis H37Rv DNA for cloning in to pUS1800: Acil 
Internal to Rv2940c
CCGCGCGGGCGCCGCTTTGGACTATTCGGCGCTGTATCCCGCTGGGCGGCTGGTGGATGCGCCGCTGCC
GGCGTGGACCCACGCCCGCCTATTCATCGACGATGATGGGCAAGAACAGCGGGCACAAGGTGCCTGCAC
CATCACCGTGCATCCGTTGCTTGGCTCGCATGTGCGGCTGACTGAGGAACCTGAGCGCCACGTCTGGCA
GGGCGACGTTGGCACCTCGGTGCTGTCCTGGCTCAGCGATCATCAGGTGCATAACGTTGCCGCCCTTCC
CGGCGCCGCCTACTGCGAGATGGCTTTGGCTGCGGCCGCTGAGGTCTTCGGCGAAGCGGCTGAGGTTCG
CGACATCACCTTTGAGCAGATGTTGTTGCTCGACGAGCAGACCCCGATCGACGCCGTCGCATCGATCGA
CGCGCCTGGTGTCGTCAACTTCACCGTGGAGACCAACCGGGACGGTGAAACCACCCGGCATGCCACCGC
GG
Clone 296
Size o f cloned M.tuberculosis H37Rv DNA: 284bp
Nucleotides o f M.tuberculosis H37Rv genome cloned: 1541494bp-1541777bp M.tuberculosis genome base pair before lacZ in pUS1800: 1541777bp
Restriction site used to digest genomic M.tuberculosis H37Rv DNA for cloning in to pUSl 800: Hpall 
Internal to Rvl368
CCGGGGGCTGGGCGCGGTCGTCGGGCAAGTGCAAAACCCGACAATCCAGGGACGTGACGCCATCGACGG
CCTGGCCACCGTCAAGGTGTCCGGGACCATCGACGCCGCGGTGATCGATCCGATCGTGCCTCAGCTAGG
TAAGGGTGGGGGCAGGCTCCCGATAACCTTGTGGATCGTCGACACCAACGCCTCAACGCCGGCACCCGC
CGCGAACCTGGTGCGGATGGTCATTGACAAGGACCAAGGCAACGTCGACATCACGCTGTCCAATTGGGG
TGCGCCGG
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Clone 302
Size o f cloned M.tuberculosis H37R.V DNA: 346bp
Nucleotides o f  M.tuberculosis H37Rv genome cloned: 2100809bp-2101154bp M. tuberculosis genome base pair before lacZ in pUS1800: 2100809bp
Restriction site used to digest genomic M.tuberculosis H37Rv DNA for cloning in to pUS1800: Hpall 
CCGGATTCTCATGGTGTCACCGCCCAGCGGGGTCGCGGCCGCCGACACCAGGTGCACCGTGTCGGGCGC
R v l8 5 2 < ----------- 1
GGTTCGGCGTGCCTGGACACCGCCCCGACAGTCGATGCGCGGCAACCGATTCGGCGACGCGACCACjGAG 
U R v l 8 53
^ agagtI ga ctccatcgg cg gccag ttga ctacgaaccca ggccacgacatcgctgg ca gctgggtcct
CGGTCAACGATTGCAGCACCGTCGGGCGGCCGTCGCGCACCGCGTCCGCATCGCGGGCCATCACCGCCA
GGTCGGCGCCCACCAATGCAGCCAGGTCAGTCTTGTTGACTACCAACAAATCCGAATAGGTCACCCCCG
G
Clone 303
Size o f cloned M.tuberculosis H37Rv DNA: 326bp
Nucleotides of M.tuberculosis H37Rv genome cloned: 4306285bp-4306610bp M.tuberculosis genome base pair before lacZ in pUS1800:4306285bp
Restriction site used to digest genomic M.tuberculosis H37Rv DNA for cloning in to pUS1800: Taql 
Internal to Rv2832c
TCGATGGTCGAGCGCCTGAACCGCCGCTACGGCCAGCGGGCGCGCATCATCCGCGGCGATGGCACCCAG
ACCGGGCTGCCCGATGATCACTTCACGTCCGTGGTGTGTTTCACGATGCTGCACCATGTTGCCAGCGCC
CAACTGCAGGACCAGCTATTCGCTGAGGCGTACCGGGTGCTGCAACCAGGTGGCGTCTTTGCCGGCAGC
GACGGTGTGCCGTCGCTGCCGTTTCGCCTAATACACATCGCCGACACCTACACTCCGATCGCCCCGGCG
GACCTCCCCGGTCGGCTGCGAGCTGTGGGATTCACTGATATCCACGTCGA
Clone 305
Size o f  cloned M.tuberculosis H37Rv DNA: 252bp
Nucleotides o f  M.tuberculosis H37Rv genome cloned: 3423885bp-3424136bp M.tuberculosis genome base pair before lacZ in pUS1800: 3423885bp
Restriction site used to digest genomic M.tuberculosis H37Rv DNA for cloning in to pUS1800: Hpall 
Internal to Rv3061c
CCGGGTGGGTGATCTTGACGCTGATTCAGCACGGAACGCCTTGGCAGATTGAAAGATTCGTCGAGAAAG
CGCTGCGCCAGCAGGAGATATGGTGCCAACTGTTCTCCGAACCTGACGCGGGGTCTGACGCGGCCTCGG
TCAAGACCCGCGCAACTCGGGTGGAGGGCGGCTGGAAGATCAACGGGCAAAAGGTGTGGACCAGCGGAG
CGCAGTACTGCGCGCGTGGCCTGGCTACCGTGCGTACCGATCCGG
Clone 311
Size o f cloned M.tuberculosis H37Rv DNA: 326bp
Nucleotides o f  M.tuberculosis H37Rv genome cloned: 4306285bp-4306610bp M.tuberculosis genome base pair before lacZ in pUS1800: 4306285bp
Restriction site used to digest genomic M.tuberculosis H37Rv DNA for cloning in to pUS1800: Taql 
Internal to Rv3832c
TCGATGGTCGAGCGCCTGAACCGCCGCTACGGCCAGCGGGCGCGCATCATCCGCGGCGATGGCACCCAG
ACCGGGCTGCCCGATGATCACTTCACGTCCGTGGTGTGTTTCACGATGCTGCACCATGTTGCCAGCGCC
CAACTGCAGGACCAGCTATTCGCTGAGGCGTACCGGGTGCTGCAACCAGGTGGCGTCTTTGCCGGCAGC
GACGGTGTGCCGTCGCTGCCGTTTCGCCTAATACACATCGCCGACACCTACACTCCGATCGCCCCGGCG
GACCTCCCCGGTCGGCTGCGAGCTGTGGGATTCACTGATATCCACGTCGA
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Clone 320
Size o f cloned M.tuberculosis H37Rv DNA: 230bp
Nucleotides o f M.tuberculosis H37Rv genome cloned: 549556bp-549785bp M.tuberculosis genome base pair before lacZ in pUS1800: 549556bp
Restriction site used to digest genomic M.tuberculosis H37Rv DNA for cloning in to pUS1800: Taql
TCGAAGTAGCGCCCATGGACCGGCGCGACCCACTGGCCCCCGATGAAGTTTTGGTACCGGGATTCATAG
Rv04 58<---------1
GACATCAGCGCCCCGGCGGAACCGGGACGGGAAAAGACAGTCATCGTATTCGGCTCCTCGTCAAAATCA
I ►Rv0457c
TGTAATACAGCTCACACTACCGCCGGGGCCACAATGGCTTCCATGACATTTGAGCCTGCCCCAGACGGC
GCTGACCCCTACCTATGGCTCGA
Clone 323
Size o f  cloned M.tuberculosis H37Rv DNA: 449bp
Nucleotides o f M.tuberculosis H37Rv genome cloned: 601327bp-601775bpM.tuberculosis genome base pair before lacZ in pUS1800: 601327bp
Restriction site used to digest genomic M.tuberculosis H37Rv DNA for cloning in to pUS1800: Acil 
Internal to Rv0509
CCGCTTGGCACCACCGGTAATTCACCTGCAGTGGCGACGGCATCGACGGCGGTCTGGTCAAGCTCGAAG
AGTTCGCGCAGCGCCTCGGCGTAGCTGTCACCGCCGGGCGCACTGGCGAGCTGCTTGATCCGCACGGTA
GGCGCGTGCAACAGCTTGTCCACGACTCGCCGTACGGTGCGGGCCACCTCCTCGCGCTGGACACTCTGC
AGGCCGGGCAGCCGGTTGTCCAGGCGCAGCAATTCCGCTTCGACCACTTCGGCGGCTCGCTGGCGCAAC
GCCGTCACGGTTGGGGTGACCTCGGCCATCCGCTGCCCCACCAGATAGCTGGCAACTTCGGCGGCGACG
ATGTGGCGGGCGGCCTCAACGTCGGCAGCCGCGGCATGTGCCGAGGGTTCATGTTGCACGCTATCCACG
TCCACGACCCACACACACGGTAATCTGGCCACCGC
Clone 325
Size o f cloned M.tuberculosis H37Rv DNA: 503bp
Nucleotides o f M.tuberculosis H37Rv genome cloned: 1235973bp-1236475bp M.tuberculosis genome base pair before lacZ in pUS1800: 1235973bp
Restriction site used to digest genomic M.tuberculosis H37Rv DNA for cloning in to pUS1800: Acil
CCGCCTGGCTGGCCAGGGTCATTGGGTACATCAGGATGGTTCGTGGCAGCTTCATCGTCTCCTCAACGG
R v ll0 9 c «  1
CGACTGTCGCCGCGCCGACCAATAGCCGAACCCCATACGGTGCAGTAGCCATGGATCCAAGACTGCCTC
AAGCAGCGGCTAACTCCAAGCCGGTGGCCGTGAGCTGGCGGGTTCGTGTCGGCCCAAAGTACCCTGAAT
|  > R v ll 10
GCCATGGTTCCGACGGTCGACATGGGGATTCCCGGGGCTTCGGTATCGTCGCGATCGGTGGCCGACCGT
CCCAACCGTAAGCGGGTGCTGCTGGCCGAGCCGCGTGGCTACTGCGCTGGCGTGGATCGGGCCGTCGAA
ACGGTCGAACGCGCGCTTCAAAAACACGGCCCGCCTGTCTACGTGCGTCACGAGATCGTGCATAACCGC
CACGTGGTTGACACCCTGGCTAAGGCCGGTGCGGTTTTCGTCGAAGAGACCGAGCAGGTTCCCGAGGGA
GCGATTGTGGTGTTCTCCGC
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Appendix 5: Sequence Data
Clone 330
Size o f  cloned M.tuberculosis H37Rv DNA: 597bp
Nucleotides o f M.tuberculosis H37Rv genome cloned: 2614036bp-2614632bp M.tuberculosis genome base pair before lacZ in pUS1800: 2614632bp
Restriction site used to digest genomic M.tuberculosis H37Rv DNA for cloning in to pUSl 800: Acil
R v 2 3 3 8 c < ------------1  ^    ^ ......
CCGCACCGGCTGGCATCGCATCATCCTCCCACGACGGGCCGCTCATCAGCTTGGGCCATTTCAATGTAC 
TTGATACCCCGCGCTGCGGGTAGGCCACTGCGACGATTCAAACACGGTGTCACACGGTGAATAGTGTCG 
AGATGGGCTCTGATCAACCGTCGCAAACCCGGTTTCGCATCGATAGCGGAATCGCACCGGGTTGCATGG 
AGGCTGCTGACCTTGGAAAACAAGATGTATTCATTACGACAAAACAAGCGCCGCGGAAACTTTGCACGC 
TCGAGCATTCCGCCGCGGCTCACGCACATCCTGGCCGCCTTCCCGCAACCGTCCCCCGGAATTACTGAT 
CAAACCCTGGGTTTACCAACTTCCGGGCATGGGGCGAAGGTCGACAGCCAGAACATGGCCGTGCGTGAT 
ATGGGCATTCACGGGACGGAGCCGCTAAGGAGACCGGTACGATTCAATCTCCATATGAGCGGTGCGGCG 
GCTGTTGTCAGGTACGTTGAACACCGGTGGCGATCGGGTGCCGGCAGGTTGGTCTTCTCCTGTGATGCG 
AGCGCGCCTCCGCGCCAACCACCGC 5 9bp to start of Rv2339
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